https://www.caf-dcf.be/litterature/reduced-thrombotic-risk-with-recombinant-factor-viia-in-neonatal-cardiac-surgery/ 2026-05-12T08:11:50+01:00 https://www.caf-dcf.be/fr/litterature/reduced-thrombotic-risk-with-recombinant-factor-viia-in-neonatal-cardiac-surgery/ 2026-05-12T08:11:08+01:00 https://www.caf-dcf.be/litterature/almost-three-decades-of-post-marketing-experience-with-a-human-intravenous-immunoglobulin-5-analysis-of-a-propriety-pharmacovigilance-database/ 2026-05-12T08:08:28+01:00 https://www.caf-dcf.be/fr/litterature/almost-three-decades-of-post-marketing-experience-with-a-human-intravenous-immunoglobulin-5-analysis-of-a-propriety-pharmacovigilance-database/ 2026-05-12T08:08:27+01:00 https://www.caf-dcf.be/fr/litterature/current-status-of-clinical-gene-therapy-for-hemophilia-and-globin-disorders/ 2026-05-11T15:46:43+01:00 https://www.caf-dcf.be/litterature/current-status-of-clinical-gene-therapy-for-hemophilia-and-globin-disorders/ 2026-05-11T15:46:43+01:00 https://www.caf-dcf.be/litterature/treatment-outcomes-safety-and-characteristics-of-immune-tolerance-induction-in-patients-with-hemophilia-b-and-inhibitors-a-systematic-review/ 2026-05-11T15:45:19+01:00 https://www.caf-dcf.be/fr/litterature/treatment-outcomes-safety-and-characteristics-of-immune-tolerance-induction-in-patients-with-hemophilia-b-and-inhibitors-a-systematic-review/ 2026-05-11T15:45:18+01:00 https://www.caf-dcf.be/litterature/factor-ii-and-factor-v-deficiencies-current-management-care-gaps-and-call-to-action-for-therapeutic-advances/ 2026-05-11T15:43:07+01:00 https://www.caf-dcf.be/fr/litterature/factor-ii-and-factor-v-deficiencies-current-management-care-gaps-and-call-to-action-for-therapeutic-advances/ 2026-05-11T15:43:06+01:00 https://www.caf-dcf.be/fr/litterature/surgery-in-people-with-mild-haemophilia/ 2026-05-11T15:41:22+01:00 https://www.caf-dcf.be/litterature/surgery-in-people-with-mild-haemophilia/ 2026-05-11T15:41:22+01:00 https://www.caf-dcf.be/fr/litterature/implementing-shared-decision-making-in-haemophilia-care-best-practice-recommendations-from-a-western-european-multi-stakeholder-delphi-process/ 2026-05-11T15:39:25+01:00 https://www.caf-dcf.be/litterature/implementing-shared-decision-making-in-haemophilia-care-best-practice-recommendations-from-a-western-european-multi-stakeholder-delphi-process/ 2026-05-11T15:39:25+01:00 https://www.caf-dcf.be/litterature/acquired-hemostasis-disorders/ 2026-05-11T15:36:54+01:00 https://www.caf-dcf.be/fr/litterature/acquired-hemostasis-disorders/ 2026-05-11T15:36:53+01:00 https://www.caf-dcf.be/fr/litterature/beyond-a-century-of-discovery-the-global-and-persistent-burden-of-underdiagnosis-in-von-willebrand-disease/ 2026-05-11T15:35:12+01:00 https://www.caf-dcf.be/litterature/beyond-a-century-of-discovery-the-global-and-persistent-burden-of-underdiagnosis-in-von-willebrand-disease/ 2026-05-11T15:35:12+01:00 https://www.caf-dcf.be/litterature/ageing-with-haemophilia-comorbidities-in-focus/ 2026-05-11T15:31:04+01:00 https://www.caf-dcf.be/fr/litterature/ageing-with-haemophilia-comorbidities-in-focus/ 2026-05-11T15:31:03+01:00 https://www.caf-dcf.be/fr/litterature/delphi-consensus-recommendations-for-the-definition-of-a-severe-bleeding-phenotype-and-initiation-of-prophylaxis-in-patients-with-non-severe-haemophilia/ 2026-05-11T15:28:41+01:00 https://www.caf-dcf.be/litterature/delphi-consensus-recommendations-for-the-definition-of-a-severe-bleeding-phenotype-and-initiation-of-prophylaxis-in-patients-with-non-severe-haemophilia/ 2026-05-11T15:28:41+01:00 https://www.caf-dcf.be/fr/litterature/100-years-of-von-willebrand-disease-the-journey-to-contemporary-diagnostic-pathways-an-illustrative-case-based-narrative-review/ 2026-05-11T15:14:51+01:00 https://www.caf-dcf.be/litterature/100-years-of-von-willebrand-disease-the-journey-to-contemporary-diagnostic-pathways-an-illustrative-case-based-narrative-review/ 2026-05-11T15:14:51+01:00 https://www.caf-dcf.be/fr/litterature/an-analysis-of-attitudes-toward-gene-therapy-in-people-with-severe-hemophilia-in-germany-a-survey-based-cross-sectional-study/ 2026-05-11T15:12:58+01:00 https://www.caf-dcf.be/litterature/an-analysis-of-attitudes-toward-gene-therapy-in-people-with-severe-hemophilia-in-germany-a-survey-based-cross-sectional-study/ 2026-05-11T15:12:58+01:00 https://www.caf-dcf.be/litterature/immune-response-mechanisms-in-haemophilia-a/ 2026-05-11T15:10:51+01:00 https://www.caf-dcf.be/fr/litterature/immune-response-mechanisms-in-haemophilia-a/ 2026-05-11T15:10:50+01:00 https://www.caf-dcf.be/litterature/evaluation-of-fibrinogen-concentrate-for-hemostasis-during-thoracic-aortic-surgery-complete-republication/ 2026-04-02T15:33:17+01:00 https://www.caf-dcf.be/fr/litterature/evaluation-of-fibrinogen-concentrate-for-hemostasis-during-thoracic-aortic-surgery-complete-republication/ 2026-04-02T15:32:51+01:00 https://www.caf-dcf.be/litterature/hyperfibrinolysis-and-reduced-functional-fibrinogen-in-haemorrhagic-caesarean-delivery-a-secondary-analysis-of-the-traces-trial-evaluating-fibrinogen-kinetics-following-fibrinogen-concentrate-or-plas/ 2026-04-02T15:30:26+01:00 https://www.caf-dcf.be/fr/litterature/hyperfibrinolysis-and-reduced-functional-fibrinogen-in-haemorrhagic-caesarean-delivery-a-secondary-analysis-of-the-traces-trial-evaluating-fibrinogen-kinetics-following-fibrinogen-concentrate-or-plas/ 2026-04-02T15:29:52+01:00 https://www.caf-dcf.be/fr/litterature/characteristics-of-adverse-events-and-clinical-risks-of-intravenous-immunoglobulin-a-pharmacovigilance-study-based-on-fda-adverse-event-reporting-system-faers/ 2026-04-02T15:27:28+01:00 https://www.caf-dcf.be/fr/litterature/adverse-reactions-to-intravenous-immunoglobulin-in-primary-immunodeficiency-a-retrospective-analysis/ 2026-04-02T15:23:25+01:00 https://www.caf-dcf.be/fr/litterature/health-related-quality-of-life-in-adults-with-von-willebrand-disease-results-of-the-french-real-life-willebrand-study-on-health-related-quality-of-life/ 2026-04-02T15:21:47+01:00 https://www.caf-dcf.be/fr/litterature/gene-therapy-of-haemophilia-current-status-and-future-directions/ 2026-04-02T15:19:59+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-factor-at-the-crossroads-of-hemostasis-and-inflammation/ 2026-04-02T15:18:25+01:00 https://www.caf-dcf.be/fr/litterature/challenges-in-balancing-hemostasis-and-thrombosis-in-therapy-tailoring-for-hemophilia-a-narrative-review/ 2026-04-02T15:16:33+01:00 https://www.caf-dcf.be/fr/litterature/factor-xiii-deficiency-a-review-of-biology-testing-and-treatment/ 2026-04-02T15:14:35+01:00 https://www.caf-dcf.be/fr/litterature/biology-of-von-willebrand-disease/ 2026-04-02T15:12:53+01:00 https://www.caf-dcf.be/fr/litterature/country-level-prediction-of-blood-type-distribution-in-hemophilia-a-in-support-of-factor-viii-consumption/ 2026-04-02T15:11:08+01:00 https://www.caf-dcf.be/fr/litterature/nine-areas-with-outstanding-challenges-for-hemophilia-b-research/ 2026-04-02T15:08:46+01:00 https://www.caf-dcf.be/litterature/reduced-thrombotic-risk-with-recombinant-factor-viia-in-neonatal-cardiac-surgery/ 2026-03-12T08:09:56+01:00 https://www.caf-dcf.be/litterature/reduced-thrombotic-risk-with-recombinant-factor-viia-in-neonatal-cardiac-surgery/ 2026-03-12T08:09:56+01:00 https://www.caf-dcf.be/litterature/almost-three-decades-of-post-marketing-experience-with-a-human-intravenous-immunoglobulin-5-analysis-of-a-propriety-pharmacovigilance-database/ 2026-03-12T07:33:35+01:00 https://www.caf-dcf.be/litterature/treatment-outcomes-safety-and-characteristics-of-immune-tolerance-induction-in-patients-with-hemophilia-b-and-inhibitors-a-systematic-review/ 2026-03-11T15:43:27+01:00 https://www.caf-dcf.be/litterature/treatment-outcomes-safety-and-characteristics-of-immune-tolerance-induction-in-patients-with-hemophilia-b-and-inhibitors-a-systematic-review/ 2026-03-11T15:43:27+01:00 https://www.caf-dcf.be/litterature/treatment-outcomes-safety-and-characteristics-of-immune-tolerance-induction-in-patients-with-hemophilia-b-and-inhibitors-a-systematic-review/ 2026-03-11T15:43:27+01:00 https://www.caf-dcf.be/litterature/treatment-outcomes-safety-and-characteristics-of-immune-tolerance-induction-in-patients-with-hemophilia-b-and-inhibitors-a-systematic-review/ 2026-03-11T15:43:27+01:00 https://www.caf-dcf.be/litterature/treatment-outcomes-safety-and-characteristics-of-immune-tolerance-induction-in-patients-with-hemophilia-b-and-inhibitors-a-systematic-review/ 2026-03-11T15:43:27+01:00 https://www.caf-dcf.be/litterature/acquired-hemostasis-disorders/ 2026-03-11T15:35:35+01:00 https://www.caf-dcf.be/litterature/beyond-a-century-of-discovery-the-global-and-persistent-burden-of-underdiagnosis-in-von-willebrand-disease/ 2026-03-11T15:33:38+01:00 https://www.caf-dcf.be/litterature/beyond-a-century-of-discovery-the-global-and-persistent-burden-of-underdiagnosis-in-von-willebrand-disease/ 2026-03-11T15:33:38+01:00 https://www.caf-dcf.be/litterature/delphi-consensus-recommendations-for-the-definition-of-a-severe-bleeding-phenotype-and-initiation-of-prophylaxis-in-patients-with-non-severe-haemophilia/ 2026-03-11T15:15:15+01:00 https://www.caf-dcf.be/litterature/an-analysis-of-attitudes-toward-gene-therapy-in-people-with-severe-hemophilia-in-germany-a-survey-based-cross-sectional-study/ 2026-03-11T15:11:13+01:00 https://www.caf-dcf.be/litterature/immune-response-mechanisms-in-haemophilia-a/ 2026-03-11T14:57:49+01:00 https://www.caf-dcf.be/litterature/immune-response-mechanisms-in-haemophilia-a/ 2026-03-11T14:57:49+01:00 https://www.caf-dcf.be/litterature/immune-response-mechanisms-in-haemophilia-a/ 2026-03-11T14:57:49+01:00 https://www.caf-dcf.be/litterature/immune-response-mechanisms-in-haemophilia-a/ 2026-03-11T14:57:49+01:00 https://www.caf-dcf.be/litterature/fibrinogen-replacement-during-postpartum-hemorrhage-comparing-plasma-cryoprecipitate-and-fibrinogen-concentrate/ 2026-02-25T16:22:51+01:00 https://www.caf-dcf.be/fr/litterature/fibrinogen-replacement-during-postpartum-hemorrhage-comparing-plasma-cryoprecipitate-and-fibrinogen-concentrate/ 2026-02-25T16:22:26+01:00 https://www.caf-dcf.be/fr/litterature/viral-clearance-in-biopharmaceutical-manufacturing-current-strategies-challenges-and-future-directions/ 2026-02-25T16:20:22+01:00 https://www.caf-dcf.be/litterature/viral-clearance-in-biopharmaceutical-manufacturing-current-strategies-challenges-and-future-directions/ 2026-02-25T16:20:22+01:00 https://www.caf-dcf.be/fr/litterature/efficacy-of-intravenous-immunoglobulin-in-patients-with-chronic-inflammatory-demyelinating-polyneuropathy-with-or-without-diabetes-insights-from-a-multicenter-prospective-comparative-study/ 2026-02-25T16:18:24+01:00 https://www.caf-dcf.be/litterature/efficacy-of-intravenous-immunoglobulin-in-patients-with-chronic-inflammatory-demyelinating-polyneuropathy-with-or-without-diabetes-insights-from-a-multicenter-prospective-comparative-study/ 2026-02-25T16:18:24+01:00 https://www.caf-dcf.be/litterature/iga-and-igm-enriched-immunoglobulins-in-primary-immunodeficiencies-a-pilot-study/ 2026-02-25T16:15:20+01:00 https://www.caf-dcf.be/fr/litterature/iga-and-igm-enriched-immunoglobulins-in-primary-immunodeficiencies-a-pilot-study/ 2026-02-25T16:15:19+01:00 https://www.caf-dcf.be/fr/litterature/historical-current-and-future-treatments-for-von-willebrand-disease/ 2026-02-25T16:13:21+01:00 https://www.caf-dcf.be/litterature/historical-current-and-future-treatments-for-von-willebrand-disease/ 2026-02-25T16:13:21+01:00 https://www.caf-dcf.be/fr/litterature/thrombin-generation-profiling-in-rare-coagulation-factor-deficiencies-associations-with-bleeding-severity-and-potential-for-screening/ 2026-02-25T16:11:14+01:00 https://www.caf-dcf.be/litterature/thrombin-generation-profiling-in-rare-coagulation-factor-deficiencies-associations-with-bleeding-severity-and-potential-for-screening/ 2026-02-25T16:11:14+01:00 https://www.caf-dcf.be/litterature/hmb-002-a-monovalent-antibody-that-elevates-circulating-vwf-and-fviii-levels-for-treatment-of-von-willebrand-disease/ 2026-02-25T16:09:18+01:00 https://www.caf-dcf.be/fr/litterature/hmb-002-a-monovalent-antibody-that-elevates-circulating-vwf-and-fviii-levels-for-treatment-of-von-willebrand-disease/ 2026-02-25T16:09:17+01:00 https://www.caf-dcf.be/fr/litterature/the-landmark-contribution-by-erik-von-willebrand/ 2026-02-25T16:04:42+01:00 https://www.caf-dcf.be/litterature/the-landmark-contribution-by-erik-von-willebrand/ 2026-02-25T16:04:42+01:00 https://www.caf-dcf.be/fr/litterature/clinical-and-laboratory-diagnosis-of-von-willebrand-disease/ 2026-02-25T16:02:38+01:00 https://www.caf-dcf.be/litterature/clinical-and-laboratory-diagnosis-of-von-willebrand-disease/ 2026-02-25T16:02:38+01:00 https://www.caf-dcf.be/litterature/molecular-genetic-testing-in-von-willebrand-disease-past-present-and-beyond/ 2026-02-25T16:00:57+01:00 https://www.caf-dcf.be/fr/litterature/molecular-genetic-testing-in-von-willebrand-disease-past-present-and-beyond/ 2026-02-25T16:00:56+01:00 https://www.caf-dcf.be/fr/litterature/updated-global-prevalence-and-ethnic-diversity-of-von-willebrand-disease-based-on-population-genetics-analysis/ 2026-02-25T15:59:14+01:00 https://www.caf-dcf.be/litterature/updated-global-prevalence-and-ethnic-diversity-of-von-willebrand-disease-based-on-population-genetics-analysis/ 2026-02-25T15:59:14+01:00 https://www.caf-dcf.be/fr/litterature/long-term-experience-with-acquired-haemophilia-a-a-40-year-single-centre-study-of-clinical-features-and-outcome/ 2026-02-25T15:56:49+01:00 https://www.caf-dcf.be/litterature/long-term-experience-with-acquired-haemophilia-a-a-40-year-single-centre-study-of-clinical-features-and-outcome/ 2026-02-25T15:56:49+01:00 https://www.caf-dcf.be/litterature/comparative-safety-of-drug-therapies-used-in-hemophilia-a-and-b-in-canada-a-multi-center-retrospective-study/ 2026-02-25T15:53:40+01:00 https://www.caf-dcf.be/fr/litterature/comparative-safety-of-drug-therapies-used-in-hemophilia-a-and-b-in-canada-a-multi-center-retrospective-study/ 2026-02-25T15:53:39+01:00 https://www.caf-dcf.be/litterature/factor-vii-deficiency-is-more-prevalent-than-previously-reported/ 2026-02-25T15:51:49+01:00 https://www.caf-dcf.be/fr/litterature/factor-vii-deficiency-is-more-prevalent-than-previously-reported/ 2026-02-25T15:51:48+01:00 https://www.caf-dcf.be/litterature/structure-and-multiple-functions-of-von-willebrand-factor/ 2026-02-25T15:49:57+01:00 https://www.caf-dcf.be/fr/litterature/structure-and-multiple-functions-of-von-willebrand-factor/ 2026-02-25T15:49:56+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-disease-classification-and-epidemiology/ 2026-02-25T15:47:59+01:00 https://www.caf-dcf.be/litterature/von-willebrand-disease-classification-and-epidemiology/ 2026-02-25T15:47:59+01:00 https://www.caf-dcf.be/fr/litterature/identifying-the-silent-deficiency-severe-factor-xi-deficiency-in-an-asymptomatic-patient-with-isolated-prolonged-activated-partial-thromboplastin-time-a-case-report/ 2026-02-25T15:43:19+01:00 https://www.caf-dcf.be/litterature/identifying-the-silent-deficiency-severe-factor-xi-deficiency-in-an-asymptomatic-patient-with-isolated-prolonged-activated-partial-thromboplastin-time-a-case-report/ 2026-02-25T15:43:19+01:00 https://www.caf-dcf.be/litterature/adverse-reactions-to-intravenous-immunoglobulin-in-primary-immunodeficiency-a-retrospective-analysis/ 2026-02-02T15:22:22+01:00 https://www.caf-dcf.be/litterature/health-related-quality-of-life-in-adults-with-von-willebrand-disease-results-of-the-french-real-life-willebrand-study-on-health-related-quality-of-life/ 2026-02-02T15:20:39+01:00 https://www.caf-dcf.be/litterature/gene-therapy-of-haemophilia-current-status-and-future-directions/ 2026-02-02T15:19:00+01:00 https://www.caf-dcf.be/litterature/von-willebrand-factor-at-the-crossroads-of-hemostasis-and-inflammation/ 2026-02-02T15:17:13+01:00 https://www.caf-dcf.be/litterature/challenges-in-balancing-hemostasis-and-thrombosis-in-therapy-tailoring-for-hemophilia-a-narrative-review/ 2026-02-02T15:15:14+01:00 https://www.caf-dcf.be/litterature/factor-xiii-deficiency-a-review-of-biology-testing-and-treatment/ 2026-02-02T15:13:34+01:00 https://www.caf-dcf.be/litterature/biology-of-von-willebrand-disease/ 2026-02-02T15:11:44+01:00 https://www.caf-dcf.be/litterature/country-level-prediction-of-blood-type-distribution-in-hemophilia-a-in-support-of-factor-viii-consumption/ 2026-02-02T15:10:04+01:00 https://www.caf-dcf.be/litterature/nine-areas-with-outstanding-challenges-for-hemophilia-b-research/ 2026-02-02T15:07:06+01:00 https://www.caf-dcf.be/litterature/international-practices-in-managing-preconception-pregnancy-and-childbirth-in-women-with-glanzmann-thrombasthenia-a-survey-from-the-european-association-of-haemophilia-and-allied-disorders-eahad/ 2026-01-27T15:52:58+01:00 https://www.caf-dcf.be/fr/litterature/international-practices-in-managing-preconception-pregnancy-and-childbirth-in-women-with-glanzmann-thrombasthenia-a-survey-from-the-european-association-of-haemophilia-and-allied-disorders-eahad/ 2026-01-27T15:52:42+01:00 https://www.caf-dcf.be/litterature/compliance-with-esaic-guidelines-for-fibrinogen-concentrate-prescription-in-cardiac-surgery-a-multicentre-french-cohort-study/ 2026-01-27T15:51:01+01:00 https://www.caf-dcf.be/fr/litterature/compliance-with-esaic-guidelines-for-fibrinogen-concentrate-prescription-in-cardiac-surgery-a-multicentre-french-cohort-study/ 2026-01-27T15:50:39+01:00 https://www.caf-dcf.be/litterature/optimizing-surgical-approaches-for-patients-with-inherited-factor-vii-deficiency/ 2026-01-27T14:25:46+01:00 https://www.caf-dcf.be/fr/litterature/optimizing-surgical-approaches-for-patients-with-inherited-factor-vii-deficiency/ 2026-01-27T14:25:33+01:00 https://www.caf-dcf.be/fr/litterature/obstetrical-use-of-intravenous-immunoglobulin-a-single-centre-retrospective-study/ 2026-01-27T14:23:16+01:00 https://www.caf-dcf.be/fr/litterature/advances-in-von-willebrand-disease/ 2026-01-27T14:21:58+01:00 https://www.caf-dcf.be/litterature/advances-in-von-willebrand-disease/ 2026-01-27T14:21:58+01:00 https://www.caf-dcf.be/litterature/real-world-experience-with-use-of-coagulation-factor-viia-at-an-academic-medical-center/ 2026-01-27T14:20:20+01:00 https://www.caf-dcf.be/fr/litterature/real-world-experience-with-use-of-coagulation-factor-viia-at-an-academic-medical-center/ 2026-01-27T14:19:49+01:00 https://www.caf-dcf.be/fr/litterature/real-world-experience-with-eptacog-beta-for-on-label-and-off-label-indications-the-spanish-experience/ 2026-01-27T14:05:34+01:00 https://www.caf-dcf.be/fr/litterature/historical-review-more-than-two-decades-understanding-the-genetic-architecture-of-hemostasis-and-thrombosis/ 2026-01-27T14:03:59+01:00 https://www.caf-dcf.be/fr/litterature/new-therapies-in-hemophilia-extend-the-half-life-mimic-or-rebalance/ 2026-01-27T14:02:08+01:00 https://www.caf-dcf.be/fr/litterature/allele-selective-disruption-of-pathogenic-vwf-variants-in-type-2-von-willebrand-disease-using-crispr-cas9/ 2026-01-27T14:00:41+01:00 https://www.caf-dcf.be/fr/litterature/deep-molecular-modeling-and-mechanistic-insights-into-type-2a-von-willebrand-disease-with-von-willebrand-factor-a2-domain-mutations/ 2026-01-27T13:59:10+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-disease-combined-with-other-hemostasis-disorders-an-overlooked-clinical-entity/ 2026-01-27T13:57:31+01:00 https://www.caf-dcf.be/fr/litterature/advancing-care-for-women-and-girls-with-haemophilia-evidence-from-a-comprehensive-longitudinal-analysis/ 2026-01-27T13:55:39+01:00 https://www.caf-dcf.be/litterature/the-aging-hemophilia-patient/ 2026-01-27T13:53:25+01:00 https://www.caf-dcf.be/fr/litterature/the-aging-hemophilia-patient/ 2026-01-27T13:53:24+01:00 https://www.caf-dcf.be/fr/litterature/health-related-quality-of-life-in-adult-patients-with-von-willebrand-disease-from-germany-results-of-the-wil-qol-study/ 2026-01-27T13:52:42+01:00 https://www.caf-dcf.be/litterature/health-related-quality-of-life-in-adult-patients-with-von-willebrand-disease-from-germany-results-of-the-wil-qol-study/ 2026-01-27T13:52:42+01:00 https://www.caf-dcf.be/fr/litterature/current-gynaecological-management-of-women-and-girls-with-bleeding-disorders-in-the-united-kingdom-a-ukhcdo-haemophilia-treatment-centre-survey-and-evaluation-of-real-world-clinical-practice-for-the/ 2026-01-27T13:48:31+01:00 https://www.caf-dcf.be/litterature/comparative-efficacy-and-safety-of-prothrombin-complex-concentrate-versus-fresh-frozen-plasma-in-cardiac-surgery-a-meta-analysis-of-randomized-controlled-trials/ 2026-01-27T13:40:33+01:00 https://www.caf-dcf.be/litterature/plasma-fibrinogen-level-and-severe-bleeding-in-cardiac-surgery-an-observational-post-hoc-study-of-the-albics-trial/ 2026-01-27T13:40:11+01:00 https://www.caf-dcf.be/fr/litterature/a-retrospective-review-of-diagnosis-and-management-of-heavy-menstrual-bleeding-and-co-morbidities-in-patients-seen-in-young-womens-blood-clinic/ 2026-01-27T13:37:34+01:00 https://www.caf-dcf.be/litterature/a-retrospective-review-of-diagnosis-and-management-of-heavy-menstrual-bleeding-and-co-morbidities-in-patients-seen-in-young-womens-blood-clinic/ 2026-01-27T13:37:34+01:00 https://www.caf-dcf.be/litterature/clinical-obstetric-gynaecological-and-hrqol-data-of-female-vwd-patients-in-the-wil-qol-study/ 2026-01-27T13:37:13+01:00 https://www.caf-dcf.be/fr/litterature/clinical-obstetric-gynaecological-and-hrqol-data-of-female-vwd-patients-in-the-wil-qol-study/ 2026-01-27T13:37:12+01:00 https://www.caf-dcf.be/litterature/overview-on-rare-congenital-bleeding-disorders-and-epidemiological-data-from-the-german-haemophilia-registry-dhr-and-a-survey-in-germany-austria-and-switzerland-2/ 2026-01-27T13:36:54+01:00 https://www.caf-dcf.be/fr/litterature/overview-on-rare-congenital-bleeding-disorders-and-epidemiological-data-from-the-german-haemophilia-registry-dhr-and-a-survey-in-germany-austria-and-switzerland-2/ 2026-01-27T13:36:53+01:00 https://www.caf-dcf.be/fr/litterature/transformative-approaches-in-hemophilia-management-from-traditional-therapies-to-prenatal-stem-cell-treatment/ 2026-01-27T13:36:36+01:00 https://www.caf-dcf.be/litterature/transformative-approaches-in-hemophilia-management-from-traditional-therapies-to-prenatal-stem-cell-treatment/ 2026-01-27T13:36:36+01:00 https://www.caf-dcf.be/fr/litterature/the-landscape-of-rare-coagulation-factor-deficiency-management-in-italy-a-national-hemophilia-center-survey/ 2026-01-27T13:36:19+01:00 https://www.caf-dcf.be/litterature/the-landscape-of-rare-coagulation-factor-deficiency-management-in-italy-a-national-hemophilia-center-survey/ 2026-01-27T13:36:19+01:00 https://www.caf-dcf.be/fr/litterature/factor-ixa-and-factor-x-influence-factor-viiia-stability-and-inactivation-mechanisms-in-vitro-and-in-vivo/ 2026-01-27T13:36:02+01:00 https://www.caf-dcf.be/litterature/factor-ixa-and-factor-x-influence-factor-viiia-stability-and-inactivation-mechanisms-in-vitro-and-in-vivo/ 2026-01-27T13:36:02+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-factor-and-von-willebrand-disease-in-ageing-mechanisms-evolving-phenotypes-and-clinical-implications/ 2026-01-27T13:35:45+01:00 https://www.caf-dcf.be/litterature/von-willebrand-factor-and-von-willebrand-disease-in-ageing-mechanisms-evolving-phenotypes-and-clinical-implications/ 2026-01-27T13:35:45+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-disease-diagnosis-from-complexity-to-simplicity/ 2026-01-27T13:35:27+01:00 https://www.caf-dcf.be/litterature/von-willebrand-disease-diagnosis-from-complexity-to-simplicity/ 2026-01-27T13:35:27+01:00 https://www.caf-dcf.be/litterature/how-close-are-we-to-achieving-durable-and-efficacious-gene-therapy-for-hemophilia-a-and-b/ 2026-01-27T13:35:09+01:00 https://www.caf-dcf.be/fr/litterature/how-close-are-we-to-achieving-durable-and-efficacious-gene-therapy-for-hemophilia-a-and-b/ 2026-01-27T13:35:08+01:00 https://www.caf-dcf.be/fr/litterature/diagnosing-thrombophilia-the-case-for-genetic-or-functional-testing/ 2026-01-27T13:34:51+01:00 https://www.caf-dcf.be/litterature/diagnosing-thrombophilia-the-case-for-genetic-or-functional-testing/ 2026-01-27T13:34:51+01:00 https://www.caf-dcf.be/litterature/treatment-of-von-willebrand-disease/ 2026-01-27T13:34:34+01:00 https://www.caf-dcf.be/fr/litterature/treatment-of-von-willebrand-disease/ 2026-01-27T13:34:33+01:00 https://www.caf-dcf.be/litterature/infusion-related-reactions-with-human-polyclonal-immunoglobulins-analysis-from-the-french-national-pharmacovigilance-database/ 2026-01-27T13:34:18+01:00 https://www.caf-dcf.be/fr/litterature/infusion-related-reactions-with-human-polyclonal-immunoglobulins-analysis-from-the-french-national-pharmacovigilance-database/ 2026-01-27T13:34:17+01:00 https://www.caf-dcf.be/fr/litterature/comparative-efficacy-and-safety-of-prothrombin-complex-concentrate-versus-fresh-frozen-plasma-in-cardiac-surgery-a-meta-analysis-of-randomized-controlled-trials/ 2026-01-27T13:33:59+01:00 https://www.caf-dcf.be/fr/litterature/plasma-fibrinogen-level-and-severe-bleeding-in-cardiac-surgery-an-observational-post-hoc-study-of-the-albics-trial/ 2026-01-27T13:20:52+01:00 https://www.caf-dcf.be/fr/litterature/haemophilia-b-an-illustrative-review-of-current-challenges-and-opportunities/ 2026-01-27T13:19:36+01:00 https://www.caf-dcf.be/litterature/compatibility-and-stability-of-reconstituted-fibrinogen-concentrate-clottafact-fibclot-with-codan-infusion-set/ 2026-01-09T11:25:01+01:00 https://www.caf-dcf.be/fr/litterature/compatibility-and-stability-of-reconstituted-fibrinogen-concentrate-clottafact-fibclot-with-codan-infusion-set/ 2026-01-09T11:24:40+01:00 https://www.caf-dcf.be/litterature/characteristics-associated-with-mortality-in-623-patients-who-received-recombinant-factor-viia-for-bleeding-in-cardiac-surgery/ 2026-01-09T11:15:13+01:00 https://www.caf-dcf.be/fr/litterature/characteristics-associated-with-mortality-in-623-patients-who-received-recombinant-factor-viia-for-bleeding-in-cardiac-surgery/ 2026-01-09T11:14:50+01:00 https://www.caf-dcf.be/litterature/survey-of-cryoprecipitate-production-and-cryoprecipitate-and-fibrinogen-concentrate-utilization-in-north-america-variable-practices-observed-from-july-2016-to-june-2021-the-best-collaborative-study/ 2026-01-09T11:11:13+01:00 https://www.caf-dcf.be/fr/litterature/survey-of-cryoprecipitate-production-and-cryoprecipitate-and-fibrinogen-concentrate-utilization-in-north-america-variable-practices-observed-from-july-2016-to-june-2021-the-best-collaborative-study/ 2026-01-09T11:10:49+01:00 https://www.caf-dcf.be/litterature/fibrinogen-in-resuscitation-of-older-adult-trauma-patients-are-they-too-old-to-receive-new-adjuncts/ 2026-01-09T11:07:37+01:00 https://www.caf-dcf.be/fr/litterature/fibrinogen-in-resuscitation-of-older-adult-trauma-patients-are-they-too-old-to-receive-new-adjuncts/ 2026-01-09T11:07:10+01:00 https://www.caf-dcf.be/litterature/the-impact-of-prothrombin-complex-concentrate-versus-fresh-frozen-plasma-for-hemorrhage-management-in-cardiac-surgery-a-systematic-review-and-meta-analysis-of-randomized-clinical-trials/ 2026-01-09T11:02:47+01:00 https://www.caf-dcf.be/fr/litterature/the-impact-of-prothrombin-complex-concentrate-versus-fresh-frozen-plasma-for-hemorrhage-management-in-cardiac-surgery-a-systematic-review-and-meta-analysis-of-randomized-clinical-trials/ 2026-01-09T11:01:48+01:00 https://www.caf-dcf.be/litterature/immunological-complications-of-blood-transfusion-current-insights-and-advances/ 2026-01-09T10:59:48+01:00 https://www.caf-dcf.be/fr/litterature/immunological-complications-of-blood-transfusion-current-insights-and-advances/ 2026-01-09T10:58:29+01:00 https://www.caf-dcf.be/fr/litterature/polyvalent-human-immunoglobulins-between-essential-indications-and-uses-to-be-avoided-2025-update-of-the-prescription-priorization-proposed-by-the-french-national-agency-for-medicines-and-health-pro/ 2026-01-09T10:55:04+01:00 https://www.caf-dcf.be/fr/litterature/characterization-of-thromboembolic-events-after-recombinant-coagulation-factor-viia-rfviia-novoseven-use-in-cardiac-surgery-a-descriptive-pilot-study/ 2026-01-09T10:47:18+01:00 https://www.caf-dcf.be/fr/litterature/management-of-von-willebrand-disease-with-a-factor-viii-poor-von-willebrand-factor-concentrate-results-from-the-paediatric-cohort-of-a-prospective-observational-post-marketing-study/ 2026-01-09T10:44:16+01:00 https://www.caf-dcf.be/fr/litterature/rewriting-the-script-gene-therapy-and-genome-editing-for-von-willebrand-disease/ 2026-01-09T10:41:46+01:00 https://www.caf-dcf.be/fr/litterature/the-effectiveness-and-safety-of-various-treatments-for-hemophilia-in-china-a-literature-review-and-evidence-mapping/ 2026-01-09T10:39:46+01:00 https://www.caf-dcf.be/fr/litterature/how-to-start-prophylaxis-in-untreated-children-with-severe-and-moderate-haemophilia-in-2025-opinion-of-paediatricians-from-the-french-society-of-thrombosis-and-haemostasis/ 2026-01-09T10:37:43+01:00 https://www.caf-dcf.be/litterature/prevalence-and-impact-of-heavy-menstrual-bleeding-in-women-with-von-willebrand-disease-across-age-groups-a-retrospective-study/ 2026-01-09T09:51:59+01:00 https://www.caf-dcf.be/fr/litterature/prevalence-and-impact-of-heavy-menstrual-bleeding-in-women-with-von-willebrand-disease-across-age-groups-a-retrospective-study/ 2026-01-09T09:51:58+01:00 https://www.caf-dcf.be/fr/litterature/overview-on-rare-congenital-bleeding-disorders-and-epidemiological-data-from-the-german-haemophilia-registry-dhr-and-a-survey-in-germany-austria-and-switzerland/ 2026-01-09T09:49:39+01:00 https://www.caf-dcf.be/fr/litterature/how-genetic-advances-are-being-translated-into-improved-diagnostic-outcomes-for-patients-with-inherited-bleeding-disorders/ 2026-01-09T09:47:37+01:00 https://www.caf-dcf.be/litterature/lifetime-economic-burden-of-hemophilia-using-nationwide-real-world-healthcare-data/ 2026-01-09T09:45:08+01:00 https://www.caf-dcf.be/fr/litterature/lifetime-economic-burden-of-hemophilia-using-nationwide-real-world-healthcare-data/ 2026-01-09T09:42:36+01:00 https://www.caf-dcf.be/litterature/obstetrical-use-of-intravenous-immunoglobulin-a-single-centre-retrospective-study/ 2025-12-27T14:22:20+01:00 https://www.caf-dcf.be/litterature/real-world-experience-with-eptacog-beta-for-on-label-and-off-label-indications-the-spanish-experience/ 2025-12-27T14:04:28+01:00 https://www.caf-dcf.be/litterature/real-world-experience-with-eptacog-beta-for-on-label-and-off-label-indications-the-spanish-experience/ 2025-12-27T14:04:28+01:00 https://www.caf-dcf.be/litterature/historical-review-more-than-two-decades-understanding-the-genetic-architecture-of-hemostasis-and-thrombosis/ 2025-12-27T14:02:38+01:00 https://www.caf-dcf.be/litterature/new-therapies-in-hemophilia-extend-the-half-life-mimic-or-rebalance/ 2025-12-27T14:01:13+01:00 https://www.caf-dcf.be/litterature/allele-selective-disruption-of-pathogenic-vwf-variants-in-type-2-von-willebrand-disease-using-crispr-cas9/ 2025-12-27T13:59:38+01:00 https://www.caf-dcf.be/litterature/deep-molecular-modeling-and-mechanistic-insights-into-type-2a-von-willebrand-disease-with-von-willebrand-factor-a2-domain-mutations/ 2025-12-27T13:58:02+01:00 https://www.caf-dcf.be/litterature/von-willebrand-disease-combined-with-other-hemostasis-disorders-an-overlooked-clinical-entity/ 2025-12-27T13:56:09+01:00 https://www.caf-dcf.be/litterature/advancing-care-for-women-and-girls-with-haemophilia-evidence-from-a-comprehensive-longitudinal-analysis/ 2025-12-27T13:54:00+01:00 https://www.caf-dcf.be/litterature/current-gynaecological-management-of-women-and-girls-with-bleeding-disorders-in-the-united-kingdom-a-ukhcdo-haemophilia-treatment-centre-survey-and-evaluation-of-real-world-clinical-practice-for-the/ 2025-12-27T13:41:06+01:00 https://www.caf-dcf.be/litterature/haemophilia-b-an-illustrative-review-of-current-challenges-and-opportunities/ 2025-12-27T11:55:49+01:00 https://www.caf-dcf.be/litterature/dose-dependent-changes-in-clot-firmness-in-thromboelastometry-after-administration-of-fibrinogen-concentrate-a-retrospective-observational-study/ 2025-10-23T12:58:24+01:00 https://www.caf-dcf.be/fr/litterature/dose-dependent-changes-in-clot-firmness-in-thromboelastometry-after-administration-of-fibrinogen-concentrate-a-retrospective-observational-study/ 2025-10-23T12:58:09+01:00 https://www.caf-dcf.be/litterature/genetic-mutations-associated-with-congenital-fibrinogen-disorders-global-distribution-and-clinical-outcomes/ 2025-10-23T12:50:50+01:00 https://www.caf-dcf.be/fr/litterature/genetic-mutations-associated-with-congenital-fibrinogen-disorders-global-distribution-and-clinical-outcomes/ 2025-10-23T12:50:36+01:00 https://www.caf-dcf.be/litterature/association-of-fibrinogen-and-rotem-parameters-with-age-and-race-in-a-diverse-pediatric-population-a-single-center-study/ 2025-10-23T12:48:43+01:00 https://www.caf-dcf.be/fr/litterature/association-of-fibrinogen-and-rotem-parameters-with-age-and-race-in-a-diverse-pediatric-population-a-single-center-study/ 2025-10-23T12:48:30+01:00 https://www.caf-dcf.be/litterature/congenital-fibrinogen-deficiencies-not-so-rare/ 2025-10-23T12:46:21+01:00 https://www.caf-dcf.be/fr/litterature/congenital-fibrinogen-deficiencies-not-so-rare/ 2025-10-23T12:46:05+01:00 https://www.caf-dcf.be/litterature/the-new-era-of-primary-immune-thrombocytopenia-management-in-adults-a-narrative-review-of-current-and-emerging-treatments/ 2025-10-23T12:44:08+01:00 https://www.caf-dcf.be/fr/litterature/the-new-era-of-primary-immune-thrombocytopenia-management-in-adults-a-narrative-review-of-current-and-emerging-treatments/ 2025-10-23T12:44:07+01:00 https://www.caf-dcf.be/fr/litterature/the-critical-need-to-consolidate-all-gene-therapy-data-in-haemophilia/ 2025-10-23T12:41:38+01:00 https://www.caf-dcf.be/litterature/the-critical-need-to-consolidate-all-gene-therapy-data-in-haemophilia/ 2025-10-23T12:41:38+01:00 https://www.caf-dcf.be/fr/litterature/inhibitor-development-and-clinical-characteristics-in-children-with-severe-hemophilia-a-in-the-athn-8-us-cohort-study/ 2025-10-23T12:38:52+01:00 https://www.caf-dcf.be/litterature/inhibitor-development-and-clinical-characteristics-in-children-with-severe-hemophilia-a-in-the-athn-8-us-cohort-study/ 2025-10-23T12:38:52+01:00 https://www.caf-dcf.be/fr/litterature/navigating-the-transition-from-adolescence-to-adulthood-among-young-people-with-severe-haemophilia-the-qualitative-phase-of-the-transhemo-project/ 2025-10-23T12:03:50+01:00 https://www.caf-dcf.be/litterature/navigating-the-transition-from-adolescence-to-adulthood-among-young-people-with-severe-haemophilia-the-qualitative-phase-of-the-transhemo-project/ 2025-10-23T12:03:50+01:00 https://www.caf-dcf.be/litterature/transamniotic-delivery-of-coagulation-factor-viii-mrna-a-step-toward-a-potential-novel-strategy-for-the-perinatal-management-of-hemophilia-a/ 2025-10-23T12:01:47+01:00 https://www.caf-dcf.be/fr/litterature/transamniotic-delivery-of-coagulation-factor-viii-mrna-a-step-toward-a-potential-novel-strategy-for-the-perinatal-management-of-hemophilia-a/ 2025-10-23T12:01:46+01:00 https://www.caf-dcf.be/litterature/european-management-of-glanzmanns-thrombasthenia-a-survey-of-current-clinical-practice/ 2025-10-23T11:59:21+01:00 https://www.caf-dcf.be/fr/litterature/european-management-of-glanzmanns-thrombasthenia-a-survey-of-current-clinical-practice/ 2025-10-23T11:59:20+01:00 https://www.caf-dcf.be/fr/litterature/regulation-of-immune-cell-metabolism-by-therapeutic-normal-igg-intravenous-immunoglobulin/ 2025-10-17T10:44:40+01:00 https://www.caf-dcf.be/litterature/regulation-of-immune-cell-metabolism-by-therapeutic-normal-igg-intravenous-immunoglobulin/ 2025-10-17T10:44:40+01:00 https://www.caf-dcf.be/litterature/brazilian-academy-of-neurology-recommendations-for-diagnosis-management-and-treatment-of-chronic-inflammatory-demyelinating-polyradiculoneuropathy-cidp/ 2025-10-17T10:42:03+01:00 https://www.caf-dcf.be/fr/litterature/brazilian-academy-of-neurology-recommendations-for-diagnosis-management-and-treatment-of-chronic-inflammatory-demyelinating-polyradiculoneuropathy-cidp/ 2025-10-17T10:42:02+01:00 https://www.caf-dcf.be/fr/litterature/expanding-the-mosaic-functions-of-intravenous-immunoglobulin/ 2025-10-17T10:39:55+01:00 https://www.caf-dcf.be/litterature/expanding-the-mosaic-functions-of-intravenous-immunoglobulin/ 2025-10-17T10:39:55+01:00 https://www.caf-dcf.be/litterature/efficacy-and-safety-of-recombinant-activated-factor-vii-in-glanzmann-thrombasthenia-a-systematic-literature-review/ 2025-10-17T10:37:34+01:00 https://www.caf-dcf.be/fr/litterature/efficacy-and-safety-of-recombinant-activated-factor-vii-in-glanzmann-thrombasthenia-a-systematic-literature-review/ 2025-10-17T10:37:33+01:00 https://www.caf-dcf.be/fr/litterature/treatment-of-severe-bleeds-with-eptacog-beta-in-hemophilia-a-or-b-with-inhibitors-a-post-hoc-analysis-of-the-persept-1-and-2-trials/ 2025-10-17T10:35:35+01:00 https://www.caf-dcf.be/litterature/treatment-of-severe-bleeds-with-eptacog-beta-in-hemophilia-a-or-b-with-inhibitors-a-post-hoc-analysis-of-the-persept-1-and-2-trials/ 2025-10-17T10:35:35+01:00 https://www.caf-dcf.be/litterature/bleed-treatment-with-eptacog-beta-rfviia-results-in-a-low-incidence-of-rebleeding-in-adult-and-adolescent-patients-with-haemophilia-a-or-b-with-inhibitors/ 2025-10-17T10:32:28+01:00 https://www.caf-dcf.be/fr/litterature/bleed-treatment-with-eptacog-beta-rfviia-results-in-a-low-incidence-of-rebleeding-in-adult-and-adolescent-patients-with-haemophilia-a-or-b-with-inhibitors/ 2025-10-17T10:32:27+01:00 https://www.caf-dcf.be/fr/litterature/rebalancing-agents-in-hemophilia-knowns-unknowns-and-uncertainties/ 2025-10-17T10:24:42+01:00 https://www.caf-dcf.be/litterature/rebalancing-agents-in-hemophilia-knowns-unknowns-and-uncertainties/ 2025-10-17T10:24:42+01:00 https://www.caf-dcf.be/fr/litterature/health-related-quality-of-life-in-rare-bleeding-disorders-results-from-the-rare-bleeding-disorders-in-the-netherlands-study/ 2025-10-17T10:19:04+01:00 https://www.caf-dcf.be/litterature/health-related-quality-of-life-in-rare-bleeding-disorders-results-from-the-rare-bleeding-disorders-in-the-netherlands-study/ 2025-10-17T10:19:04+01:00 https://www.caf-dcf.be/litterature/acquired-autoimmune-hemophilia-demographics-outcomes-and-readmissions/ 2025-10-17T10:16:28+01:00 https://www.caf-dcf.be/fr/litterature/acquired-autoimmune-hemophilia-demographics-outcomes-and-readmissions/ 2025-10-17T10:16:27+01:00 https://www.caf-dcf.be/fr/litterature/genetic-determinants-of-clinical-variability-in-type-2-von-willebrand-disease-bridging-genotype-and-phenotype/ 2025-10-17T10:14:42+01:00 https://www.caf-dcf.be/litterature/genetic-determinants-of-clinical-variability-in-type-2-von-willebrand-disease-bridging-genotype-and-phenotype/ 2025-10-17T10:14:42+01:00 https://www.caf-dcf.be/litterature/diagnosis-of-von-willebrand-disease/ 2025-10-17T10:12:45+01:00 https://www.caf-dcf.be/fr/litterature/diagnosis-of-von-willebrand-disease/ 2025-10-17T10:12:44+01:00 https://www.caf-dcf.be/litterature/the-past-present-and-future-of-blood-plasma-fractionation/ 2025-10-17T09:07:43+01:00 https://www.caf-dcf.be/fr/litterature/the-past-present-and-future-of-blood-plasma-fractionation/ 2025-10-17T09:07:42+01:00 https://www.caf-dcf.be/fr/litterature/genotypic-distribution-of-hepatitis-e-virus-among-asymptomatic-blood-donors-and-its-impact-on-transfusion-safety/ 2025-10-17T08:56:03+01:00 https://www.caf-dcf.be/litterature/genotypic-distribution-of-hepatitis-e-virus-among-asymptomatic-blood-donors-and-its-impact-on-transfusion-safety/ 2025-10-17T08:56:03+01:00 https://www.caf-dcf.be/litterature/pharmacovigilance-analysis-of-drug-induced-hypofibrinogenemia-using-the-fda-adverse-event-reporting-system/ 2025-10-17T08:53:08+01:00 https://www.caf-dcf.be/fr/litterature/pharmacovigilance-analysis-of-drug-induced-hypofibrinogenemia-using-the-fda-adverse-event-reporting-system/ 2025-10-17T08:52:48+01:00 https://www.caf-dcf.be/fr/litterature/why-is-the-uptake-of-gene-therapy-in-hemophilia-less-than-expected/ 2025-10-16T15:49:15+01:00 https://www.caf-dcf.be/litterature/why-is-the-uptake-of-gene-therapy-in-hemophilia-less-than-expected/ 2025-10-16T15:49:15+01:00 https://www.caf-dcf.be/fr/litterature/qualification-criteria-of-gene-therapy-for-haemophilia-opinion-of-the-eahad-gene-therapy-working-group/ 2025-10-16T15:46:59+01:00 https://www.caf-dcf.be/fr/litterature/safety-and-use-of-eptacog-beta-225-μg-kg-in-patients-with-haemophilia-a-or-b-with-inhibitors/ 2025-10-16T15:44:27+01:00 https://www.caf-dcf.be/fr/litterature/therapeutic-innovations-in-hemophilia-the-essential-role-of-a-positive-reinvestment-cycle/ 2025-10-16T15:42:30+01:00 https://www.caf-dcf.be/fr/litterature/current-trends-and-advances-in-the-management-of-acquired-hemophilia-a/ 2025-10-16T15:40:35+01:00 https://www.caf-dcf.be/fr/litterature/epidemiology-health-care-resource-utilization-and-costs-of-hemophilia-a-and-b-by-treatment-regimen-a-retrospective-analysis-of-german-claims-data-from-2016-to-2021/ 2025-10-16T15:38:51+01:00 https://www.caf-dcf.be/fr/litterature/real-world-use-of-protein-c-concentrate-for-the-treatment-of-patients-with-protein-c-deficiency-an-international-registry/ 2025-10-16T15:36:26+01:00 https://www.caf-dcf.be/litterature/real-world-use-of-protein-c-concentrate-for-the-treatment-of-patients-with-protein-c-deficiency-an-international-registry/ 2025-10-16T15:36:26+01:00 https://www.caf-dcf.be/fr/litterature/haemophilia-2/ 2025-10-16T13:50:42+01:00 https://www.caf-dcf.be/fr/litterature/predictors-of-iti-success-in-231-children-with-severe-hemophilia-a-with-high-titer-inhibitors-lessons-learned-from-the-pednet-prospective-cohort-study/ 2025-10-16T13:45:19+01:00 https://www.caf-dcf.be/fr/litterature/patient-anti-fviii-drug-antibodies-bind-preferentially-to-a-subset-of-fviii-covalent-states/ 2025-10-16T13:10:58+01:00 https://www.caf-dcf.be/litterature/understanding-supply-sustainability-of-plasma-derived-medicinal-products-drivers-and-consequences-of-shortages/ 2025-10-14T14:10:40+01:00 https://www.caf-dcf.be/fr/litterature/understanding-supply-sustainability-of-plasma-derived-medicinal-products-drivers-and-consequences-of-shortages/ 2025-10-14T14:10:39+01:00 https://www.caf-dcf.be/litterature/management-of-young-and-ageing-women-with-afibrinogenemia-and-hypofibrinogenemia/ 2025-10-14T14:07:24+01:00 https://www.caf-dcf.be/fr/litterature/management-of-young-and-ageing-women-with-afibrinogenemia-and-hypofibrinogenemia/ 2025-10-14T14:07:07+01:00 https://www.caf-dcf.be/litterature/gene-therapy-for-hemophilia-from-basic-science-to-first-approvals-of-one-and-done-therapies-2/ 2025-10-14T14:05:02+01:00 https://www.caf-dcf.be/fr/litterature/gene-therapy-for-hemophilia-from-basic-science-to-first-approvals-of-one-and-done-therapies-2/ 2025-10-14T14:05:01+01:00 https://www.caf-dcf.be/fr/litterature/gene-based-therapies-for-hemophilia/ 2025-10-14T14:03:24+01:00 https://www.caf-dcf.be/litterature/gene-based-therapies-for-hemophilia/ 2025-10-14T14:03:24+01:00 https://www.caf-dcf.be/fr/litterature/the-genetic-spectrum-of-rare-bleeding-disorders/ 2025-10-14T14:01:33+01:00 https://www.caf-dcf.be/litterature/the-genetic-spectrum-of-rare-bleeding-disorders/ 2025-10-14T14:01:33+01:00 https://www.caf-dcf.be/litterature/pain-reduction-following-eptacog-beta-treatment-of-bleeding-episodes-in-adolescents-and-adults-with-haemophilia-a-or-b-complicated-by-inhibitors/ 2025-10-14T13:59:49+01:00 https://www.caf-dcf.be/fr/litterature/pain-reduction-following-eptacog-beta-treatment-of-bleeding-episodes-in-adolescents-and-adults-with-haemophilia-a-or-b-complicated-by-inhibitors/ 2025-10-14T13:59:48+01:00 https://www.caf-dcf.be/fr/litterature/health-related-quality-of-life-in-children-with-von-willebrand-disease-results-of-the-french-real-life-wish-qol-study/ 2025-10-14T13:57:35+01:00 https://www.caf-dcf.be/litterature/health-related-quality-of-life-in-children-with-von-willebrand-disease-results-of-the-french-real-life-wish-qol-study/ 2025-10-14T13:57:35+01:00 https://www.caf-dcf.be/fr/litterature/2025-focused-update-of-the-2020-isth-guidelines-for-management-of-thrombotic-thrombocytopenic-purpura/ 2025-10-14T12:56:45+01:00 https://www.caf-dcf.be/litterature/2025-focused-update-of-the-2020-isth-guidelines-for-management-of-thrombotic-thrombocytopenic-purpura/ 2025-10-14T12:56:45+01:00 https://www.caf-dcf.be/fr/litterature/thrombotic-thrombocytopenic-purpura-in-pediatric-patients/ 2025-10-14T12:52:53+01:00 https://www.caf-dcf.be/fr/litterature/treatment-and-disease-burden-in-a-cohort-of-people-with-haemophilia-without-inhibitors-in-the-united-states/ 2025-10-14T12:47:43+01:00 https://www.caf-dcf.be/fr/litterature/impact-of-family-history-of-haemophilia-on-diagnosis-management-and-outcomes-in-severe-haemophilia/ 2025-10-14T12:40:44+01:00 https://www.caf-dcf.be/fr/litterature/anti-tissue-factor-pathway-inhibitors-for-hemophilia-are-these-treatments-the-answer-to-overcoming-current-treatment-limitations/ 2025-10-14T12:39:13+01:00 https://www.caf-dcf.be/litterature/anti-tissue-factor-pathway-inhibitors-for-hemophilia-are-these-treatments-the-answer-to-overcoming-current-treatment-limitations/ 2025-10-14T12:39:13+01:00 https://www.caf-dcf.be/fr/litterature/the-association-of-factor-viii-activity-levels-with-bleeding-and-quality-of-life-in-haemophilia-a-findings-from-the-european-chess-ii-study/ 2025-10-14T12:36:25+01:00 https://www.caf-dcf.be/litterature/the-association-of-factor-viii-activity-levels-with-bleeding-and-quality-of-life-in-haemophilia-a-findings-from-the-european-chess-ii-study/ 2025-10-14T12:36:25+01:00 https://www.caf-dcf.be/fr/litterature/inhibitor-development-in-nonsevere-hemophilia-data-from-the-european-haemophilia-safety-surveillance-euhass-registry/ 2025-10-14T12:31:07+01:00 https://www.caf-dcf.be/fr/litterature/transient-acquired-von-willebrand-disease-with-a-type-2b-phenotype-recognizing-the-diagnostic-challenges/ 2025-10-14T12:29:00+01:00 https://www.caf-dcf.be/litterature/clinical-significance-of-on-admission-fibrinogen-levels-in-patients-with-blunt-traumatic-brain-injury-a-retrospective-observational-study-2/ 2025-10-13T15:13:27+01:00 https://www.caf-dcf.be/fr/litterature/clinical-significance-of-on-admission-fibrinogen-levels-in-patients-with-blunt-traumatic-brain-injury-a-retrospective-observational-study/ 2025-10-13T15:12:25+01:00 https://www.caf-dcf.be/litterature/clinical-significance-of-rotational-thromboelastometry-rotem-for-detection-of-early-coagulopathy-in-trauma-patients-a-retrospective-study/ 2025-10-13T15:10:37+01:00 https://www.caf-dcf.be/fr/litterature/the-results-of-advance-cidp-ivig-trial-intravenous-immunoglobulin-10-therapy-with-gammagard-liquid-kiovig-for-treatment-of-relapse-in-chronic-inflammatory-demyelinating-polyradiculoneuropathy/ 2025-10-13T15:09:18+01:00 https://www.caf-dcf.be/litterature/the-results-of-advance-cidp-ivig-trial-intravenous-immunoglobulin-10-therapy-with-gammagard-liquid-kiovig-for-treatment-of-relapse-in-chronic-inflammatory-demyelinating-polyradiculoneuropathy/ 2025-10-13T15:09:18+01:00 https://www.caf-dcf.be/fr/litterature/clinical-significance-of-rotational-thromboelastometry-rotem-for-detection-of-early-coagulopathy-in-trauma-patients-a-retrospective-study/ 2025-10-13T15:05:52+01:00 https://www.caf-dcf.be/fr/litterature/efficacy-and-safety-analysis-of-chinas-first-10-ivig-ronsenglob-therapy-in-treating-adult-itp/ 2025-10-13T14:54:33+01:00 https://www.caf-dcf.be/fr/litterature/glanzmann-thrombasthenia-a-multi-center-study-of-demographics-clinical-spectrum-and-treatment-efficacy/ 2025-10-13T13:19:19+01:00 https://www.caf-dcf.be/litterature/glanzmann-thrombasthenia-a-multi-center-study-of-demographics-clinical-spectrum-and-treatment-efficacy/ 2025-10-13T13:19:19+01:00 https://www.caf-dcf.be/fr/litterature/european-principles-of-nursing-care-for-persons-with-inherited-bleeding-disorders/ 2025-10-13T13:16:26+01:00 https://www.caf-dcf.be/litterature/european-principles-of-nursing-care-for-persons-with-inherited-bleeding-disorders/ 2025-10-13T13:16:26+01:00 https://www.caf-dcf.be/fr/litterature/recombinant-activated-factor-viia-combined-with-tranexamic-acid-control-haemostasis-in-patients-with-severe-factor-xi-deficiency-undergoing-urological-procedures/ 2025-10-13T13:13:17+01:00 https://www.caf-dcf.be/fr/litterature/a-family-with-factor-vii-deficiency-a-possible-autosomal-dominant-transmission/ 2025-10-13T13:10:59+01:00 https://www.caf-dcf.be/fr/litterature/ex-vivo-lentiviral-gene-therapy-for-severe-hemophilia-a-an-alternative-to-recombinant-adeno-associated-viral-based-strategies/ 2025-10-13T13:09:03+01:00 https://www.caf-dcf.be/fr/litterature/in-the-prophylaxis-era-people-with-hemophilia-still-need-major-orthopedic-surgery/ 2025-10-13T13:07:23+01:00 https://www.caf-dcf.be/fr/litterature/unveiling-a-25-year-journey-the-story-of-an-acquired-hemophilia-patient/ 2025-10-13T13:04:53+01:00 https://www.caf-dcf.be/fr/litterature/genetic-study-of-von-willebrand-factor-antigen-levels-≤-50-iu-dl-identifies-variants-associated-with-increased-risk-of-vwd-and-bleeding/ 2025-10-13T13:00:45+01:00 https://www.caf-dcf.be/fr/litterature/haemophilia-prophylaxis-in-the-age-of-innovation-exploring-opportunities-for-personalized-treatment/ 2025-10-13T12:53:05+01:00 https://www.caf-dcf.be/fr/litterature/efficacy-and-safety-of-rviii-singlechain-in-surgical-prophylaxis/ 2025-10-13T12:50:33+01:00 https://www.caf-dcf.be/litterature/fibrinogen-replacement-a-questionable-dogma/ 2025-10-10T10:52:57+01:00 https://www.caf-dcf.be/fr/litterature/fibrinogen-replacement-a-questionable-dogma/ 2025-10-10T10:52:26+01:00 https://www.caf-dcf.be/fr/litterature/mild-or-moderate-hemophilia-is-not-always-a-mild-or-moderate-bleeding-disorder-back-to-the-clinical-phenotype/ 2025-10-10T10:50:07+01:00 https://www.caf-dcf.be/fr/litterature/clinical-and-economic-burden-of-patients-with-haemophilia-a-and-b-in-france-analysis-of-a-nationwide-claims-database/ 2025-10-10T10:48:01+01:00 https://www.caf-dcf.be/litterature/haemophilia-and-access-to-gene-therapy/ 2025-10-10T10:27:17+01:00 https://www.caf-dcf.be/fr/litterature/haemophilia-and-access-to-gene-therapy/ 2025-10-10T10:27:16+01:00 https://www.caf-dcf.be/fr/litterature/gene-therapy-for-hemophilia-from-basic-science-to-first-approvals-of-one-and-done-therapies/ 2025-10-10T10:25:24+01:00 https://www.caf-dcf.be/litterature/gene-therapy-for-hemophilia-from-basic-science-to-first-approvals-of-one-and-done-therapies/ 2025-10-10T10:25:24+01:00 https://www.caf-dcf.be/fr/litterature/gene-therapy-for-hemophilia-b-results-from-the-phase1-2-101hemb-1-2-studies/ 2025-10-10T10:22:44+01:00 https://www.caf-dcf.be/litterature/gene-therapy-for-hemophilia-b-results-from-the-phase1-2-101hemb-1-2-studies/ 2025-10-10T10:22:44+01:00 https://www.caf-dcf.be/fr/litterature/extravascular-factor-ix-after-gene-therapy-in-hemophilia-b-does-it-matter/ 2025-10-10T10:20:31+01:00 https://www.caf-dcf.be/fr/litterature/prognostic-factors-for-recurrence-in-acquired-hemophilia-a-results-from-a-long-term-observational-study/ 2025-10-10T10:18:51+01:00 https://www.caf-dcf.be/litterature/prognostic-factors-for-recurrence-in-acquired-hemophilia-a-results-from-a-long-term-observational-study/ 2025-10-10T10:18:51+01:00 https://www.caf-dcf.be/litterature/obstetric-and-gynaecological-challenges-and-outcomes-in-women-and-girls-with-glanzmanns-thrombasthenia/ 2025-10-10T10:16:47+01:00 https://www.caf-dcf.be/fr/litterature/obstetric-and-gynaecological-challenges-and-outcomes-in-women-and-girls-with-glanzmanns-thrombasthenia/ 2025-10-10T10:16:46+01:00 https://www.caf-dcf.be/fr/litterature/blood-group-o-does-not-increase-the-risk-of-inhibitors-in-severe-haemophilia-a-data-from-the-pednet-study-group/ 2025-10-10T10:06:37+01:00 https://www.caf-dcf.be/fr/litterature/acquired-hemophilia-a-after-multiple-transfusions-following-trauma-2/ 2025-10-10T10:04:36+01:00 https://www.caf-dcf.be/fr/litterature/global-patterns-of-hemophilia-drug-trials-hemophilia-care-and-health-care-measures/ 2025-10-10T10:02:59+01:00 https://www.caf-dcf.be/litterature/global-patterns-of-hemophilia-drug-trials-hemophilia-care-and-health-care-measures/ 2025-10-10T10:02:59+01:00 https://www.caf-dcf.be/litterature/management-of-patients-with-congenital-bleeding-disorders-and-cardiac-indications-for-antithrombotic-therapy/ 2025-10-10T10:00:22+01:00 https://www.caf-dcf.be/fr/litterature/management-of-patients-with-congenital-bleeding-disorders-and-cardiac-indications-for-antithrombotic-therapy/ 2025-10-10T10:00:21+01:00 https://www.caf-dcf.be/litterature/polyvalent-human-immunoglobulins-between-essential-indications-and-uses-to-be-avoided-2025-update-of-the-prescription-priorization-proposed-by-the-french-national-agency-for-medicines-and-health-pro/ 2025-10-09T10:47:50+01:00 https://www.caf-dcf.be/litterature/characterization-of-thromboembolic-events-after-recombinant-coagulation-factor-viia-rfviia-novoseven-use-in-cardiac-surgery-a-descriptive-pilot-study/ 2025-10-09T10:45:50+01:00 https://www.caf-dcf.be/litterature/management-of-von-willebrand-disease-with-a-factor-viii-poor-von-willebrand-factor-concentrate-results-from-the-paediatric-cohort-of-a-prospective-observational-post-marketing-study/ 2025-10-09T10:42:21+01:00 https://www.caf-dcf.be/litterature/rewriting-the-script-gene-therapy-and-genome-editing-for-von-willebrand-disease/ 2025-10-09T10:40:23+01:00 https://www.caf-dcf.be/litterature/the-effectiveness-and-safety-of-various-treatments-for-hemophilia-in-china-a-literature-review-and-evidence-mapping/ 2025-10-09T10:38:16+01:00 https://www.caf-dcf.be/litterature/how-to-start-prophylaxis-in-untreated-children-with-severe-and-moderate-haemophilia-in-2025-opinion-of-paediatricians-from-the-french-society-of-thrombosis-and-haemostasis/ 2025-10-09T10:36:45+01:00 https://www.caf-dcf.be/litterature/overview-on-rare-congenital-bleeding-disorders-and-epidemiological-data-from-the-german-haemophilia-registry-dhr-and-a-survey-in-germany-austria-and-switzerland/ 2025-10-09T09:48:10+01:00 https://www.caf-dcf.be/litterature/how-genetic-advances-are-being-translated-into-improved-diagnostic-outcomes-for-patients-with-inherited-bleeding-disorders/ 2025-10-09T09:46:05+01:00 https://www.caf-dcf.be/litterature/acquired-autoimmune-hemophilia-demographics-outcomes-and-readmissions/ 2025-08-17T10:15:04+01:00 https://www.caf-dcf.be/litterature/qualification-criteria-of-gene-therapy-for-haemophilia-opinion-of-the-eahad-gene-therapy-working-group/ 2025-07-16T15:45:50+01:00 https://www.caf-dcf.be/litterature/safety-and-use-of-eptacog-beta-225-μg-kg-in-patients-with-haemophilia-a-or-b-with-inhibitors/ 2025-07-16T15:43:03+01:00 https://www.caf-dcf.be/litterature/therapeutic-innovations-in-hemophilia-the-essential-role-of-a-positive-reinvestment-cycle/ 2025-07-16T15:41:20+01:00 https://www.caf-dcf.be/litterature/current-trends-and-advances-in-the-management-of-acquired-hemophilia-a/ 2025-07-16T15:39:25+01:00 https://www.caf-dcf.be/litterature/epidemiology-health-care-resource-utilization-and-costs-of-hemophilia-a-and-b-by-treatment-regimen-a-retrospective-analysis-of-german-claims-data-from-2016-to-2021/ 2025-07-16T15:37:26+01:00 https://www.caf-dcf.be/litterature/haemophilia-2/ 2025-07-16T13:46:10+01:00 https://www.caf-dcf.be/litterature/predictors-of-iti-success-in-231-children-with-severe-hemophilia-a-with-high-titer-inhibitors-lessons-learned-from-the-pednet-prospective-cohort-study/ 2025-07-16T13:11:58+01:00 https://www.caf-dcf.be/litterature/patient-anti-fviii-drug-antibodies-bind-preferentially-to-a-subset-of-fviii-covalent-states/ 2025-07-16T13:05:54+01:00 https://www.caf-dcf.be/litterature/thrombotic-thrombocytopenic-purpura-in-pediatric-patients/ 2025-06-14T12:51:16+01:00 https://www.caf-dcf.be/litterature/treatment-and-disease-burden-in-a-cohort-of-people-with-haemophilia-without-inhibitors-in-the-united-states/ 2025-06-14T12:46:25+01:00 https://www.caf-dcf.be/litterature/impact-of-family-history-of-haemophilia-on-diagnosis-management-and-outcomes-in-severe-haemophilia/ 2025-06-14T12:39:33+01:00 https://www.caf-dcf.be/litterature/inhibitor-development-in-nonsevere-hemophilia-data-from-the-european-haemophilia-safety-surveillance-euhass-registry/ 2025-06-14T12:29:37+01:00 https://www.caf-dcf.be/litterature/transient-acquired-von-willebrand-disease-with-a-type-2b-phenotype-recognizing-the-diagnostic-challenges/ 2025-06-14T12:11:13+01:00 https://www.caf-dcf.be/litterature/the-results-of-advance-cidp-ivig-trial-intravenous-immunoglobulin-10-therapy-with-gammagard-liquid-kiovig-for-treatment-of-relapse-in-chronic-inflammatory-demyelinating-polyradiculoneuropathy/ 2025-05-13T14:55:05+01:00 https://www.caf-dcf.be/litterature/the-results-of-advance-cidp-ivig-trial-intravenous-immunoglobulin-10-therapy-with-gammagard-liquid-kiovig-for-treatment-of-relapse-in-chronic-inflammatory-demyelinating-polyradiculoneuropathy/ 2025-05-13T14:55:05+01:00 https://www.caf-dcf.be/litterature/the-results-of-advance-cidp-ivig-trial-intravenous-immunoglobulin-10-therapy-with-gammagard-liquid-kiovig-for-treatment-of-relapse-in-chronic-inflammatory-demyelinating-polyradiculoneuropathy/ 2025-05-13T14:55:05+01:00 https://www.caf-dcf.be/litterature/the-results-of-advance-cidp-ivig-trial-intravenous-immunoglobulin-10-therapy-with-gammagard-liquid-kiovig-for-treatment-of-relapse-in-chronic-inflammatory-demyelinating-polyradiculoneuropathy/ 2025-05-13T14:55:05+01:00 https://www.caf-dcf.be/litterature/efficacy-and-safety-analysis-of-chinas-first-10-ivig-ronsenglob-therapy-in-treating-adult-itp/ 2025-05-13T14:07:30+01:00 https://www.caf-dcf.be/litterature/recombinant-activated-factor-viia-combined-with-tranexamic-acid-control-haemostasis-in-patients-with-severe-factor-xi-deficiency-undergoing-urological-procedures/ 2025-05-13T13:11:43+01:00 https://www.caf-dcf.be/litterature/a-family-with-factor-vii-deficiency-a-possible-autosomal-dominant-transmission/ 2025-05-13T13:09:41+01:00 https://www.caf-dcf.be/litterature/ex-vivo-lentiviral-gene-therapy-for-severe-hemophilia-a-an-alternative-to-recombinant-adeno-associated-viral-based-strategies/ 2025-05-13T13:07:39+01:00 https://www.caf-dcf.be/litterature/in-the-prophylaxis-era-people-with-hemophilia-still-need-major-orthopedic-surgery/ 2025-05-13T13:05:27+01:00 https://www.caf-dcf.be/litterature/unveiling-a-25-year-journey-the-story-of-an-acquired-hemophilia-patient/ 2025-05-13T13:03:24+01:00 https://www.caf-dcf.be/litterature/genetic-study-of-von-willebrand-factor-antigen-levels-≤-50-iu-dl-identifies-variants-associated-with-increased-risk-of-vwd-and-bleeding/ 2025-05-13T12:59:27+01:00 https://www.caf-dcf.be/litterature/haemophilia-prophylaxis-in-the-age-of-innovation-exploring-opportunities-for-personalized-treatment/ 2025-05-13T12:51:27+01:00 https://www.caf-dcf.be/litterature/efficacy-and-safety-of-rviii-singlechain-in-surgical-prophylaxis/ 2025-05-13T12:32:06+01:00 https://www.caf-dcf.be/litterature/mild-or-moderate-hemophilia-is-not-always-a-mild-or-moderate-bleeding-disorder-back-to-the-clinical-phenotype/ 2025-04-10T10:48:38+01:00 https://www.caf-dcf.be/litterature/clinical-and-economic-burden-of-patients-with-haemophilia-a-and-b-in-france-analysis-of-a-nationwide-claims-database/ 2025-04-10T10:46:52+01:00 https://www.caf-dcf.be/litterature/extravascular-factor-ix-after-gene-therapy-in-hemophilia-b-does-it-matter/ 2025-04-10T10:19:17+01:00 https://www.caf-dcf.be/litterature/blood-group-o-does-not-increase-the-risk-of-inhibitors-in-severe-haemophilia-a-data-from-the-pednet-study-group/ 2025-04-10T10:05:08+01:00 https://www.caf-dcf.be/litterature/acquired-hemophilia-a-after-multiple-transfusions-following-trauma-2/ 2025-04-10T10:03:15+01:00 https://www.caf-dcf.be/litterature/how-i-treat-quantitative-fibrinogen-disorders/ 2025-02-04T14:24:23+01:00 https://www.caf-dcf.be/fr/litterature/how-i-treat-quantitative-fibrinogen-disorders/ 2025-02-04T14:23:06+01:00 https://www.caf-dcf.be/litterature/looking-beyond-thrombocytopenia-for-bleeding-in-a-case-of-dengue-fever-from-dengue-to-hemophilia-c/ 2025-02-04T14:12:32+01:00 https://www.caf-dcf.be/fr/litterature/looking-beyond-thrombocytopenia-for-bleeding-in-a-case-of-dengue-fever-from-dengue-to-hemophilia-c/ 2025-02-04T14:12:31+01:00 https://www.caf-dcf.be/fr/litterature/international-society-on-thrombosis-and-haemostasis-clinical-practice-guideline-for-treatment-of-congenital-haemophilia-a-critical-appraisal/ 2025-02-04T14:12:14+01:00 https://www.caf-dcf.be/litterature/international-society-on-thrombosis-and-haemostasis-clinical-practice-guideline-for-treatment-of-congenital-haemophilia-a-critical-appraisal/ 2025-02-04T14:12:14+01:00 https://www.caf-dcf.be/fr/litterature/blood-coagulation-factor-ix-structural-insights-impacting-hemophilia-b-therapy/ 2025-02-04T14:11:49+01:00 https://www.caf-dcf.be/litterature/blood-coagulation-factor-ix-structural-insights-impacting-hemophilia-b-therapy/ 2025-02-04T14:11:49+01:00 https://www.caf-dcf.be/fr/litterature/intravenous-immunoglobulin-as-a-therapy-for-autoimmune-conditions/ 2025-02-04T14:09:33+01:00 https://www.caf-dcf.be/fr/litterature/the-history-of-rare-bleeding-disorders/ 2025-02-04T14:06:16+01:00 https://www.caf-dcf.be/fr/litterature/prophylaxis-in-von-willebrand-disease-with-von-willebrand-factor-concentrate-and-nonfactor-therapies/ 2025-02-04T14:04:23+01:00 https://www.caf-dcf.be/fr/litterature/pain-related-quality-of-life-outcomes-in-people-with-haemophilia-a-receiving-emicizumab-a-post-hoc-analysis-of-the-haven-1-3-and-4-and-stasey-studies/ 2025-02-04T14:02:33+01:00 https://www.caf-dcf.be/fr/litterature/eahad-statement-on-the-isth-clinical-practice-guideline-for-treatment-of-congenital-haemophilia-a-and-b/ 2025-02-04T14:00:27+01:00 https://www.caf-dcf.be/fr/litterature/the-history-of-women-and-hemophilia-a-narrative-review-of-evolving-beliefs-and-testing-practices/ 2025-02-04T13:58:20+01:00 https://www.caf-dcf.be/litterature/intravenous-immunoglobulin-as-a-therapy-for-autoimmune-conditions/ 2024-12-04T14:06:44+01:00 https://www.caf-dcf.be/litterature/the-history-of-rare-bleeding-disorders/ 2024-12-04T14:04:55+01:00 https://www.caf-dcf.be/litterature/prophylaxis-in-von-willebrand-disease-with-von-willebrand-factor-concentrate-and-nonfactor-therapies/ 2024-12-04T14:03:05+01:00 https://www.caf-dcf.be/litterature/pain-related-quality-of-life-outcomes-in-people-with-haemophilia-a-receiving-emicizumab-a-post-hoc-analysis-of-the-haven-1-3-and-4-and-stasey-studies/ 2024-12-04T14:01:03+01:00 https://www.caf-dcf.be/litterature/eahad-statement-on-the-isth-clinical-practice-guideline-for-treatment-of-congenital-haemophilia-a-and-b/ 2024-12-04T13:59:07+01:00 https://www.caf-dcf.be/litterature/the-history-of-women-and-hemophilia-a-narrative-review-of-evolving-beliefs-and-testing-practices/ 2024-12-04T13:56:49+01:00 https://www.caf-dcf.be/litterature/lower-dose-emicizumab-prophylaxis-can-less-be-more/ 2024-05-15T11:08:20+01:00 https://www.caf-dcf.be/fr/litterature/lower-dose-emicizumab-prophylaxis-can-less-be-more/ 2024-05-15T11:07:17+01:00 https://www.caf-dcf.be/litterature/innovative-therapies-for-acquired-hemophilia-a/ 2024-05-15T11:04:42+01:00 https://www.caf-dcf.be/fr/litterature/innovative-therapies-for-acquired-hemophilia-a/ 2024-05-15T11:04:10+01:00 https://www.caf-dcf.be/litterature/100-years-of-thrombotic-thrombocytopenic-purpura-a-story-of-death-and-life/ 2024-05-15T11:02:43+01:00 https://www.caf-dcf.be/fr/litterature/100-years-of-thrombotic-thrombocytopenic-purpura-a-story-of-death-and-life/ 2024-05-15T11:02:11+01:00 https://www.caf-dcf.be/fr/litterature/a-global-analysis-of-the-use-of-immunoglobulin-shortages-in-supply-and-mitigating-measures-a-survey-of-hospital-providers-a-best-collaborative-study/ 2024-05-15T11:00:31+01:00 https://www.caf-dcf.be/fr/litterature/the-big-question-can-we-stop-the-use-of-hbig/ 2024-05-15T10:58:51+01:00 https://www.caf-dcf.be/fr/litterature/pregnancy-in-myasthenia-gravis-a-retrospective-analysis-of-maternal-and-neonatal-outcome-from-a-large-tertiary-care-centre-in-germany/ 2024-05-15T10:57:05+01:00 https://www.caf-dcf.be/fr/litterature/guideline-for-laboratory-diagnosis-and-monitoring-of-von-willebrand-disease-a-joint-guideline-from-the-united-kingdom-haemophilia-centre-doctors-organisation-and-the-british-society-for-haemato/ 2024-05-15T10:55:14+01:00 https://www.caf-dcf.be/fr/litterature/haemophilia-in-the-era-of-novel-therapies-where-do-inhibitors-feature-in-the-new-landscape/ 2024-05-15T10:53:06+01:00 https://www.caf-dcf.be/fr/litterature/challenges-in-ageing-persons-with-haemophilia/ 2024-05-15T10:50:53+01:00 https://www.caf-dcf.be/fr/litterature/women-and-girls-with-inherited-bleeding-disorders-focus-on-haemophilia-carriers-and-heavy-menstrual-bleeding/ 2024-05-15T10:49:12+01:00 https://www.caf-dcf.be/fr/litterature/clinical-and-treatment-characteristics-of-infants-and-toddlers-less-than-two-years-of-age-with-hemophilia/ 2024-05-15T10:45:57+01:00 https://www.caf-dcf.be/fr/litterature/an-evolving-understanding-of-low-vwf-and-type-1-vwd/ 2024-05-15T10:42:22+01:00 https://www.caf-dcf.be/fr/litterature/how-much-prophylaxis-is-enough-in-haemophilia/ 2024-05-15T10:34:58+01:00 https://www.caf-dcf.be/fr/litterature/classification-of-recombinant-factor-viii-products-and-implications-for-clinical-practice-a-systematic-literature-review/ 2024-05-15T10:32:49+01:00 https://www.caf-dcf.be/litterature/massive-transfusion-in-trauma/ 2024-05-15T10:25:58+01:00 https://www.caf-dcf.be/fr/litterature/massive-transfusion-in-trauma/ 2024-05-15T10:25:18+01:00 https://www.caf-dcf.be/litterature/analyzing-and-modeling-massive-transfusion-strategies-and-the-role-of-fibrinogen-how-much-is-the-patient-actually-receiving/ 2024-05-15T10:22:56+01:00 https://www.caf-dcf.be/fr/litterature/analyzing-and-modeling-massive-transfusion-strategies-and-the-role-of-fibrinogen-how-much-is-the-patient-actually-receiving/ 2024-05-15T10:22:15+01:00 https://www.caf-dcf.be/litterature/guidelines-in-trauma-related-bleeding-and-coagulopathy-an-update/ 2024-05-15T10:19:59+01:00 https://www.caf-dcf.be/fr/litterature/guidelines-in-trauma-related-bleeding-and-coagulopathy-an-update/ 2024-05-15T10:19:31+01:00 https://www.caf-dcf.be/litterature/management-and-outcomes-of-women-with-low-fibrinogen-concentration-during-pregnancy-or-immediately-postpartum-a-uk-national-population-based-cohort-study/ 2024-05-15T10:17:11+01:00 https://www.caf-dcf.be/fr/litterature/management-and-outcomes-of-women-with-low-fibrinogen-concentration-during-pregnancy-or-immediately-postpartum-a-uk-national-population-based-cohort-study/ 2024-05-15T10:16:05+01:00 https://www.caf-dcf.be/fr/litterature/assessment-of-rare-bleeding-disorders-in-adolescents-with-heavy-menstrual-bleeding/ 2024-05-15T10:14:08+01:00 https://www.caf-dcf.be/fr/litterature/the-concept-of-thromboinflammation/ 2024-05-15T09:56:03+01:00 https://www.caf-dcf.be/fr/litterature/immune-gene-polymorphisms-associated-with-poor-response-to-platelet-transfusion-and-recombinant-factor-vii-administration-in-glanzmann-thrombasthenia/ 2024-05-15T09:53:57+01:00 https://www.caf-dcf.be/fr/litterature/current-understanding-of-immune-thrombocytopenia-a-review-of-pathogenesis-and-treatment-options/ 2024-05-15T09:46:21+01:00 https://www.caf-dcf.be/fr/litterature/management-and-follow-up-of-pregnancy-onset-thrombotic-thrombocytopenic-purpura-the-french-experience/ 2024-05-15T09:43:36+01:00 https://www.caf-dcf.be/fr/litterature/real-world-treatment-of-patients-with-severe-congenital-protein-c-deficiency-with-protein-c-concentrate-a-physician-survey/ 2024-05-15T09:41:10+01:00 https://www.caf-dcf.be/fr/litterature/diagnosis-and-treatment-of-von-willebrand-disease-in-2024-and-beyond/ 2024-05-15T09:38:26+01:00 https://www.caf-dcf.be/fr/litterature/rare-bleeding-disorders-advances-in-management/ 2024-05-15T09:35:35+01:00 https://www.caf-dcf.be/litterature/use-of-vonicog-alpha-and-acquired-von-willebrand-syndrome-a-new-approach-a-case-report/ 2024-05-15T09:28:10+01:00 https://www.caf-dcf.be/fr/litterature/use-of-vonicog-alpha-and-acquired-von-willebrand-syndrome-a-new-approach-a-case-report/ 2024-05-15T09:28:09+01:00 https://www.caf-dcf.be/litterature/a-global-analysis-of-the-use-of-immunoglobulin-shortages-in-supply-and-mitigating-measures-a-survey-of-hospital-providers-a-best-collaborative-study/ 2024-04-15T10:59:32+01:00 https://www.caf-dcf.be/litterature/the-big-question-can-we-stop-the-use-of-hbig/ 2024-04-15T10:57:48+01:00 https://www.caf-dcf.be/litterature/pregnancy-in-myasthenia-gravis-a-retrospective-analysis-of-maternal-and-neonatal-outcome-from-a-large-tertiary-care-centre-in-germany/ 2024-04-15T10:55:48+01:00 https://www.caf-dcf.be/litterature/guideline-for-laboratory-diagnosis-and-monitoring-of-von-willebrand-disease-a-joint-guideline-from-the-united-kingdom-haemophilia-centre-doctors-organisation-and-the-british-society-for-haemato/ 2024-04-15T10:53:48+01:00 https://www.caf-dcf.be/litterature/haemophilia-in-the-era-of-novel-therapies-where-do-inhibitors-feature-in-the-new-landscape/ 2024-04-15T10:51:57+01:00 https://www.caf-dcf.be/litterature/challenges-in-ageing-persons-with-haemophilia/ 2024-04-15T10:49:55+01:00 https://www.caf-dcf.be/litterature/women-and-girls-with-inherited-bleeding-disorders-focus-on-haemophilia-carriers-and-heavy-menstrual-bleeding/ 2024-04-15T10:47:54+01:00 https://www.caf-dcf.be/litterature/clinical-and-treatment-characteristics-of-infants-and-toddlers-less-than-two-years-of-age-with-hemophilia/ 2024-04-15T10:44:15+01:00 https://www.caf-dcf.be/litterature/an-evolving-understanding-of-low-vwf-and-type-1-vwd/ 2024-04-15T10:35:39+01:00 https://www.caf-dcf.be/litterature/how-much-prophylaxis-is-enough-in-haemophilia/ 2024-04-15T10:33:39+01:00 https://www.caf-dcf.be/litterature/classification-of-recombinant-factor-viii-products-and-implications-for-clinical-practice-a-systematic-literature-review/ 2024-04-15T10:31:17+01:00 https://www.caf-dcf.be/litterature/comprehensive-analysis-of-the-role-of-fibrinogen-and-thrombin-in-clot-formation-and-structure-for-plasma-and-purified-fibrinogen/ 2024-03-29T15:41:59+01:00 https://www.caf-dcf.be/fr/litterature/comprehensive-analysis-of-the-role-of-fibrinogen-and-thrombin-in-clot-formation-and-structure-for-plasma-and-purified-fibrinogen/ 2024-03-29T15:41:26+01:00 https://www.caf-dcf.be/litterature/post-reconstitution-hemostatic-stability-profiles-of-canadian-and-german-freeze-dried-plasma/ 2024-03-29T15:39:10+01:00 https://www.caf-dcf.be/fr/litterature/post-reconstitution-hemostatic-stability-profiles-of-canadian-and-german-freeze-dried-plasma/ 2024-03-29T15:38:36+01:00 https://www.caf-dcf.be/litterature/the-history-of-extracorporeal-membrane-oxygenation-and-the-development-of-extracorporeal-membrane-oxygenation-anticoagulation/ 2024-03-29T15:36:23+01:00 https://www.caf-dcf.be/fr/litterature/the-history-of-extracorporeal-membrane-oxygenation-and-the-development-of-extracorporeal-membrane-oxygenation-anticoagulation/ 2024-03-29T15:35:46+01:00 https://www.caf-dcf.be/fr/litterature/challenges-in-the-early-diagnosis-and-treatment-of-chronic-inflammatory-demyelinating-polyradiculoneuropathy-in-adults-current-perspectives/ 2024-03-29T15:32:40+01:00 https://www.caf-dcf.be/litterature/challenges-in-the-early-diagnosis-and-treatment-of-chronic-inflammatory-demyelinating-polyradiculoneuropathy-in-adults-current-perspectives/ 2024-03-29T15:32:40+01:00 https://www.caf-dcf.be/fr/litterature/acquired-hemophilia-a-a-single-center-study-of-165-patients/ 2024-03-29T15:30:38+01:00 https://www.caf-dcf.be/litterature/acquired-hemophilia-a-a-single-center-study-of-165-patients/ 2024-03-29T15:30:38+01:00 https://www.caf-dcf.be/fr/litterature/pharmacokinetic-pharmacodynamic-modelling-in-hemophilia-a-relating-thrombin-and-plasmin-generation-to-factor-viii-activity-after-administration-of-a-vwf-fviii-concentrate/ 2024-03-29T15:28:52+01:00 https://www.caf-dcf.be/litterature/pharmacokinetic-pharmacodynamic-modelling-in-hemophilia-a-relating-thrombin-and-plasmin-generation-to-factor-viii-activity-after-administration-of-a-vwf-fviii-concentrate/ 2024-03-29T15:28:52+01:00 https://www.caf-dcf.be/fr/litterature/an-observational-study-of-haemophilia-a-patients-without-inhibitors-using-the-french-national-claims-snds-database/ 2024-03-29T15:26:19+01:00 https://www.caf-dcf.be/litterature/an-observational-study-of-haemophilia-a-patients-without-inhibitors-using-the-french-national-claims-snds-database/ 2024-03-29T15:26:19+01:00 https://www.caf-dcf.be/fr/litterature/genetic-landscape-of-factor-vii-deficiency-insights-from-a-comprehensive-analysis-of-pathogenic-variants-and-their-impact-on-coagulation-activity/ 2024-03-29T15:24:42+01:00 https://www.caf-dcf.be/litterature/genetic-landscape-of-factor-vii-deficiency-insights-from-a-comprehensive-analysis-of-pathogenic-variants-and-their-impact-on-coagulation-activity/ 2024-03-29T15:24:42+01:00 https://www.caf-dcf.be/fr/litterature/the-spectrum-of-neutralizing-and-non-neutralizing-anti-fviii-antibodies-in-a-nationwide-cohort-of-788-persons-with-hemophilia/ 2024-03-29T15:22:39+01:00 https://www.caf-dcf.be/litterature/the-spectrum-of-neutralizing-and-non-neutralizing-anti-fviii-antibodies-in-a-nationwide-cohort-of-788-persons-with-hemophilia/ 2024-03-29T15:22:39+01:00 https://www.caf-dcf.be/fr/litterature/bleeding-disorder-of-unknown-cause-a-diagnosis-of-exclusion/ 2024-03-29T15:20:38+01:00 https://www.caf-dcf.be/litterature/bleeding-disorder-of-unknown-cause-a-diagnosis-of-exclusion/ 2024-03-29T15:20:38+01:00 https://www.caf-dcf.be/fr/litterature/rare-variants-in-alpha-1-antitrypsin-deficiency-a-systematic-literature-review/ 2024-03-29T15:17:52+01:00 https://www.caf-dcf.be/litterature/rare-variants-in-alpha-1-antitrypsin-deficiency-a-systematic-literature-review/ 2024-03-29T15:17:52+01:00 https://www.caf-dcf.be/litterature/assessment-of-rare-bleeding-disorders-in-adolescents-with-heavy-menstrual-bleeding/ 2024-03-15T09:56:56+01:00 https://www.caf-dcf.be/litterature/the-concept-of-thromboinflammation/ 2024-03-15T09:54:59+01:00 https://www.caf-dcf.be/litterature/immune-gene-polymorphisms-associated-with-poor-response-to-platelet-transfusion-and-recombinant-factor-vii-administration-in-glanzmann-thrombasthenia/ 2024-03-15T09:47:29+01:00 https://www.caf-dcf.be/litterature/current-understanding-of-immune-thrombocytopenia-a-review-of-pathogenesis-and-treatment-options/ 2024-03-15T09:44:57+01:00 https://www.caf-dcf.be/litterature/management-and-follow-up-of-pregnancy-onset-thrombotic-thrombocytopenic-purpura-the-french-experience/ 2024-03-15T09:42:08+01:00 https://www.caf-dcf.be/litterature/real-world-treatment-of-patients-with-severe-congenital-protein-c-deficiency-with-protein-c-concentrate-a-physician-survey/ 2024-03-15T09:39:25+01:00 https://www.caf-dcf.be/litterature/diagnosis-and-treatment-of-von-willebrand-disease-in-2024-and-beyond/ 2024-03-15T09:37:00+01:00 https://www.caf-dcf.be/litterature/rare-bleeding-disorders-advances-in-management/ 2024-03-15T09:31:55+01:00 https://www.caf-dcf.be/litterature/controversies-regarding-albumin-therapy-in-cirrhosis/ 2024-02-16T11:06:32+01:00 https://www.caf-dcf.be/fr/litterature/controversies-regarding-albumin-therapy-in-cirrhosis/ 2024-02-16T11:06:02+01:00 https://www.caf-dcf.be/litterature/management-of-pregnancy-and-delivery-in-congenital-fibrinogen-disorders-communication-from-the-isth-ssc-subcommittee-on-factor-xiii-and-fibrinogen/ 2024-02-16T11:03:36+01:00 https://www.caf-dcf.be/fr/litterature/management-of-pregnancy-and-delivery-in-congenital-fibrinogen-disorders-communication-from-the-isth-ssc-subcommittee-on-factor-xiii-and-fibrinogen/ 2024-02-16T11:03:05+01:00 https://www.caf-dcf.be/fr/litterature/impact-of-2021-european-academy-of-neurology-peripheral-nerve-society-diagnostic-criteria-on-diagnosis-and-therapy-of-chronic-inflammatory-demyelinating-polyradiculoneuropathy-variants/ 2024-02-16T11:01:36+01:00 https://www.caf-dcf.be/litterature/impact-of-2021-european-academy-of-neurology-peripheral-nerve-society-diagnostic-criteria-on-diagnosis-and-therapy-of-chronic-inflammatory-demyelinating-polyradiculoneuropathy-variants/ 2024-02-16T11:01:36+01:00 https://www.caf-dcf.be/fr/litterature/myasthenia-gravis-the-changing-treatment-landscape-in-the-era-of-molecular-therapies/ 2024-02-16T10:59:16+01:00 https://www.caf-dcf.be/litterature/myasthenia-gravis-the-changing-treatment-landscape-in-the-era-of-molecular-therapies/ 2024-02-16T10:59:16+01:00 https://www.caf-dcf.be/fr/litterature/acquired-hemophilia-a-after-multiple-transfusions-following-trauma/ 2024-02-16T10:57:41+01:00 https://www.caf-dcf.be/litterature/acquired-hemophilia-a-after-multiple-transfusions-following-trauma/ 2024-02-16T10:57:41+01:00 https://www.caf-dcf.be/fr/litterature/the-under-evaluated-impacts-of-the-therapeutic-revolution-of-hemophilia-on-women-and-girls/ 2024-02-16T10:56:03+01:00 https://www.caf-dcf.be/litterature/the-under-evaluated-impacts-of-the-therapeutic-revolution-of-hemophilia-on-women-and-girls/ 2024-02-16T10:56:03+01:00 https://www.caf-dcf.be/fr/litterature/determinants-of-bleeding-before-and-during-immune-tolerance-in-222-boys-with-severe-hemophilia-a-and-inhibitors-5-bu/ 2024-02-16T10:54:14+01:00 https://www.caf-dcf.be/litterature/determinants-of-bleeding-before-and-during-immune-tolerance-in-222-boys-with-severe-hemophilia-a-and-inhibitors-5-bu/ 2024-02-16T10:54:14+01:00 https://www.caf-dcf.be/fr/litterature/the-world-federation-of-hemophilia-world-bleeding-disorders-registry-insights-from-the-first-10000-patients/ 2024-02-16T10:52:24+01:00 https://www.caf-dcf.be/litterature/the-world-federation-of-hemophilia-world-bleeding-disorders-registry-insights-from-the-first-10000-patients/ 2024-02-16T10:52:24+01:00 https://www.caf-dcf.be/litterature/hereditary-coagulation-factor-xi-deficiency-a-rare-or-neglected-disease-results-from-a-retrospective-single-centre-cohort-in-northern-italy/ 2024-02-16T10:50:38+01:00 https://www.caf-dcf.be/fr/litterature/hereditary-coagulation-factor-xi-deficiency-a-rare-or-neglected-disease-results-from-a-retrospective-single-centre-cohort-in-northern-italy/ 2024-02-16T10:50:37+01:00 https://www.caf-dcf.be/fr/litterature/factor-xi-deficiency-phenotypic-age-related-considerations-and-clinical-approach-towards-bleeding-risk-assessment/ 2024-02-16T10:43:30+01:00 https://www.caf-dcf.be/litterature/factor-xi-deficiency-phenotypic-age-related-considerations-and-clinical-approach-towards-bleeding-risk-assessment/ 2024-02-16T10:43:30+01:00 https://www.caf-dcf.be/fr/litterature/impact-of-inherited-bleeding-disorders-on-maternal-bleeding-and-other-pregnancy-outcomes-a-population-based-cohort-study/ 2024-02-16T10:41:14+01:00 https://www.caf-dcf.be/litterature/impact-of-inherited-bleeding-disorders-on-maternal-bleeding-and-other-pregnancy-outcomes-a-population-based-cohort-study/ 2024-02-16T10:41:14+01:00 https://www.caf-dcf.be/fr/litterature/minimum-factor-viii-levels-to-prevent-joint-bleeding-in-mild-hemophilia-a/ 2024-02-16T10:38:52+01:00 https://www.caf-dcf.be/litterature/minimum-factor-viii-levels-to-prevent-joint-bleeding-in-mild-hemophilia-a/ 2024-02-16T10:38:52+01:00 https://www.caf-dcf.be/litterature/fibrinogen-early-in-severe-trauma-study-feisty-results-from-an-australian-multicenter-randomized-controlled-pilot-trial/ 2024-01-12T14:37:42+01:00 https://www.caf-dcf.be/fr/litterature/fibrinogen-early-in-severe-trauma-study-feisty-results-from-an-australian-multicenter-randomized-controlled-pilot-trial/ 2024-01-12T14:37:10+01:00 https://www.caf-dcf.be/fr/litterature/acquired-hemophilia-a-a-rare-acquired-coagulopathy-in-the-postpartum-setting/ 2024-01-12T14:35:35+01:00 https://www.caf-dcf.be/litterature/acquired-hemophilia-a-a-rare-acquired-coagulopathy-in-the-postpartum-setting/ 2024-01-12T14:35:35+01:00 https://www.caf-dcf.be/fr/litterature/key-drivers-of-coagulation-factor-use-in-von-willebrand-disease-during-hospitalization-an-overview-of-the-french-berhlingo-cohort/ 2024-01-12T14:33:58+01:00 https://www.caf-dcf.be/litterature/key-drivers-of-coagulation-factor-use-in-von-willebrand-disease-during-hospitalization-an-overview-of-the-french-berhlingo-cohort/ 2024-01-12T14:33:58+01:00 https://www.caf-dcf.be/fr/litterature/association-of-patient-treatment-and-disease-characteristics-with-patient-reported-outcomes-results-of-the-echo-registry/ 2024-01-12T14:32:22+01:00 https://www.caf-dcf.be/litterature/association-of-patient-treatment-and-disease-characteristics-with-patient-reported-outcomes-results-of-the-echo-registry/ 2024-01-12T14:32:22+01:00 https://www.caf-dcf.be/fr/litterature/the-year-in-coagulation-and-transfusion-selected-highlights-from-2022/ 2024-01-12T14:30:35+01:00 https://www.caf-dcf.be/litterature/the-year-in-coagulation-and-transfusion-selected-highlights-from-2022/ 2024-01-12T14:30:35+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-factor-aging-is-better/ 2024-01-12T14:29:07+01:00 https://www.caf-dcf.be/litterature/von-willebrand-factor-aging-is-better/ 2024-01-12T14:29:07+01:00 https://www.caf-dcf.be/litterature/association-between-clauss-fibrinogen-concentration-and-rotem-fibtem/ 2024-01-12T14:27:23+01:00 https://www.caf-dcf.be/fr/litterature/association-between-clauss-fibrinogen-concentration-and-rotem-fibtem/ 2024-01-12T14:27:23+01:00 https://www.caf-dcf.be/fr/litterature/european-pathways-of-care-in-alpha-1-antitrypsin-deficiency/ 2024-01-12T14:23:53+01:00 https://www.caf-dcf.be/litterature/european-pathways-of-care-in-alpha-1-antitrypsin-deficiency/ 2024-01-12T14:23:53+01:00 https://www.caf-dcf.be/fr/litterature/treatment-for-alpha-1-antitrypsin-deficiency-does-augmentation-therapy-work/ 2024-01-12T14:22:23+01:00 https://www.caf-dcf.be/litterature/treatment-for-alpha-1-antitrypsin-deficiency-does-augmentation-therapy-work/ 2024-01-12T14:22:23+01:00 https://www.caf-dcf.be/fr/litterature/inhibitor-development-according-to-concentrate-in-severe-hemophilia-reporting-on-1392-previously-untreated-patients-from-europe-and-canada/ 2024-01-12T14:20:26+01:00 https://www.caf-dcf.be/litterature/inhibitor-development-according-to-concentrate-in-severe-hemophilia-reporting-on-1392-previously-untreated-patients-from-europe-and-canada/ 2024-01-12T14:20:26+01:00 https://www.caf-dcf.be/litterature/viscoelastic-testing-methods/ 2024-01-12T14:02:51+01:00 https://www.caf-dcf.be/fr/litterature/viscoelastic-testing-methods/ 2024-01-12T14:02:17+01:00 https://www.caf-dcf.be/litterature/the-molecular-structure-of-fibrinogen/ 2024-01-12T14:00:36+01:00 https://www.caf-dcf.be/fr/litterature/the-molecular-structure-of-fibrinogen/ 2024-01-12T13:59:59+01:00 https://www.caf-dcf.be/litterature/international-council-for-standardization-in-haematology-recommendations-on-fibrinogen-assays-thrombin-clotting-time-and-related-tests-in-the-investigation-of-bleeding-disorders/ 2024-01-12T13:58:34+01:00 https://www.caf-dcf.be/fr/litterature/international-council-for-standardization-in-haematology-recommendations-on-fibrinogen-assays-thrombin-clotting-time-and-related-tests-in-the-investigation-of-bleeding-disorders/ 2024-01-12T13:58:08+01:00 https://www.caf-dcf.be/litterature/prothrombin-complex-concentrate-pcc-for-treatment-of-trauma-induced-coagulopathy-systematic-review-and-meta-analyses/ 2024-01-12T13:56:26+01:00 https://www.caf-dcf.be/fr/litterature/prothrombin-complex-concentrate-pcc-for-treatment-of-trauma-induced-coagulopathy-systematic-review-and-meta-analyses/ 2024-01-12T13:55:51+01:00 https://www.caf-dcf.be/litterature/early-goal-directed-hemostatic-therapy-for-severe-acute-bleeding-management-in-the-intensive-care-unit-a-narrative-review/ 2024-01-12T13:53:34+01:00 https://www.caf-dcf.be/fr/litterature/early-goal-directed-hemostatic-therapy-for-severe-acute-bleeding-management-in-the-intensive-care-unit-a-narrative-review/ 2024-01-12T13:52:49+01:00 https://www.caf-dcf.be/fr/litterature/efficacy-of-emicizumab-is-maintained-throughout-dosing-intervals-for-bleed-prophylaxis/ 2024-01-12T13:50:21+01:00 https://www.caf-dcf.be/litterature/efficacy-of-emicizumab-is-maintained-throughout-dosing-intervals-for-bleed-prophylaxis/ 2024-01-12T13:50:21+01:00 https://www.caf-dcf.be/fr/litterature/innovations-2022-in-hemostasis-and-thrombosis-whats-new/ 2024-01-12T13:48:23+01:00 https://www.caf-dcf.be/litterature/innovations-2022-in-hemostasis-and-thrombosis-whats-new/ 2024-01-12T13:48:23+01:00 https://www.caf-dcf.be/litterature/von-willebrand-factor-as-a-biomarker-for-liver-disease-an-update/ 2024-01-12T13:46:43+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-factor-as-a-biomarker-for-liver-disease-an-update/ 2024-01-12T13:46:42+01:00 https://www.caf-dcf.be/fr/litterature/prophylactic-and-therapeutic-strategies-for-intraoperative-bleeding-in-women-with-von-willebrand-disease-and-heavy-menstrual-bleeding-a-systematic-review/ 2024-01-12T12:15:43+01:00 https://www.caf-dcf.be/litterature/prophylactic-and-therapeutic-strategies-for-intraoperative-bleeding-in-women-with-von-willebrand-disease-and-heavy-menstrual-bleeding-a-systematic-review/ 2024-01-12T12:15:43+01:00 https://www.caf-dcf.be/litterature/preoperative-fibrinogen-level-and-blood-transfusions-in-liver-transplantation-a-systematic-review/ 2023-11-07T11:11:22+01:00 https://www.caf-dcf.be/fr/litterature/preoperative-fibrinogen-level-and-blood-transfusions-in-liver-transplantation-a-systematic-review/ 2023-11-07T11:10:48+01:00 https://www.caf-dcf.be/litterature/fifty-years-of-fibrinogen-structure-and-function/ 2023-11-07T11:08:48+01:00 https://www.caf-dcf.be/fr/litterature/fifty-years-of-fibrinogen-structure-and-function/ 2023-11-07T11:08:17+01:00 https://www.caf-dcf.be/litterature/trauma-induced-coagulopathy-what-you-need-to-know/ 2023-11-07T11:06:27+01:00 https://www.caf-dcf.be/fr/litterature/trauma-induced-coagulopathy-what-you-need-to-know/ 2023-11-07T11:05:57+01:00 https://www.caf-dcf.be/litterature/management-of-major-bleeding-for-anticoagulated-patients-in-the-emergency-department-an-european-experts-consensus-statement/ 2023-11-07T11:03:55+01:00 https://www.caf-dcf.be/fr/litterature/management-of-major-bleeding-for-anticoagulated-patients-in-the-emergency-department-an-european-experts-consensus-statement/ 2023-11-07T11:03:17+01:00 https://www.caf-dcf.be/fr/litterature/efficacy-and-safety-of-intravenous-immunoglobulin-treatment-in-selected-neurological-diseases-one-centres-experience-based-on-the-therapy-of-141-patients/ 2023-11-07T11:00:23+01:00 https://www.caf-dcf.be/litterature/efficacy-and-safety-of-intravenous-immunoglobulin-treatment-in-selected-neurological-diseases-one-centres-experience-based-on-the-therapy-of-141-patients/ 2023-11-07T11:00:23+01:00 https://www.caf-dcf.be/fr/litterature/low-dose-intravenous-immunoglobulin-ivig-in-different-immune-mediated-conditions/ 2023-11-07T10:45:25+01:00 https://www.caf-dcf.be/litterature/low-dose-intravenous-immunoglobulin-ivig-in-different-immune-mediated-conditions/ 2023-11-07T10:45:25+01:00 https://www.caf-dcf.be/fr/litterature/anti-inflammatory-and-immunomodulatory-effect-of-high-dose-immunoglobulins-in-children-from-approved-indications-to-off-label-use/ 2023-11-07T10:43:30+01:00 https://www.caf-dcf.be/litterature/anti-inflammatory-and-immunomodulatory-effect-of-high-dose-immunoglobulins-in-children-from-approved-indications-to-off-label-use/ 2023-11-07T10:43:30+01:00 https://www.caf-dcf.be/fr/litterature/coagulation-factors-ii-v-vii-ix-x-and-xi-and-mortality-a-cohort-study/ 2023-11-07T10:41:21+01:00 https://www.caf-dcf.be/litterature/coagulation-factors-ii-v-vii-ix-x-and-xi-and-mortality-a-cohort-study/ 2023-11-07T10:41:21+01:00 https://www.caf-dcf.be/fr/litterature/hemophilia-gene-therapy-first-do-no-harm/ 2023-11-07T10:39:23+01:00 https://www.caf-dcf.be/litterature/hemophilia-gene-therapy-first-do-no-harm/ 2023-11-07T10:39:23+01:00 https://www.caf-dcf.be/fr/litterature/clinical-and-laboratory-presentation-and-underlying-mechanism-in-patients-with-low-vwf/ 2023-11-07T10:37:22+01:00 https://www.caf-dcf.be/litterature/clinical-and-laboratory-presentation-and-underlying-mechanism-in-patients-with-low-vwf/ 2023-11-07T10:37:22+01:00 https://www.caf-dcf.be/fr/litterature/acquired-hemophilia-a-bleeding-pattern-and-hemostatic-therapeutic-strategies/ 2023-11-07T10:35:25+01:00 https://www.caf-dcf.be/litterature/acquired-hemophilia-a-bleeding-pattern-and-hemostatic-therapeutic-strategies/ 2023-11-07T10:35:25+01:00 https://www.caf-dcf.be/fr/litterature/targeting-von-willebrand-disease-the-current-status-and-future-directions-of-management-therapies/ 2023-11-07T10:33:27+01:00 https://www.caf-dcf.be/litterature/targeting-von-willebrand-disease-the-current-status-and-future-directions-of-management-therapies/ 2023-11-07T10:33:27+01:00 https://www.caf-dcf.be/fr/litterature/accreditation-model-of-european-haemophilia-centers-in-the-era-of-novel-treatments-and-gene-therapy/ 2023-11-07T10:31:36+01:00 https://www.caf-dcf.be/litterature/accreditation-model-of-european-haemophilia-centers-in-the-era-of-novel-treatments-and-gene-therapy/ 2023-11-07T10:31:36+01:00 https://www.caf-dcf.be/fr/litterature/eptacog-beta-efficacy-and-safety-in-underweight-normal-weight-and-overweight-obese-persons-with-hemophilia-a-or-b-and-inhibitors/ 2023-11-07T10:28:26+01:00 https://www.caf-dcf.be/litterature/eptacog-beta-efficacy-and-safety-in-underweight-normal-weight-and-overweight-obese-persons-with-hemophilia-a-or-b-and-inhibitors/ 2023-11-07T10:28:26+01:00 https://www.caf-dcf.be/litterature/real-world-experience-with-a-human-fibrinogen-concentrate-clinical-data-from-adult-and-pediatric-patients-requiring-fibrinogen-for-bleeding-control-and-prevention/ 2023-07-04T12:43:52+01:00 https://www.caf-dcf.be/fr/litterature/real-world-experience-with-a-human-fibrinogen-concentrate-clinical-data-from-adult-and-pediatric-patients-requiring-fibrinogen-for-bleeding-control-and-prevention/ 2023-07-04T12:43:32+01:00 https://www.caf-dcf.be/litterature/interventions-of-postpartum-hemorrhage/ 2023-07-04T12:42:04+01:00 https://www.caf-dcf.be/fr/litterature/interventions-of-postpartum-hemorrhage/ 2023-07-04T12:41:43+01:00 https://www.caf-dcf.be/litterature/association-between-plasma-fibrinogen-concentration-after-cardiopulmonary-bypass-and-postoperative-blood-loss-in-children-undergoing-cardiac-surgery-a-retrospective-cohort-study/ 2023-07-04T12:40:29+01:00 https://www.caf-dcf.be/fr/litterature/association-between-plasma-fibrinogen-concentration-after-cardiopulmonary-bypass-and-postoperative-blood-loss-in-children-undergoing-cardiac-surgery-a-retrospective-cohort-study/ 2023-07-04T12:40:11+01:00 https://www.caf-dcf.be/litterature/gastrointestinal-bleeding-in-recipients-of-left-ventricular-assist-devices-a-systematic-review/ 2023-07-04T12:38:12+01:00 https://www.caf-dcf.be/fr/litterature/gastrointestinal-bleeding-in-recipients-of-left-ventricular-assist-devices-a-systematic-review/ 2023-07-04T12:37:35+01:00 https://www.caf-dcf.be/fr/litterature/fatigue-depression-and-product-tolerability-during-long-term-treatment-with-intravenous-immunoglobulin-gamunex-10-in-patients-with-chronic-inflammatory-demyelinating-polyneuropathy/ 2023-07-04T12:36:06+01:00 https://www.caf-dcf.be/litterature/fatigue-depression-and-product-tolerability-during-long-term-treatment-with-intravenous-immunoglobulin-gamunex-10-in-patients-with-chronic-inflammatory-demyelinating-polyneuropathy/ 2023-07-04T12:36:06+01:00 https://www.caf-dcf.be/fr/litterature/the-unknown-functions-of-a-known-protein-the-case-of-coagulation-factor-xi/ 2023-07-04T12:34:21+01:00 https://www.caf-dcf.be/litterature/the-unknown-functions-of-a-known-protein-the-case-of-coagulation-factor-xi/ 2023-07-04T12:34:21+01:00 https://www.caf-dcf.be/fr/litterature/no-immunological-changes-after-factor-viii-product-switch-an-in-depth-analysis-in-haemophilia-a-patients/ 2023-07-04T12:32:39+01:00 https://www.caf-dcf.be/litterature/no-immunological-changes-after-factor-viii-product-switch-an-in-depth-analysis-in-haemophilia-a-patients/ 2023-07-04T12:32:39+01:00 https://www.caf-dcf.be/fr/litterature/hematological-treatment-and-prophylaxis-in-patients-with-and-without-inhibitors/ 2023-07-04T12:31:05+01:00 https://www.caf-dcf.be/litterature/hematological-treatment-and-prophylaxis-in-patients-with-and-without-inhibitors/ 2023-07-04T12:31:05+01:00 https://www.caf-dcf.be/fr/litterature/bleeding-events-in-people-with-congenital-haemophilia-a-without-factor-viii-inhibitors-receiving-prophylactic-factor-viii-treatment-a-systematic-literature-review/ 2023-07-04T12:29:44+01:00 https://www.caf-dcf.be/litterature/bleeding-events-in-people-with-congenital-haemophilia-a-without-factor-viii-inhibitors-receiving-prophylactic-factor-viii-treatment-a-systematic-literature-review/ 2023-07-04T12:29:44+01:00 https://www.caf-dcf.be/fr/litterature/recombinant-fviii-the-milestone-of-modern-hemophilia-treatment/ 2023-07-04T12:28:11+01:00 https://www.caf-dcf.be/litterature/recombinant-fviii-the-milestone-of-modern-hemophilia-treatment/ 2023-07-04T12:28:11+01:00 https://www.caf-dcf.be/fr/litterature/towards-achieving-a-haemophilia-free-mind/ 2023-07-04T12:26:37+01:00 https://www.caf-dcf.be/litterature/towards-achieving-a-haemophilia-free-mind/ 2023-07-04T12:26:37+01:00 https://www.caf-dcf.be/fr/litterature/emicizumab-for-acquired-haemophilia-a-a-case-series/ 2023-07-04T10:41:00+01:00 https://www.caf-dcf.be/litterature/emicizumab-for-acquired-haemophilia-a-a-case-series/ 2023-07-04T10:41:00+01:00 https://www.caf-dcf.be/litterature/perioperative-outcomes-of-patients-with-bleeding-disorders-undergoing-major-surgery-at-an-academic-hemophilia-treatment-center/ 2023-05-26T09:43:15+01:00 https://www.caf-dcf.be/fr/litterature/perioperative-outcomes-of-patients-with-bleeding-disorders-undergoing-major-surgery-at-an-academic-hemophilia-treatment-center/ 2023-05-26T09:42:44+01:00 https://www.caf-dcf.be/litterature/coagulation-management-and-transfusion-in-massive-postpartum-hemorrhage/ 2023-05-26T09:40:58+01:00 https://www.caf-dcf.be/fr/litterature/coagulation-management-and-transfusion-in-massive-postpartum-hemorrhage/ 2023-05-26T09:40:31+01:00 https://www.caf-dcf.be/litterature/physiological-and-clinical-effects-of-different-infusion-rates-of-intravenous-fluids-for-volume-expansion-a-scoping-review/ 2023-05-26T09:38:52+01:00 https://www.caf-dcf.be/fr/litterature/physiological-and-clinical-effects-of-different-infusion-rates-of-intravenous-fluids-for-volume-expansion-a-scoping-review/ 2023-05-26T09:38:17+01:00 https://www.caf-dcf.be/fr/litterature/immune-mediated-neuropathies-pathophysiology-and-management/ 2023-05-26T08:56:54+01:00 https://www.caf-dcf.be/litterature/immune-mediated-neuropathies-pathophysiology-and-management/ 2023-05-26T08:56:54+01:00 https://www.caf-dcf.be/fr/litterature/antibody-diversity-in-ivig-therapeutic-opportunities-for-novel-immunotherapeutic-drugs/ 2023-05-26T08:54:49+01:00 https://www.caf-dcf.be/litterature/antibody-diversity-in-ivig-therapeutic-opportunities-for-novel-immunotherapeutic-drugs/ 2023-05-26T08:54:49+01:00 https://www.caf-dcf.be/fr/litterature/efficacy-and-safety-of-damoctocog-alfa-pegol-prophylaxis-in-patients-⩾40-years-with-severe-haemophilia-a-and-comorbidities-post-hoc-analysis-from-the-protect-viii-study/ 2023-05-26T08:49:21+01:00 https://www.caf-dcf.be/litterature/efficacy-and-safety-of-damoctocog-alfa-pegol-prophylaxis-in-patients-⩾40-years-with-severe-haemophilia-a-and-comorbidities-post-hoc-analysis-from-the-protect-viii-study/ 2023-05-26T08:49:21+01:00 https://www.caf-dcf.be/fr/litterature/a-thrombophilic-allele-of-clotting-factor-vii-viia-promoting-recurrent-pulmonary-emboli-clinical-details-and-a-structural-model-of-the-altered-protein-a-case-report/ 2023-05-26T08:47:20+01:00 https://www.caf-dcf.be/litterature/a-thrombophilic-allele-of-clotting-factor-vii-viia-promoting-recurrent-pulmonary-emboli-clinical-details-and-a-structural-model-of-the-altered-protein-a-case-report/ 2023-05-26T08:47:20+01:00 https://www.caf-dcf.be/fr/litterature/eftrenonacog-alfa-a-review-in-haemophilia-b/ 2023-05-26T08:44:46+01:00 https://www.caf-dcf.be/litterature/eftrenonacog-alfa-a-review-in-haemophilia-b/ 2023-05-26T08:44:46+01:00 https://www.caf-dcf.be/fr/litterature/plasma-kallikrein-as-a-forgotten-clotting-factor/ 2023-05-26T08:25:06+01:00 https://www.caf-dcf.be/litterature/plasma-kallikrein-as-a-forgotten-clotting-factor/ 2023-05-26T08:25:06+01:00 https://www.caf-dcf.be/litterature/a-real-world-evidence-analysis-of-the-impact-of-switching-from-factor-viii-to-emicizumab-prophylaxis-in-patients-with-hemophilia-a-without-inhibitors/ 2023-05-26T08:22:12+01:00 https://www.caf-dcf.be/fr/litterature/a-real-world-evidence-analysis-of-the-impact-of-switching-from-factor-viii-to-emicizumab-prophylaxis-in-patients-with-hemophilia-a-without-inhibitors/ 2023-05-26T08:22:11+01:00 https://www.caf-dcf.be/fr/litterature/real-world-analysis-of-patients-with-haemophilia-a-and-haemophilia-a-carriers-in-the-united-states-demographics-clinical-characteristics-and-costs/ 2023-05-26T08:19:50+01:00 https://www.caf-dcf.be/litterature/real-world-analysis-of-patients-with-haemophilia-a-and-haemophilia-a-carriers-in-the-united-states-demographics-clinical-characteristics-and-costs/ 2023-05-26T08:19:50+01:00 https://www.caf-dcf.be/litterature/considerations-for-shared-decision-management-in-previously-untreated-patients-with-hemophilia-a-or-b/ 2023-05-26T08:16:41+01:00 https://www.caf-dcf.be/fr/litterature/considerations-for-shared-decision-management-in-previously-untreated-patients-with-hemophilia-a-or-b/ 2023-05-26T08:16:41+01:00 https://www.caf-dcf.be/litterature/post-marketing-observational-study-of-the-safety-and-efficacy-of-fibrinogen-concentrate-in-congenital-fibrinogen-deficiency-in-patients-of-all-ages/ 2023-05-23T13:19:07+01:00 https://www.caf-dcf.be/fr/litterature/post-marketing-observational-study-of-the-safety-and-efficacy-of-fibrinogen-concentrate-in-congenital-fibrinogen-deficiency-in-patients-of-all-ages/ 2023-05-23T13:18:37+01:00 https://www.caf-dcf.be/litterature/comprehensive-analysis-of-coagulation-factor-delivery-strategies-in-a-cohort-of-trauma-patients/ 2023-05-23T13:15:53+01:00 https://www.caf-dcf.be/fr/litterature/comprehensive-analysis-of-coagulation-factor-delivery-strategies-in-a-cohort-of-trauma-patients/ 2023-05-23T13:15:13+01:00 https://www.caf-dcf.be/litterature/perioperative-management-of-a-patient-with-hemophilia-c-and-allergy-to-fresh-frozen-plasma/ 2023-05-23T13:12:28+01:00 https://www.caf-dcf.be/fr/litterature/perioperative-management-of-a-patient-with-hemophilia-c-and-allergy-to-fresh-frozen-plasma/ 2023-05-23T13:11:56+01:00 https://www.caf-dcf.be/litterature/potential-for-prolongation-of-fibrinogen-concentrates-post-reconstitution/ 2023-05-23T13:09:08+01:00 https://www.caf-dcf.be/fr/litterature/potential-for-prolongation-of-fibrinogen-concentrates-post-reconstitution/ 2023-05-23T13:07:15+01:00 https://www.caf-dcf.be/litterature/prediction-of-hypofibrinogenaemia-based-on-the-starting-fibrinogen-and-extent-of-haemodilution-during-cardiac-surgery/ 2023-05-23T13:04:20+01:00 https://www.caf-dcf.be/fr/litterature/prediction-of-hypofibrinogenaemia-based-on-the-starting-fibrinogen-and-extent-of-haemodilution-during-cardiac-surgery/ 2023-05-23T13:03:12+01:00 https://www.caf-dcf.be/fr/litterature/increased-access-to-immunoglobulin-replacement-therapy-for-patients-with-primary-immunodeficiency-in-poland-based-on-clinical-usage-data-of-immunoglobulin-g-over-a-5-year-period/ 2023-05-23T13:00:13+01:00 https://www.caf-dcf.be/fr/litterature/comparison-of-ivig-and-tpe-efficacy-in-the-treatment-of-neurological-disorders-a-systematic-literature-review/ 2023-05-23T12:56:36+01:00 https://www.caf-dcf.be/fr/litterature/use-of-immunoglobulin-replacement-therapy-in-patients-with-secondary-antibody-deficiency-in-daily-practice-a-european-expert-qa-based-review/ 2023-05-23T11:19:38+01:00 https://www.caf-dcf.be/fr/litterature/secondary-immunodeficiencies-and-infectious-considerations-of-biologic-immunomodulatory-therapies/ 2023-05-23T11:16:46+01:00 https://www.caf-dcf.be/fr/litterature/intravenous-immunoglobulin-mechanism-of-action-in-autoimmune-and-inflammatory-conditions/ 2023-05-23T11:10:55+01:00 https://www.caf-dcf.be/fr/litterature/real-pandemic-world-results-of-pharmacokinetic-tailored-personalized-prophylaxis-of-bleeds-in-polish-children-and-adolescents-with-severe-hemophilia-a/ 2023-05-23T11:08:43+01:00 https://www.caf-dcf.be/fr/litterature/current-understanding-of-inherited-modifiers-of-fviii-pharmacokinetic-variation/ 2023-05-23T11:02:30+01:00 https://www.caf-dcf.be/fr/litterature/health-related-quality-of-life-and-psychopathological-symptoms-in-people-with-hemophilia-bloodborne-co-infections-and-comorbidities-an-italian-multicenter-observational-study/ 2023-05-23T11:00:18+01:00 https://www.caf-dcf.be/fr/litterature/haemophilia-a-a-review-of-clinical-manifestations-treatment-mutations-and-the-development-of-inhibitors/ 2023-05-23T10:56:46+01:00 https://www.caf-dcf.be/fr/litterature/suspected-adverse-reactions-reported-for-blood-blood-components-and-blood-products-in-vigibase/ 2023-05-23T10:54:52+01:00 https://www.caf-dcf.be/litterature/suspected-adverse-reactions-reported-for-blood-blood-components-and-blood-products-in-vigibase/ 2023-05-23T10:54:52+01:00 https://www.caf-dcf.be/fr/litterature/alpha-1-antitrypsin-deficiency-current-therapy-and-emerging-targets/ 2023-05-23T10:51:20+01:00 https://www.caf-dcf.be/fr/litterature/prenatal-screening-service-for-fetal-rhd-genotyping-to-guide-prophylaxis-the-two-year-experience-of-the-friuli-venezia-giulia-region-in-italy/ 2023-05-23T09:59:15+01:00 https://www.caf-dcf.be/litterature/prenatal-screening-service-for-fetal-rhd-genotyping-to-guide-prophylaxis-the-two-year-experience-of-the-friuli-venezia-giulia-region-in-italy/ 2023-05-23T09:59:15+01:00 https://www.caf-dcf.be/fr/litterature/factor-vii-activating-protease-fsap-and-its-importance-in-hemostasis-part-i-fsap-structure-synthesis-and-activity-regulation-a-narrative-review/ 2023-05-22T15:19:45+01:00 https://www.caf-dcf.be/litterature/factor-vii-activating-protease-fsap-and-its-importance-in-hemostasis-part-i-fsap-structure-synthesis-and-activity-regulation-a-narrative-review/ 2023-05-22T15:19:45+01:00 https://www.caf-dcf.be/fr/litterature/efanesoctocog-alfa-first-approval/ 2023-05-22T15:17:18+01:00 https://www.caf-dcf.be/litterature/efanesoctocog-alfa-first-approval/ 2023-05-22T15:17:18+01:00 https://www.caf-dcf.be/fr/litterature/current-factor-ix-replacement-options-for-hemophilia-b-and-the-challenges-ahead/ 2023-05-22T15:15:35+01:00 https://www.caf-dcf.be/litterature/current-factor-ix-replacement-options-for-hemophilia-b-and-the-challenges-ahead/ 2023-05-22T15:15:35+01:00 https://www.caf-dcf.be/fr/litterature/impact-of-switching-prophylaxis-treatment-from-factor-viii-to-emicizumab-in-hemophilia-a-patients-without-inhibitors/ 2023-05-22T15:13:46+01:00 https://www.caf-dcf.be/litterature/impact-of-switching-prophylaxis-treatment-from-factor-viii-to-emicizumab-in-hemophilia-a-patients-without-inhibitors/ 2023-05-22T15:13:46+01:00 https://www.caf-dcf.be/fr/litterature/budget-impact-of-prophylactic-treatment-of-rviii-singlechain-in-moderate-and-severe-hemophilia-a-in-italy/ 2023-05-22T15:11:40+01:00 https://www.caf-dcf.be/litterature/budget-impact-of-prophylactic-treatment-of-rviii-singlechain-in-moderate-and-severe-hemophilia-a-in-italy/ 2023-05-22T15:11:40+01:00 https://www.caf-dcf.be/fr/litterature/clinical-predictors-and-prediction-models-for-rfviii-fc-half-life-in-real-world-people-with-severe-hemophilia-a/ 2023-05-22T15:09:38+01:00 https://www.caf-dcf.be/litterature/clinical-predictors-and-prediction-models-for-rfviii-fc-half-life-in-real-world-people-with-severe-hemophilia-a/ 2023-05-22T15:09:38+01:00 https://www.caf-dcf.be/fr/litterature/safe-and-successful-surgical-outcome-in-persons-with-hemophilia-a-with-and-without-inhibitors-treated-with-emicizumab-a-large-single-center-real-world-experience/ 2023-05-22T14:38:47+01:00 https://www.caf-dcf.be/litterature/safe-and-successful-surgical-outcome-in-persons-with-hemophilia-a-with-and-without-inhibitors-treated-with-emicizumab-a-large-single-center-real-world-experience/ 2023-05-22T14:38:47+01:00 https://www.caf-dcf.be/fr/litterature/immune-tolerance-against-infused-fviii-in-hemophilia-a-is-mediated-by-pd-l1/ 2023-05-22T14:35:53+01:00 https://www.caf-dcf.be/litterature/immune-tolerance-against-infused-fviii-in-hemophilia-a-is-mediated-by-pd-l1/ 2023-05-22T14:35:53+01:00 https://www.caf-dcf.be/fr/litterature/eu-gets-first-hemophilia-b-gene-therapy/ 2023-05-22T14:11:47+01:00 https://www.caf-dcf.be/litterature/eu-gets-first-hemophilia-b-gene-therapy/ 2023-05-22T14:11:47+01:00 https://www.caf-dcf.be/litterature/alternative-blood-products-in-trauma/ 2023-05-11T13:30:12+01:00 https://www.caf-dcf.be/fr/litterature/alternative-blood-products-in-trauma/ 2023-05-11T13:29:54+01:00 https://www.caf-dcf.be/litterature/blood-product-replacement-for-postpartum-hemorrhage/ 2023-05-11T13:27:36+01:00 https://www.caf-dcf.be/fr/litterature/blood-product-replacement-for-postpartum-hemorrhage/ 2023-05-11T13:27:18+01:00 https://www.caf-dcf.be/litterature/comparison-of-prothrombin-complex-concentrate-with-activated-factor-vii-use-for-bleeding-following-cardiopulmonary-bypass-in-children-2/ 2023-05-11T13:25:42+01:00 https://www.caf-dcf.be/fr/litterature/comparison-of-prothrombin-complex-concentrate-with-activated-factor-vii-use-for-bleeding-following-cardiopulmonary-bypass-in-children-2/ 2023-05-11T13:25:13+01:00 https://www.caf-dcf.be/litterature/transfusion-management-in-trauma-what-is-current-best-practice/ 2023-05-11T13:23:17+01:00 https://www.caf-dcf.be/fr/litterature/transfusion-management-in-trauma-what-is-current-best-practice/ 2023-05-11T13:22:46+01:00 https://www.caf-dcf.be/litterature/intravenous-and-subcutaneous-immunoglobulins-associated-eczematous-reactions-occur-with-a-broad-range-of-immunoglobulin-types-a-french-national-multicenter-study/ 2023-05-11T13:20:04+01:00 https://www.caf-dcf.be/fr/litterature/intravenous-and-subcutaneous-immunoglobulins-associated-eczematous-reactions-occur-with-a-broad-range-of-immunoglobulin-types-a-french-national-multicenter-study/ 2023-05-11T13:20:03+01:00 https://www.caf-dcf.be/fr/litterature/management-of-hypogammaglobulinemia/ 2023-05-11T13:17:36+01:00 https://www.caf-dcf.be/litterature/management-of-hypogammaglobulinemia/ 2023-05-11T13:17:36+01:00 https://www.caf-dcf.be/fr/litterature/immune-globulin-usage-trends-in-commercially-insured-and-medicare-populations-2009-2019/ 2023-05-11T13:14:21+01:00 https://www.caf-dcf.be/litterature/immune-globulin-usage-trends-in-commercially-insured-and-medicare-populations-2009-2019/ 2023-05-11T13:14:21+01:00 https://www.caf-dcf.be/litterature/intravenous-immunoglobulin-in-chronic-inflammatory-demyelinating-polyradiculoneuropathy-cidp-mechanisms-of-action-and-clinical-and-genetic-considerations/ 2023-05-11T13:12:25+01:00 https://www.caf-dcf.be/fr/litterature/intravenous-immunoglobulin-in-chronic-inflammatory-demyelinating-polyradiculoneuropathy-cidp-mechanisms-of-action-and-clinical-and-genetic-considerations/ 2023-05-11T13:12:24+01:00 https://www.caf-dcf.be/fr/litterature/acquired-hemophilia-a-an-update-on-the-etiopathogenesis-diagnosis-and-treatment/ 2023-05-11T13:09:38+01:00 https://www.caf-dcf.be/litterature/acquired-hemophilia-a-an-update-on-the-etiopathogenesis-diagnosis-and-treatment/ 2023-05-11T13:09:38+01:00 https://www.caf-dcf.be/fr/litterature/management-of-rare-inherited-bleeding-disorders-proposals-of-the-french-reference-centre-on-haemophilia-and-rare-coagulation-disorders/ 2023-05-11T13:07:50+01:00 https://www.caf-dcf.be/litterature/management-of-rare-inherited-bleeding-disorders-proposals-of-the-french-reference-centre-on-haemophilia-and-rare-coagulation-disorders/ 2023-05-11T13:07:50+01:00 https://www.caf-dcf.be/litterature/prevalence-of-selected-bleeding-and-thrombotic-events-in-persons-with-hemophilia-versus-the-general-population-a-scoping-review/ 2023-05-11T13:05:47+01:00 https://www.caf-dcf.be/fr/litterature/prevalence-of-selected-bleeding-and-thrombotic-events-in-persons-with-hemophilia-versus-the-general-population-a-scoping-review/ 2023-05-11T13:05:46+01:00 https://www.caf-dcf.be/fr/litterature/genetic-determinants-of-enhanced-von-willebrand-factor-clearance-from-plasma/ 2023-05-11T13:03:48+01:00 https://www.caf-dcf.be/litterature/genetic-determinants-of-enhanced-von-willebrand-factor-clearance-from-plasma/ 2023-05-11T13:03:48+01:00 https://www.caf-dcf.be/fr/litterature/factor-xi-inhibitors-what-should-clinicians-know/ 2023-05-11T13:01:52+01:00 https://www.caf-dcf.be/litterature/factor-xi-inhibitors-what-should-clinicians-know/ 2023-05-11T13:01:52+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-factor-neutralizing-and-non-neutralizing-alloantibodies-in-213-subjects-with-type-3-von-willebrand-disease-enrolled-in-3winters-ips/ 2023-05-11T12:59:33+01:00 https://www.caf-dcf.be/litterature/von-willebrand-factor-neutralizing-and-non-neutralizing-alloantibodies-in-213-subjects-with-type-3-von-willebrand-disease-enrolled-in-3winters-ips/ 2023-05-11T12:59:33+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-disease-hemophilia-and-other-inherited-bleeding-disorders-in-pregnancy/ 2023-05-11T12:57:34+01:00 https://www.caf-dcf.be/litterature/von-willebrand-disease-hemophilia-and-other-inherited-bleeding-disorders-in-pregnancy/ 2023-05-11T12:57:34+01:00 https://www.caf-dcf.be/fr/litterature/determinants-of-successful-immune-tolerance-induction-in-hemophilia-a-systematic-review-and-meta-analysis/ 2023-05-11T12:55:47+01:00 https://www.caf-dcf.be/litterature/determinants-of-successful-immune-tolerance-induction-in-hemophilia-a-systematic-review-and-meta-analysis/ 2023-05-11T12:55:47+01:00 https://www.caf-dcf.be/fr/litterature/emicizumab-in-people-with-moderate-or-mild-haemophilia-a-haven-6-a-multicentre-open-label-single-arm-phase-3-study/ 2023-05-11T12:54:05+01:00 https://www.caf-dcf.be/litterature/emicizumab-in-people-with-moderate-or-mild-haemophilia-a-haven-6-a-multicentre-open-label-single-arm-phase-3-study/ 2023-05-11T12:54:05+01:00 https://www.caf-dcf.be/fr/litterature/long-term-impact-of-primary-prophylaxis-on-joint-status-in-patients-with-severe-hemophilia-a/ 2023-05-11T12:52:19+01:00 https://www.caf-dcf.be/litterature/long-term-impact-of-primary-prophylaxis-on-joint-status-in-patients-with-severe-hemophilia-a/ 2023-05-11T12:52:19+01:00 https://www.caf-dcf.be/fr/litterature/hemophilia-treatment-innovation-50-years-of-progress-and-more-to-come/ 2023-05-11T12:49:22+01:00 https://www.caf-dcf.be/litterature/hemophilia-treatment-innovation-50-years-of-progress-and-more-to-come/ 2023-05-11T12:49:22+01:00 https://www.caf-dcf.be/fr/litterature/acquired-haemophilia-a-in-four-north-european-countries-survey-of-181-patients/ 2023-05-11T12:47:15+01:00 https://www.caf-dcf.be/litterature/acquired-haemophilia-a-in-four-north-european-countries-survey-of-181-patients/ 2023-05-11T12:47:15+01:00 https://www.caf-dcf.be/fr/litterature/50-years-of-pediatric-hemostasis-knowledge-diagnosis-and-treatment/ 2023-05-11T12:45:26+01:00 https://www.caf-dcf.be/litterature/50-years-of-pediatric-hemostasis-knowledge-diagnosis-and-treatment/ 2023-05-11T12:45:26+01:00 https://www.caf-dcf.be/fr/litterature/surgical-outcomes-in-people-with-hemophilia-a-taking-emicizumab-prophylaxis-experience-from-the-haven-1-4-studies/ 2023-05-11T11:28:03+01:00 https://www.caf-dcf.be/litterature/surgical-outcomes-in-people-with-hemophilia-a-taking-emicizumab-prophylaxis-experience-from-the-haven-1-4-studies/ 2023-05-11T11:28:03+01:00 https://www.caf-dcf.be/fr/litterature/an-evaluation-of-von-willebrand-factor-recombinant-therapy-for-adult-patients-living-with-severe-type-3-von-willebrand-disease/ 2023-05-11T11:25:40+01:00 https://www.caf-dcf.be/litterature/an-evaluation-of-von-willebrand-factor-recombinant-therapy-for-adult-patients-living-with-severe-type-3-von-willebrand-disease/ 2023-05-11T11:25:40+01:00 https://www.caf-dcf.be/fr/litterature/a-french-real-world-evidence-study-evaluating-the-efficacy-safety-and-pharmacokinetic-parameters-of-rviii-singlechain-in-patients-with-hemophilia-a-receiving-prophylaxis/ 2023-05-11T11:21:37+01:00 https://www.caf-dcf.be/litterature/a-french-real-world-evidence-study-evaluating-the-efficacy-safety-and-pharmacokinetic-parameters-of-rviii-singlechain-in-patients-with-hemophilia-a-receiving-prophylaxis/ 2023-05-11T11:21:37+01:00 https://www.caf-dcf.be/fr/litterature/trends-in-prescribing-practices-for-management-of-haemophilia-1999-2021/ 2023-05-11T11:19:45+01:00 https://www.caf-dcf.be/litterature/trends-in-prescribing-practices-for-management-of-haemophilia-1999-2021/ 2023-05-11T11:19:45+01:00 https://www.caf-dcf.be/fr/litterature/mild-and-moderate-hemophilia-a-neglected-conditions-still-with-unmet-needs/ 2023-05-11T11:10:03+01:00 https://www.caf-dcf.be/litterature/mild-and-moderate-hemophilia-a-neglected-conditions-still-with-unmet-needs/ 2023-05-11T11:10:03+01:00 https://www.caf-dcf.be/fr/litterature/evaluating-the-financial-impact-of-utilizing-recombinant-porcine-factor-viii-or-recombinant-fviia-for-patients-with-acquired-hemophilia-a/ 2023-05-11T11:08:32+01:00 https://www.caf-dcf.be/litterature/evaluating-the-financial-impact-of-utilizing-recombinant-porcine-factor-viii-or-recombinant-fviia-for-patients-with-acquired-hemophilia-a/ 2023-05-11T11:08:32+01:00 https://www.caf-dcf.be/fr/litterature/comparison-of-prothrombin-complex-concentrate-with-activated-factor-vii-use-for-bleeding-following-cardiopulmonary-bypass-in-children/ 2023-05-11T11:02:30+01:00 https://www.caf-dcf.be/litterature/comparison-of-prothrombin-complex-concentrate-with-activated-factor-vii-use-for-bleeding-following-cardiopulmonary-bypass-in-children/ 2023-05-11T11:02:30+01:00 https://www.caf-dcf.be/fr/litterature/blood-coagulation-and-beyond-position-paper-from-the-fourth-maastricht-consensus-conference-on-thrombosis/ 2023-05-11T11:00:54+01:00 https://www.caf-dcf.be/litterature/blood-coagulation-and-beyond-position-paper-from-the-fourth-maastricht-consensus-conference-on-thrombosis/ 2023-05-11T11:00:54+01:00 https://www.caf-dcf.be/litterature/eptacog-beta-rfviia-has-a-low-incidence-of-spontaneous-rebleeding-through-24-and-48-hours-in-adult-and-adolescent-patients-with-hemophilia-a-or-b-with-inhibitors/ 2023-05-11T10:57:52+01:00 https://www.caf-dcf.be/fr/litterature/eptacog-beta-rfviia-has-a-low-incidence-of-spontaneous-rebleeding-through-24-and-48-hours-in-adult-and-adolescent-patients-with-hemophilia-a-or-b-with-inhibitors/ 2023-05-11T10:57:52+01:00 https://www.caf-dcf.be/litterature/efficacy-and-safety-of-von-willebrand-factor-concentrate-almost-devoid-of-factor-viii-wilfactin-in-paediatric-patients-under-6-years-of-age-with-severe-von-willebrand-disease/ 2023-05-11T10:56:34+01:00 https://www.caf-dcf.be/fr/litterature/efficacy-and-safety-of-von-willebrand-factor-concentrate-almost-devoid-of-factor-viii-wilfactin-in-paediatric-patients-under-6-years-of-age-with-severe-von-willebrand-disease/ 2023-05-11T10:56:33+01:00 https://www.caf-dcf.be/litterature/increased-access-to-immunoglobulin-replacement-therapy-for-patients-with-primary-immunodeficiency-in-poland-based-on-clinical-usage-data-of-immunoglobulin-g-over-a-5-year-period/ 2023-04-23T12:57:45+01:00 https://www.caf-dcf.be/litterature/comparison-of-ivig-and-tpe-efficacy-in-the-treatment-of-neurological-disorders-a-systematic-literature-review/ 2023-04-23T11:20:28+01:00 https://www.caf-dcf.be/litterature/use-of-immunoglobulin-replacement-therapy-in-patients-with-secondary-antibody-deficiency-in-daily-practice-a-european-expert-qa-based-review/ 2023-04-23T11:17:37+01:00 https://www.caf-dcf.be/litterature/secondary-immunodeficiencies-and-infectious-considerations-of-biologic-immunomodulatory-therapies/ 2023-04-23T11:15:29+01:00 https://www.caf-dcf.be/litterature/intravenous-immunoglobulin-mechanism-of-action-in-autoimmune-and-inflammatory-conditions/ 2023-04-23T11:09:38+01:00 https://www.caf-dcf.be/litterature/real-pandemic-world-results-of-pharmacokinetic-tailored-personalized-prophylaxis-of-bleeds-in-polish-children-and-adolescents-with-severe-hemophilia-a/ 2023-04-23T11:03:35+01:00 https://www.caf-dcf.be/litterature/current-understanding-of-inherited-modifiers-of-fviii-pharmacokinetic-variation/ 2023-04-23T11:01:08+01:00 https://www.caf-dcf.be/litterature/health-related-quality-of-life-and-psychopathological-symptoms-in-people-with-hemophilia-bloodborne-co-infections-and-comorbidities-an-italian-multicenter-observational-study/ 2023-04-23T10:58:52+01:00 https://www.caf-dcf.be/litterature/haemophilia-a-a-review-of-clinical-manifestations-treatment-mutations-and-the-development-of-inhibitors/ 2023-04-23T10:55:32+01:00 https://www.caf-dcf.be/litterature/alpha-1-antitrypsin-deficiency-current-therapy-and-emerging-targets/ 2023-04-23T10:04:11+01:00 https://www.caf-dcf.be/litterature/intraoperative-transfusion-management-antifibrinolytic-therapy-coagulation-monitoring-and-the-impact-on-short-term-outcomes-after-liver-transplantation-a-systematic-review-of-the-literature-and-expe/ 2023-02-16T09:52:30+01:00 https://www.caf-dcf.be/fr/litterature/intraoperative-transfusion-management-antifibrinolytic-therapy-coagulation-monitoring-and-the-impact-on-short-term-outcomes-after-liver-transplantation-a-systematic-review-of-the-literature-and-expe/ 2023-02-16T09:52:04+01:00 https://www.caf-dcf.be/litterature/association-of-whole-blood-with-survival-among-patients-presenting-with-severe-hemorrhage-in-us-and-canadian-adult-civilian-trauma-centers/ 2023-02-16T09:50:27+01:00 https://www.caf-dcf.be/fr/litterature/association-of-whole-blood-with-survival-among-patients-presenting-with-severe-hemorrhage-in-us-and-canadian-adult-civilian-trauma-centers/ 2023-02-16T09:50:03+01:00 https://www.caf-dcf.be/litterature/comparison-of-factor-products-for-treatment-of-bleeding-related-to-cardiac-surgery/ 2023-02-16T09:47:57+01:00 https://www.caf-dcf.be/fr/litterature/comparison-of-factor-products-for-treatment-of-bleeding-related-to-cardiac-surgery/ 2023-02-16T09:47:22+01:00 https://www.caf-dcf.be/litterature/predicting-outcome-in-guillain-barre-syndrome-international-validation-of-the-modified-erasmus-gbs-outcome-score/ 2023-02-16T09:43:26+01:00 https://www.caf-dcf.be/fr/litterature/predicting-outcome-in-guillain-barre-syndrome-international-validation-of-the-modified-erasmus-gbs-outcome-score/ 2023-02-16T09:43:10+01:00 https://www.caf-dcf.be/litterature/cost-effectiveness-of-fibrinogen-concentrate-vs-cryoprecipitate-for-treating-acquired-hypofibrinogenemia-in-bleeding-adult-cardiac-surgical-patients/ 2023-02-15T11:30:47+01:00 https://www.caf-dcf.be/fr/litterature/cost-effectiveness-of-fibrinogen-concentrate-vs-cryoprecipitate-for-treating-acquired-hypofibrinogenemia-in-bleeding-adult-cardiac-surgical-patients/ 2023-02-15T11:30:02+01:00 https://www.caf-dcf.be/litterature/primary-prophylaxis-in-children-with-severe-haemophilia-a-and-b-implementation-over-the-last-20-years-as-illustrated-in-real-world-data-in-the-pednet-cohorts/ 2023-02-15T11:20:16+01:00 https://www.caf-dcf.be/fr/litterature/primary-prophylaxis-in-children-with-severe-haemophilia-a-and-b-implementation-over-the-last-20-years-as-illustrated-in-real-world-data-in-the-pednet-cohorts/ 2023-02-15T11:19:57+01:00 https://www.caf-dcf.be/litterature/vaccine-induced-immune-thrombotic-thrombocytopenia/ 2023-02-15T11:18:22+01:00 https://www.caf-dcf.be/fr/litterature/vaccine-induced-immune-thrombotic-thrombocytopenia/ 2023-02-15T11:18:04+01:00 https://www.caf-dcf.be/litterature/the-diagnosis-natural-history-and-management-of-von-willebrand-disease-in-women-in-the-age-of-guidelines/ 2023-02-15T11:14:55+01:00 https://www.caf-dcf.be/fr/litterature/the-diagnosis-natural-history-and-management-of-von-willebrand-disease-in-women-in-the-age-of-guidelines/ 2023-02-15T11:14:31+01:00 https://www.caf-dcf.be/litterature/the-effect-of-recombinant-versus-plasma-derived-von-willebrand-factor-on-prolonged-pfa-closure-times-in-ecmo-patients-with-acquired-von-willebrand-syndrome-an-observational-study/ 2023-02-15T11:06:21+01:00 https://www.caf-dcf.be/fr/litterature/the-effect-of-recombinant-versus-plasma-derived-von-willebrand-factor-on-prolonged-pfa-closure-times-in-ecmo-patients-with-acquired-von-willebrand-syndrome-an-observational-study/ 2023-02-15T11:06:00+01:00 https://www.caf-dcf.be/litterature/cost-analysis-of-extended-half-life-recombinant-factor-ix-products-in-the-treatment-of-haemophilia-b-in-italy-an-update/ 2023-02-15T11:00:08+01:00 https://www.caf-dcf.be/fr/litterature/cost-analysis-of-extended-half-life-recombinant-factor-ix-products-in-the-treatment-of-haemophilia-b-in-italy-an-update/ 2023-02-15T10:59:25+01:00 https://www.caf-dcf.be/litterature/the-role-of-fibrinogen-in-postpartum-hemorrhage/ 2023-02-13T16:13:20+01:00 https://www.caf-dcf.be/fr/litterature/the-role-of-fibrinogen-in-postpartum-hemorrhage/ 2023-02-13T16:12:49+01:00 https://www.caf-dcf.be/litterature/major-haemorrhage-past-present-and-future/ 2023-02-13T16:11:30+01:00 https://www.caf-dcf.be/fr/litterature/major-haemorrhage-past-present-and-future/ 2023-02-13T16:11:11+01:00 https://www.caf-dcf.be/litterature/effect-of-fibrinogen-replacement-therapy-on-bleeding-outcomes-and-1-year-mortality-in-patients-undergoing-thoracic-aortic-surgery-a-retrospective-cohort-study/ 2023-02-13T16:09:39+01:00 https://www.caf-dcf.be/fr/litterature/effect-of-fibrinogen-replacement-therapy-on-bleeding-outcomes-and-1-year-mortality-in-patients-undergoing-thoracic-aortic-surgery-a-retrospective-cohort-study/ 2023-02-13T16:09:18+01:00 https://www.caf-dcf.be/litterature/pharmacokinetics-efficacy-and-safety-of-a-novel-fibrinogen-concentrate-in-pediatric-patients-with-congenital-afibrinogenemia/ 2023-02-13T16:07:57+01:00 https://www.caf-dcf.be/fr/litterature/pharmacokinetics-efficacy-and-safety-of-a-novel-fibrinogen-concentrate-in-pediatric-patients-with-congenital-afibrinogenemia/ 2023-02-13T16:03:51+01:00 https://www.caf-dcf.be/litterature/protocol-for-postpartum-haemorrhage-including-massive-transfusion/ 2023-02-13T16:01:23+01:00 https://www.caf-dcf.be/fr/litterature/protocol-for-postpartum-haemorrhage-including-massive-transfusion/ 2023-02-13T16:00:58+01:00 https://www.caf-dcf.be/litterature/efficacy-and-safety-of-bt595-10-human-intravenous-immunoglobulin-in-adult-patients-with-chronic-immune-thrombocytopenia/ 2023-02-13T15:24:47+01:00 https://www.caf-dcf.be/fr/litterature/efficacy-and-safety-of-bt595-10-human-intravenous-immunoglobulin-in-adult-patients-with-chronic-immune-thrombocytopenia/ 2023-02-13T15:24:38+01:00 https://www.caf-dcf.be/litterature/intravenous-immunoglobulin-in-the-management-and-outcome-of-stiff-person-syndrome-a-systematic-review/ 2023-02-13T15:22:20+01:00 https://www.caf-dcf.be/fr/litterature/intravenous-immunoglobulin-in-the-management-and-outcome-of-stiff-person-syndrome-a-systematic-review/ 2023-02-13T15:22:01+01:00 https://www.caf-dcf.be/litterature/a-multicenter-real-world-experience-with-recombinant-fxiii-for-the-treatment-of-patients-with-fxiii-deficiency-from-pharmacokinetics-to-clinical-practice-the-italian-fxiii-study/ 2023-02-13T15:17:15+01:00 https://www.caf-dcf.be/fr/litterature/a-multicenter-real-world-experience-with-recombinant-fxiii-for-the-treatment-of-patients-with-fxiii-deficiency-from-pharmacokinetics-to-clinical-practice-the-italian-fxiii-study/ 2023-02-13T15:16:57+01:00 https://www.caf-dcf.be/litterature/what-have-we-learned-about-the-patients-experience-of-von-willebrand-disease-a-focus-on-women/ 2023-02-13T15:14:59+01:00 https://www.caf-dcf.be/fr/litterature/what-have-we-learned-about-the-patients-experience-of-von-willebrand-disease-a-focus-on-women/ 2023-02-13T15:14:31+01:00 https://www.caf-dcf.be/litterature/perioperative-continuous-infusions-of-factor-viii-versus-factor-ix-for-patients-with-hemophilia-a-or-b-undergoing-major-surgery/ 2023-02-13T15:12:18+01:00 https://www.caf-dcf.be/fr/litterature/perioperative-continuous-infusions-of-factor-viii-versus-factor-ix-for-patients-with-hemophilia-a-or-b-undergoing-major-surgery/ 2023-02-13T15:11:32+01:00 https://www.caf-dcf.be/litterature/plasma-derived-factor-viia-and-factor-x-mixture-agent-mc710-prophylaxis-in-haemophilia-b-patients-with-inhibitors/ 2023-02-13T15:09:05+01:00 https://www.caf-dcf.be/fr/litterature/plasma-derived-factor-viia-and-factor-x-mixture-agent-mc710-prophylaxis-in-haemophilia-b-patients-with-inhibitors/ 2023-02-13T15:08:48+01:00 https://www.caf-dcf.be/fr/litterature/area-under-the-curve-comparing-the-value-of-factor-viii-replacement-therapies-in-haemophilia-a/ 2023-02-13T15:07:31+01:00 https://www.caf-dcf.be/litterature/area-under-the-curve-comparing-the-value-of-factor-viii-replacement-therapies-in-haemophilia-a/ 2023-02-13T15:07:21+01:00 https://www.caf-dcf.be/litterature/acquired-haemophilia-a-a-review-of-what-we-know/ 2023-02-13T15:04:43+01:00 https://www.caf-dcf.be/fr/litterature/acquired-haemophilia-a-a-review-of-what-we-know/ 2023-02-13T15:04:25+01:00 https://www.caf-dcf.be/litterature/acquired-factor-xiii-deficiency-in-patients-with-multiple-trauma/ 2023-02-13T15:02:17+01:00 https://www.caf-dcf.be/fr/litterature/acquired-factor-xiii-deficiency-in-patients-with-multiple-trauma/ 2023-02-13T15:02:00+01:00 https://www.caf-dcf.be/litterature/stable-and-durable-factor-ix-levels-in-hemophilia-b-patients-over-3-years-post-etranacogene-dezaparvovec-gene-therapy/ 2023-02-13T15:00:20+01:00 https://www.caf-dcf.be/fr/litterature/stable-and-durable-factor-ix-levels-in-hemophilia-b-patients-over-3-years-post-etranacogene-dezaparvovec-gene-therapy/ 2023-02-13T15:00:00+01:00 https://www.caf-dcf.be/litterature/von-willebrand-factor-links-primary-hemostasis-to-innate-immunity/ 2023-02-13T14:58:25+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-factor-links-primary-hemostasis-to-innate-immunity/ 2023-02-13T14:58:02+01:00 https://www.caf-dcf.be/litterature/economic-evaluation-of-immune-tolerance-induction-in-children-with-severe-hemophilia-a-and-high-responding-inhibitors-a-cost-effectiveness-analysis-of-prophylaxis-with-emicizumab/ 2023-02-13T14:56:33+01:00 https://www.caf-dcf.be/fr/litterature/economic-evaluation-of-immune-tolerance-induction-in-children-with-severe-hemophilia-a-and-high-responding-inhibitors-a-cost-effectiveness-analysis-of-prophylaxis-with-emicizumab/ 2023-02-13T14:56:16+01:00 https://www.caf-dcf.be/litterature/recombinant-alpha-1-antitrypsin-as-dry-powder-for-pulmonary-administration-a-formulative-proof-of-concept/ 2023-02-13T14:49:18+01:00 https://www.caf-dcf.be/fr/litterature/recombinant-alpha-1-antitrypsin-as-dry-powder-for-pulmonary-administration-a-formulative-proof-of-concept/ 2023-02-13T14:48:57+01:00 https://www.caf-dcf.be/litterature/structure-and-function-of-recombinant-versus-plasma-derived-von-willebrand-factor-and-impact-on-multimer-pharmacokinetics-in-von-willebrand-disease/ 2023-01-11T09:30:22+01:00 https://www.caf-dcf.be/fr/litterature/structure-and-function-of-recombinant-versus-plasma-derived-von-willebrand-factor-and-impact-on-multimer-pharmacokinetics-in-von-willebrand-disease/ 2023-01-11T09:30:04+01:00 https://www.caf-dcf.be/litterature/the-detrimental-effects-of-iron-to-the-joint-aggravation-by-inflammation/ 2023-01-11T09:28:29+01:00 https://www.caf-dcf.be/fr/litterature/the-detrimental-effects-of-iron-to-the-joint-aggravation-by-inflammation/ 2023-01-11T09:28:09+01:00 https://www.caf-dcf.be/litterature/ideal-study-a-real-world-assessment-of-pattern-of-use-and-clinical-outcomes-with-recombinant-coagulation-factor-ix-albumin-fusion-protein-rix-fp-in-patients-with-haemophilia-b-in-italy/ 2023-01-11T09:25:44+01:00 https://www.caf-dcf.be/fr/litterature/ideal-study-a-real-world-assessment-of-pattern-of-use-and-clinical-outcomes-with-recombinant-coagulation-factor-ix-albumin-fusion-protein-rix-fp-in-patients-with-haemophilia-b-in-italy/ 2023-01-11T09:25:25+01:00 https://www.caf-dcf.be/litterature/clinical-significance-of-substantially-elevated-von-willebrand-factor-antigen-levels-in-patients-with-advanced-chronic-liver-disease/ 2023-01-11T09:22:44+01:00 https://www.caf-dcf.be/fr/litterature/clinical-significance-of-substantially-elevated-von-willebrand-factor-antigen-levels-in-patients-with-advanced-chronic-liver-disease/ 2023-01-11T09:22:27+01:00 https://www.caf-dcf.be/litterature/cost-effectiveness-of-recombinant-factor-viii-fc-versus-emicizumab-for-prophylaxis-in-adults-and-adolescents-with-haemophilia-a-without-inhibitors-in-the-uk/ 2023-01-11T09:19:42+01:00 https://www.caf-dcf.be/fr/litterature/cost-effectiveness-of-recombinant-factor-viii-fc-versus-emicizumab-for-prophylaxis-in-adults-and-adolescents-with-haemophilia-a-without-inhibitors-in-the-uk/ 2023-01-11T09:19:23+01:00 https://www.caf-dcf.be/litterature/drug-associated-acquired-hemophilia-a-an-analysis-based-on-185-cases-from-the-who-pharmacovigilance-database/ 2023-01-09T11:46:39+01:00 https://www.caf-dcf.be/fr/litterature/drug-associated-acquired-hemophilia-a-an-analysis-based-on-185-cases-from-the-who-pharmacovigilance-database/ 2023-01-09T11:46:10+01:00 https://www.caf-dcf.be/litterature/kinetic-and-dynamic-effects-on-degradation-of-von-willebrand-factor/ 2023-01-09T11:44:17+01:00 https://www.caf-dcf.be/fr/litterature/kinetic-and-dynamic-effects-on-degradation-of-von-willebrand-factor/ 2023-01-09T11:43:50+01:00 https://www.caf-dcf.be/litterature/molecular-basis-of-rare-congenital-bleeding-disorders/ 2023-01-09T11:42:07+01:00 https://www.caf-dcf.be/fr/litterature/molecular-basis-of-rare-congenital-bleeding-disorders/ 2023-01-09T11:41:43+01:00 https://www.caf-dcf.be/litterature/reproductive-health-and-hemostatic-issues-in-women-and-girls-with-congenital-factor-vii-deficiency-a-systematic-review/ 2023-01-09T11:39:35+01:00 https://www.caf-dcf.be/fr/litterature/reproductive-health-and-hemostatic-issues-in-women-and-girls-with-congenital-factor-vii-deficiency-a-systematic-review/ 2023-01-09T11:39:09+01:00 https://www.caf-dcf.be/litterature/economic-impact-of-self-administered-subcutaneous-versus-clinic-administered-intravenous-immunoglobulin-g-therapy-in-alberta-canada-a-population-based-cohort-study/ 2023-01-09T11:37:01+01:00 https://www.caf-dcf.be/fr/litterature/economic-impact-of-self-administered-subcutaneous-versus-clinic-administered-intravenous-immunoglobulin-g-therapy-in-alberta-canada-a-population-based-cohort-study/ 2023-01-09T11:36:29+01:00 https://www.caf-dcf.be/litterature/subcutaneous-immunoglobulin-16-5-for-the-treatment-of-pediatric-patients-with-primary-antibody-immunodeficiency/ 2023-01-09T11:34:31+01:00 https://www.caf-dcf.be/fr/litterature/subcutaneous-immunoglobulin-16-5-for-the-treatment-of-pediatric-patients-with-primary-antibody-immunodeficiency/ 2023-01-09T11:34:05+01:00 https://www.caf-dcf.be/litterature/cutaquig-is-well-tolerated-in-immunodeficient-patients-who-did-not-tolerate-other-subcutaneous-immunoglobulin-products/ 2023-01-09T11:18:43+01:00 https://www.caf-dcf.be/fr/litterature/cutaquig-is-well-tolerated-in-immunodeficient-patients-who-did-not-tolerate-other-subcutaneous-immunoglobulin-products/ 2023-01-09T11:18:15+01:00 https://www.caf-dcf.be/fr/litterature/the-choice-between-intravenous-and-subcutaneous-immunoglobulins-aspects-for-consideration/ 2023-01-09T11:16:14+01:00 https://www.caf-dcf.be/litterature/the-choice-between-intravenous-and-subcutaneous-immunoglobulins-aspects-for-consideration/ 2023-01-09T11:15:55+01:00 https://www.caf-dcf.be/litterature/comparison-of-fibrinogen-concentrates-to-cryoprecipitate-in-restoring-clot-integrity-and-stability-against-fibrinolytic-degradation/ 2023-01-09T11:12:35+01:00 https://www.caf-dcf.be/fr/litterature/comparison-of-fibrinogen-concentrates-to-cryoprecipitate-in-restoring-clot-integrity-and-stability-against-fibrinolytic-degradation/ 2023-01-09T11:10:31+01:00 https://www.caf-dcf.be/litterature/audit-of-the-use-of-fibclot-fibrinogen-concentrate-in-patients-without-congenital-afibrinogenaemia/ 2023-01-09T11:08:33+01:00 https://www.caf-dcf.be/fr/litterature/audit-of-the-use-of-fibclot-fibrinogen-concentrate-in-patients-without-congenital-afibrinogenaemia/ 2023-01-09T11:08:03+01:00 https://www.caf-dcf.be/litterature/pregnancy-and-childbirth-in-women-with-bleeding-disorders-a-retrospective-cohort-study/ 2023-01-09T11:06:05+01:00 https://www.caf-dcf.be/fr/litterature/pregnancy-and-childbirth-in-women-with-bleeding-disorders-a-retrospective-cohort-study/ 2023-01-09T11:05:20+01:00 https://www.caf-dcf.be/litterature/coagulopathy-management-of-multiple-injured-patients-a-comprehensive-literature-review-of-the-european-guideline-2019/ 2023-01-09T11:03:00+01:00 https://www.caf-dcf.be/fr/litterature/coagulopathy-management-of-multiple-injured-patients-a-comprehensive-literature-review-of-the-european-guideline-2019/ 2023-01-09T11:02:32+01:00 https://www.caf-dcf.be/litterature/viscoelastic-versus-conventional-coagulation-tests-to-reduce-blood-product-transfusion-in-patients-undergoing-liver-transplantation-a-systematic-review-and-meta-analysis/ 2023-01-09T11:00:35+01:00 https://www.caf-dcf.be/litterature/management-of-antithrombin-deficiency-in-pregnancy/ 2023-01-09T10:59:11+01:00 https://www.caf-dcf.be/fr/litterature/management-of-antithrombin-deficiency-in-pregnancy/ 2023-01-09T10:58:39+01:00 https://www.caf-dcf.be/fr/litterature/viscoelastic-versus-conventional-coagulation-tests-to-reduce-blood-product-transfusion-in-patients-undergoing-liver-transplantation-a-systematic-review-and-meta-analysis/ 2023-01-09T10:56:06+01:00 https://www.caf-dcf.be/litterature/global-epidemiology-of-factor-xi-deficiency-a-targeted-review-of-the-literature-and-foundation-reports/ 2022-12-15T14:32:41+01:00 https://www.caf-dcf.be/fr/litterature/global-epidemiology-of-factor-xi-deficiency-a-targeted-review-of-the-literature-and-foundation-reports/ 2022-12-15T14:32:23+01:00 https://www.caf-dcf.be/litterature/analysis-of-von-willebrand-disease-in-the-heart-of-europe/ 2022-12-15T14:30:50+01:00 https://www.caf-dcf.be/fr/litterature/analysis-of-von-willebrand-disease-in-the-heart-of-europe/ 2022-12-15T14:30:27+01:00 https://www.caf-dcf.be/litterature/comprehensive-analysis-and-prediction-of-long-term-durability-of-factor-ix-activity-following-etranacogene-dezaparvovec-gene-therapy-in-the-treatment-of-hemophilia-b/ 2022-12-15T14:29:12+01:00 https://www.caf-dcf.be/fr/litterature/comprehensive-analysis-and-prediction-of-long-term-durability-of-factor-ix-activity-following-etranacogene-dezaparvovec-gene-therapy-in-the-treatment-of-hemophilia-b/ 2022-12-15T14:28:58+01:00 https://www.caf-dcf.be/litterature/emicizumab-dose-up-titration-in-case-of-suboptimal-bleeding-control-in-people-with-haemophilia-a/ 2022-12-15T14:27:25+01:00 https://www.caf-dcf.be/fr/litterature/emicizumab-dose-up-titration-in-case-of-suboptimal-bleeding-control-in-people-with-haemophilia-a/ 2022-12-15T14:27:11+01:00 https://www.caf-dcf.be/litterature/applicability-of-the-european-society-of-cardiology-guidelines-on-the-management-of-acute-coronary-syndromes-to-older-people-with-haemophilia-a-a-modified-delphi-consensus-by-the-advance-working-gro/ 2022-12-15T14:25:56+01:00 https://www.caf-dcf.be/fr/litterature/applicability-of-the-european-society-of-cardiology-guidelines-on-the-management-of-acute-coronary-syndromes-to-older-people-with-haemophilia-a-a-modified-delphi-consensus-by-the-advance-working-gro/ 2022-12-15T14:25:41+01:00 https://www.caf-dcf.be/litterature/safety-of-feiba-and-emicizumab-safe-dose-escalation-study-evaluating-the-safety-of-in-vivo-administration-of-activated-prothrombin-complex-concentrate-in-haemophilia-a-patients-on-emicizumab/ 2022-12-15T14:23:58+01:00 https://www.caf-dcf.be/fr/litterature/safety-of-feiba-and-emicizumab-safe-dose-escalation-study-evaluating-the-safety-of-in-vivo-administration-of-activated-prothrombin-complex-concentrate-in-haemophilia-a-patients-on-emicizumab/ 2022-12-15T14:23:43+01:00 https://www.caf-dcf.be/litterature/updates-on-novel-non-replacement-drugs-for-hemophilia/ 2022-12-15T14:22:09+01:00 https://www.caf-dcf.be/fr/litterature/updates-on-novel-non-replacement-drugs-for-hemophilia/ 2022-12-15T14:15:23+01:00 https://www.caf-dcf.be/litterature/a-diagnostic-of-acquired-hemophilia-following-pd1-pdl1-inhibitors-in-advanced-melanoma-the-experience-of-two-patients-and-a-literature-review/ 2022-12-15T14:13:52+01:00 https://www.caf-dcf.be/fr/litterature/a-diagnostic-of-acquired-hemophilia-following-pd1-pdl1-inhibitors-in-advanced-melanoma-the-experience-of-two-patients-and-a-literature-review/ 2022-12-15T14:13:39+01:00 https://www.caf-dcf.be/litterature/von-willebrand-disease-specific-aspects-in-women/ 2022-12-15T14:12:14+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-disease-specific-aspects-in-women/ 2022-12-15T14:12:00+01:00 https://www.caf-dcf.be/litterature/update-on-platelet-procoagulant-mechanisms-in-health-and-in-bleeding-disorders/ 2022-12-15T14:10:35+01:00 https://www.caf-dcf.be/fr/litterature/update-on-platelet-procoagulant-mechanisms-in-health-and-in-bleeding-disorders/ 2022-12-15T14:10:14+01:00 https://www.caf-dcf.be/litterature/long-term-efficacy-safety-and-tolerability-of-a-subcutaneous-immunoglobulin-16-5-cutaquig-r-in-the-treatment-of-patients-with-primary-immunodeficiencies/ 2022-12-14T12:07:22+01:00 https://www.caf-dcf.be/fr/litterature/long-term-efficacy-safety-and-tolerability-of-a-subcutaneous-immunoglobulin-16-5-cutaquig-r-in-the-treatment-of-patients-with-primary-immunodeficiencies/ 2022-12-14T12:07:05+01:00 https://www.caf-dcf.be/litterature/french-recommendations-for-the-management-of-adult-pediatric-chronic-inflammatory-demyelinating-polyradiculoneuropathy-cidp/ 2022-12-14T12:05:45+01:00 https://www.caf-dcf.be/fr/litterature/french-recommendations-for-the-management-of-adult-pediatric-chronic-inflammatory-demyelinating-polyradiculoneuropathy-cidp/ 2022-12-14T12:05:25+01:00 https://www.caf-dcf.be/litterature/comparison-of-european-recommendations-about-patient-blood-management-in-postpartum-haemorrhage/ 2022-12-14T12:03:59+01:00 https://www.caf-dcf.be/fr/litterature/comparison-of-european-recommendations-about-patient-blood-management-in-postpartum-haemorrhage/ 2022-12-14T12:03:17+01:00 https://www.caf-dcf.be/litterature/transfusion-management-in-the-trauma-patient/ 2022-12-14T11:47:50+01:00 https://www.caf-dcf.be/fr/litterature/transfusion-management-in-the-trauma-patient/ 2022-12-14T11:47:35+01:00 https://www.caf-dcf.be/litterature/prophylactic-recombinant-factor-viia-for-preventing-massive-transfusion-during-orthotopic-liver-transplantation/ 2022-12-14T11:44:43+01:00 https://www.caf-dcf.be/fr/litterature/prophylactic-recombinant-factor-viia-for-preventing-massive-transfusion-during-orthotopic-liver-transplantation/ 2022-12-14T11:44:28+01:00 https://www.caf-dcf.be/litterature/thrombin-generation-for-monitoring-hemostatic-therapy-in-hemophilia-a-a-narrative-review/ 2022-12-14T11:43:17+01:00 https://www.caf-dcf.be/fr/litterature/thrombin-generation-for-monitoring-hemostatic-therapy-in-hemophilia-a-a-narrative-review/ 2022-12-14T11:43:01+01:00 https://www.caf-dcf.be/litterature/alpha-1-antitrypsin-deficiency-liver-disease/ 2022-12-14T11:41:51+01:00 https://www.caf-dcf.be/fr/litterature/alpha-1-antitrypsin-deficiency-liver-disease/ 2022-12-14T11:41:36+01:00 https://www.caf-dcf.be/litterature/efficacy-and-safety-in-patients-with-haemophilia-a-switching-to-octocog-alfa-bay-81-8973-final-results-of-the-global-real-world-study-taurus/ 2022-12-14T11:39:45+01:00 https://www.caf-dcf.be/fr/litterature/efficacy-and-safety-in-patients-with-haemophilia-a-switching-to-octocog-alfa-bay-81-8973-final-results-of-the-global-real-world-study-taurus/ 2022-12-14T11:39:29+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-factor-multimer-analysis-and-classification-a-comprehensive-review-and-updates/ 2022-12-14T11:37:39+01:00 https://www.caf-dcf.be/litterature/emicizumab-a-novel-drug-in-hemophilia-a-prophylaxis-a-narrative-review/ 2022-12-14T11:36:27+01:00 https://www.caf-dcf.be/fr/litterature/emicizumab-a-novel-drug-in-hemophilia-a-prophylaxis-a-narrative-review/ 2022-12-14T11:36:11+01:00 https://www.caf-dcf.be/litterature/accessibility-and-visibility-of-genetic-testing-for-haemophilia-across-europe-where-do-we-stand/ 2022-12-14T11:34:50+01:00 https://www.caf-dcf.be/fr/litterature/accessibility-and-visibility-of-genetic-testing-for-haemophilia-across-europe-where-do-we-stand/ 2022-12-14T11:34:29+01:00 https://www.caf-dcf.be/litterature/theory-of-change-and-strategic-priorities-of-the-world-federation-of-haemophilia/ 2022-12-14T11:32:19+01:00 https://www.caf-dcf.be/fr/litterature/theory-of-change-and-strategic-priorities-of-the-world-federation-of-haemophilia/ 2022-12-14T11:32:05+01:00 https://www.caf-dcf.be/litterature/prophylaxis-use-of-clotting-factor-replacement-products-in-people-with-non-severe-haemophilia-a-review-of-the-literature/ 2022-12-14T11:30:45+01:00 https://www.caf-dcf.be/fr/litterature/prophylaxis-use-of-clotting-factor-replacement-products-in-people-with-non-severe-haemophilia-a-review-of-the-literature/ 2022-12-14T11:30:32+01:00 https://www.caf-dcf.be/fr/litterature/early-stage-clinical-trials-for-the-treatment-of-hemophilia-a/ 2022-12-14T11:28:59+01:00 https://www.caf-dcf.be/litterature/factor-ix-inhibitors-in-haemophilia-b-a-report-of-national-haemophilia-registry-in-china/ 2022-12-14T11:27:44+01:00 https://www.caf-dcf.be/fr/litterature/factor-ix-inhibitors-in-haemophilia-b-a-report-of-national-haemophilia-registry-in-china/ 2022-12-14T11:27:30+01:00 https://www.caf-dcf.be/litterature/need-to-increase-von-willebrand-disease-awareness-vwdtest-com-a-global-initiative-to-help-address-this-gap/ 2022-12-14T11:26:18+01:00 https://www.caf-dcf.be/fr/litterature/need-to-increase-von-willebrand-disease-awareness-vwdtest-com-a-global-initiative-to-help-address-this-gap/ 2022-12-14T11:26:00+01:00 https://www.caf-dcf.be/fr/litterature/increased-acute-care-utilization-comorbidities-and-mortality-in-adults-with-haemophilia-a-population-based-cohort-study-from-2012-to-2019/ 2022-12-14T11:24:42+01:00 https://www.caf-dcf.be/litterature/increased-acute-care-utilization-comorbidities-and-mortality-in-adults-with-haemophilia-a-population-based-cohort-study-from-2012-to-2019/ 2022-12-14T11:24:28+01:00 https://www.caf-dcf.be/litterature/treatment-of-chronic-inflammatory-demyelinating-polyneuropathy/ 2022-12-14T11:22:31+01:00 https://www.caf-dcf.be/fr/litterature/treatment-of-chronic-inflammatory-demyelinating-polyneuropathy/ 2022-12-14T11:22:16+01:00 https://www.caf-dcf.be/litterature/fibrinogen-supplementation-for-the-trauma-patient-should-you-choose-fibrinogen-concentrate-over-cryoprecipitate/ 2022-12-14T11:20:56+01:00 https://www.caf-dcf.be/fr/litterature/fibrinogen-supplementation-for-the-trauma-patient-should-you-choose-fibrinogen-concentrate-over-cryoprecipitate/ 2022-12-14T11:20:41+01:00 https://www.caf-dcf.be/litterature/congenital-hypo-dysfibrinogenemia-and-bleeding-a-systematic-literature-review/ 2022-12-14T11:19:15+01:00 https://www.caf-dcf.be/fr/litterature/congenital-hypo-dysfibrinogenemia-and-bleeding-a-systematic-literature-review/ 2022-12-14T11:18:59+01:00 https://www.caf-dcf.be/litterature/preoperative-fibrinogen-level-and-postcardiac-surgery-morbidity-and-mortality-rates/ 2022-12-14T11:09:20+01:00 https://www.caf-dcf.be/fr/litterature/preoperative-fibrinogen-level-and-postcardiac-surgery-morbidity-and-mortality-rates/ 2022-12-14T11:08:43+01:00 https://www.caf-dcf.be/litterature/von-willebrand-factor-multimer-analysis-and-classification-a-comprehensive-review-and-updates/ 2022-10-14T11:36:45+01:00 https://www.caf-dcf.be/litterature/early-stage-clinical-trials-for-the-treatment-of-hemophilia-a/ 2022-10-14T11:28:04+01:00 https://www.caf-dcf.be/litterature/factor-xi-inhibition-for-the-prevention-of-venous-thromboembolism-an-update-on-current-evidence-and-future-perspectives/ 2022-09-08T15:06:49+01:00 https://www.caf-dcf.be/fr/litterature/factor-xi-inhibition-for-the-prevention-of-venous-thromboembolism-an-update-on-current-evidence-and-future-perspectives/ 2022-09-08T15:06:13+01:00 https://www.caf-dcf.be/litterature/relationship-between-bleeding-episodes-health-related-quality-of-life-and-direct-costs-in-adults-with-severe-haemophilia-a-secondary-analyses-from-the-chess-study/ 2022-09-08T15:04:58+01:00 https://www.caf-dcf.be/fr/litterature/relationship-between-bleeding-episodes-health-related-quality-of-life-and-direct-costs-in-adults-with-severe-haemophilia-a-secondary-analyses-from-the-chess-study/ 2022-09-08T15:04:35+01:00 https://www.caf-dcf.be/litterature/comparative-biochemical-efficacy-analysis-of-an-alpha1-proteinase-inhibitor-glassia-r-in-patients-with-alpha-1-antitrypsin-deficiency/ 2022-09-08T15:03:19+01:00 https://www.caf-dcf.be/fr/litterature/comparative-biochemical-efficacy-analysis-of-an-alpha1-proteinase-inhibitor-glassia-r-in-patients-with-alpha-1-antitrypsin-deficiency/ 2022-09-08T15:02:54+01:00 https://www.caf-dcf.be/litterature/structural-insights-into-blood-coagulation-factor-viii-procoagulant-complexes-membrane-binding-and-antibody-inhibition/ 2022-09-08T15:01:40+01:00 https://www.caf-dcf.be/fr/litterature/structural-insights-into-blood-coagulation-factor-viii-procoagulant-complexes-membrane-binding-and-antibody-inhibition/ 2022-09-08T15:01:17+01:00 https://www.caf-dcf.be/litterature/hemophilia-a-strategies-for-improving-long-term-holistic-management-adherence-and-quality-of-life/ 2022-09-08T14:59:56+01:00 https://www.caf-dcf.be/fr/litterature/hemophilia-a-strategies-for-improving-long-term-holistic-management-adherence-and-quality-of-life/ 2022-09-08T14:59:28+01:00 https://www.caf-dcf.be/litterature/hemophilia-a-b/ 2022-09-08T14:58:20+01:00 https://www.caf-dcf.be/fr/litterature/hemophilia-a-b/ 2022-09-08T14:57:54+01:00 https://www.caf-dcf.be/litterature/real-world-clinical-outcomes-and-replacement-factor-viii-consumption-in-patients-with-haemophilia-a-in-italy-a-comparison-between-prophylaxis-pre-and-post-octocog-alfa-bay-81-8973/ 2022-09-08T14:56:47+01:00 https://www.caf-dcf.be/fr/litterature/real-world-clinical-outcomes-and-replacement-factor-viii-consumption-in-patients-with-haemophilia-a-in-italy-a-comparison-between-prophylaxis-pre-and-post-octocog-alfa-bay-81-8973/ 2022-09-08T14:56:16+01:00 https://www.caf-dcf.be/litterature/efficient-and-sustainable-platform-for-preparation-of-a-high-quality-immunoglobulin-g-as-an-urgent-treatment-option-during-emerging-virus-outbreaks/ 2022-09-08T14:55:06+01:00 https://www.caf-dcf.be/fr/litterature/efficient-and-sustainable-platform-for-preparation-of-a-high-quality-immunoglobulin-g-as-an-urgent-treatment-option-during-emerging-virus-outbreaks/ 2022-09-08T14:54:42+01:00 https://www.caf-dcf.be/litterature/evaluation-of-plasma-fibrinogen-levels-before-and-after-coronary-artery-bypass-graft-surgery-and-its-association-with-the-need-for-blood-products/ 2022-09-08T14:53:29+01:00 https://www.caf-dcf.be/fr/litterature/evaluation-of-plasma-fibrinogen-levels-before-and-after-coronary-artery-bypass-graft-surgery-and-its-association-with-the-need-for-blood-products/ 2022-09-08T14:52:58+01:00 https://www.caf-dcf.be/litterature/impact-of-cardiopulmonary-bypass-duration-on-efficacy-of-fibrinogen-replacement-with-cryoprecipitate-compared-with-fibrinogen-concentrate-a-post-hoc-analysis-of-the-fibrinogen-replenishment-in-surger/ 2022-09-08T14:51:41+01:00 https://www.caf-dcf.be/fr/litterature/impact-of-cardiopulmonary-bypass-duration-on-efficacy-of-fibrinogen-replacement-with-cryoprecipitate-compared-with-fibrinogen-concentrate-a-post-hoc-analysis-of-the-fibrinogen-replenishment-in-surger/ 2022-09-08T14:51:10+01:00 https://www.caf-dcf.be/litterature/safety-of-eptacog-beta-comparing-the-225-μg-kg-and-75-μg-kg-dosing-regimens-across-pivotal-clinical-trials/ 2022-09-08T14:49:09+01:00 https://www.caf-dcf.be/fr/litterature/safety-of-eptacog-beta-comparing-the-225-μg-kg-and-75-μg-kg-dosing-regimens-across-pivotal-clinical-trials/ 2022-09-08T14:48:41+01:00 https://www.caf-dcf.be/litterature/emicizumab-state-of-the-art-update/ 2022-09-08T14:47:40+01:00 https://www.caf-dcf.be/fr/litterature/emicizumab-state-of-the-art-update/ 2022-09-08T14:47:15+01:00 https://www.caf-dcf.be/litterature/acquired-bleeding-disorders/ 2022-09-08T14:46:12+01:00 https://www.caf-dcf.be/fr/litterature/acquired-bleeding-disorders/ 2022-09-08T14:45:48+01:00 https://www.caf-dcf.be/litterature/von-willebrand-disease-and-von-willebrand-factor/ 2022-09-08T14:44:13+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-disease-and-von-willebrand-factor/ 2022-09-08T14:43:19+01:00 https://www.caf-dcf.be/litterature/a-rare-case-of-acquired-hemophilia-a-in-adolescents-and-young-adults/ 2022-09-08T14:42:03+01:00 https://www.caf-dcf.be/fr/litterature/a-rare-case-of-acquired-hemophilia-a-in-adolescents-and-young-adults/ 2022-09-08T14:41:29+01:00 https://www.caf-dcf.be/litterature/managing-invasive-procedures-in-haemophilia-patients-with-limited-resources-extended-half-life-concentrates-or-non-replacement-therapies-in-2022/ 2022-09-08T14:40:23+01:00 https://www.caf-dcf.be/fr/litterature/managing-invasive-procedures-in-haemophilia-patients-with-limited-resources-extended-half-life-concentrates-or-non-replacement-therapies-in-2022/ 2022-09-08T14:39:57+01:00 https://www.caf-dcf.be/litterature/towards-novel-treatment-options-in-von-willebrand-disease/ 2022-09-08T14:38:29+01:00 https://www.caf-dcf.be/fr/litterature/towards-novel-treatment-options-in-von-willebrand-disease/ 2022-09-08T14:37:39+01:00 https://www.caf-dcf.be/litterature/does-difference-between-label-and-actual-potency-of-factor-viii-concentrate-affect-pharmacokinetic-guided-dosing-of-replacement-therapy-in-haemophilia-a/ 2022-09-08T14:36:25+01:00 https://www.caf-dcf.be/fr/litterature/does-difference-between-label-and-actual-potency-of-factor-viii-concentrate-affect-pharmacokinetic-guided-dosing-of-replacement-therapy-in-haemophilia-a/ 2022-09-08T14:35:56+01:00 https://www.caf-dcf.be/litterature/pharmacokinetic-modeling-and-simulation-of-subcutaneous-and-intravenous-igg-dosing-in-patients-with-primary-immunodeficiency-diseases/ 2022-09-08T14:34:21+01:00 https://www.caf-dcf.be/fr/litterature/pharmacokinetic-modeling-and-simulation-of-subcutaneous-and-intravenous-igg-dosing-in-patients-with-primary-immunodeficiency-diseases/ 2022-09-08T14:33:55+01:00 https://www.caf-dcf.be/litterature/use-of-hyperoncotic-human-albumin-solution-in-severe-traumatic-brain-injury-revisited-a-narrative-review-and-meta-analysis/ 2022-09-08T14:32:25+01:00 https://www.caf-dcf.be/fr/litterature/use-of-hyperoncotic-human-albumin-solution-in-severe-traumatic-brain-injury-revisited-a-narrative-review-and-meta-analysis/ 2022-09-08T14:31:58+01:00 https://www.caf-dcf.be/litterature/emicizumab-enhances-thrombus-formation-in-vitro-under-high-shear-flow-conditions-in-whole-blood-from-patients-with-type-1-and-type-3-von-willebrand-disease/ 2022-09-08T14:30:20+01:00 https://www.caf-dcf.be/fr/litterature/emicizumab-enhances-thrombus-formation-in-vitro-under-high-shear-flow-conditions-in-whole-blood-from-patients-with-type-1-and-type-3-von-willebrand-disease/ 2022-09-08T14:29:52+01:00 https://www.caf-dcf.be/litterature/effectiveness-of-long-term-prophylaxis-using-pdfviii-vwf-concentrate-in-patients-with-inherited-von-willebrand-disease/ 2022-09-08T14:28:41+01:00 https://www.caf-dcf.be/fr/litterature/effectiveness-of-long-term-prophylaxis-using-pdfviii-vwf-concentrate-in-patients-with-inherited-von-willebrand-disease/ 2022-09-08T14:28:11+01:00 https://www.caf-dcf.be/litterature/enhanced-pharmacokinetics-and-reduced-bleeds-in-boys-with-hemophilia-a-after-switching-to-kovaltry-from-other-standard-half-life-factor-viii-concentrates/ 2022-09-08T14:26:33+01:00 https://www.caf-dcf.be/fr/litterature/enhanced-pharmacokinetics-and-reduced-bleeds-in-boys-with-hemophilia-a-after-switching-to-kovaltry-from-other-standard-half-life-factor-viii-concentrates/ 2022-09-08T14:26:00+01:00 https://www.caf-dcf.be/litterature/alpha-1-antitrypsin-deficiency-a-re-surfacing-adult-liver-disorder/ 2022-09-08T14:24:31+01:00 https://www.caf-dcf.be/fr/litterature/alpha-1-antitrypsin-deficiency-a-re-surfacing-adult-liver-disorder/ 2022-09-08T14:22:26+01:00 https://www.caf-dcf.be/litterature/international-guidelines-regarding-the-role-of-ivig-in-the-management-of-rh-and-abo-mediated-haemolytic-disease-of-the-newborn/ 2022-09-08T14:20:27+01:00 https://www.caf-dcf.be/fr/litterature/international-guidelines-regarding-the-role-of-ivig-in-the-management-of-rh-and-abo-mediated-haemolytic-disease-of-the-newborn/ 2022-09-08T14:20:00+01:00 https://www.caf-dcf.be/litterature/association-of-maintenance-intravenous-immunoglobulin-with-prevention-of-relapse-in-adult-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease/ 2022-09-08T14:17:46+01:00 https://www.caf-dcf.be/fr/litterature/association-of-maintenance-intravenous-immunoglobulin-with-prevention-of-relapse-in-adult-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease/ 2022-09-08T14:16:51+01:00 https://www.caf-dcf.be/litterature/long-term-safety-of-facilitated-subcutaneous-immunoglobulin-treatment-in-pregnant-women-with-primary-immunodeficiency-diseases-results-from-a-registry-study/ 2022-09-08T14:15:39+01:00 https://www.caf-dcf.be/fr/litterature/long-term-safety-of-facilitated-subcutaneous-immunoglobulin-treatment-in-pregnant-women-with-primary-immunodeficiency-diseases-results-from-a-registry-study/ 2022-09-08T14:15:09+01:00 https://www.caf-dcf.be/litterature/eptacog-beta-efficacy-and-safety-in-the-treatment-and-control-of-bleeding-in-paediatric-subjects/ 2022-09-08T13:30:40+01:00 https://www.caf-dcf.be/fr/litterature/eptacog-beta-efficacy-and-safety-in-the-treatment-and-control-of-bleeding-in-paediatric-subjects/ 2022-09-08T13:30:06+01:00 https://www.caf-dcf.be/litterature/phase-1-2-trial-of-aavs3-gene-therapy-in-patients-with-hemophilia-b/ 2022-09-08T13:28:38+01:00 https://www.caf-dcf.be/fr/litterature/phase-1-2-trial-of-aavs3-gene-therapy-in-patients-with-hemophilia-b/ 2022-09-08T13:28:01+01:00 https://www.caf-dcf.be/litterature/real-world-data-on-emicizumab-prophylaxis-in-the-milan-cohort/ 2022-09-08T13:25:30+01:00 https://www.caf-dcf.be/fr/litterature/real-world-data-on-emicizumab-prophylaxis-in-the-milan-cohort/ 2022-09-08T13:24:57+01:00 https://www.caf-dcf.be/litterature/factor-xi-deficiency-about-20-cases-and-literature-review/ 2022-09-08T13:23:45+01:00 https://www.caf-dcf.be/fr/litterature/factor-xi-deficiency-about-20-cases-and-literature-review/ 2022-09-08T13:23:18+01:00 https://www.caf-dcf.be/litterature/phenotypic-and-genetic-characterizations-of-the-milan-cohort-of-von-willebrand-disease-type-2/ 2022-09-08T13:21:17+01:00 https://www.caf-dcf.be/fr/litterature/phenotypic-and-genetic-characterizations-of-the-milan-cohort-of-von-willebrand-disease-type-2/ 2022-09-08T13:20:47+01:00 https://www.caf-dcf.be/litterature/supporting-patients-with-haemophilia-in-a-world-of-crises-new-role-for-the-wfh-and-its-partners/ 2022-09-08T12:49:24+01:00 https://www.caf-dcf.be/fr/litterature/supporting-patients-with-haemophilia-in-a-world-of-crises-new-role-for-the-wfh-and-its-partners/ 2022-09-08T12:48:59+01:00 https://www.caf-dcf.be/fr/litterature/management-of-haemophilia-a-with-inhibitors-a-regional-crosstalk/ 2022-09-08T12:47:32+01:00 https://www.caf-dcf.be/litterature/management-of-haemophilia-a-with-inhibitors-a-regional-crosstalk/ 2022-09-08T12:47:12+01:00 https://www.caf-dcf.be/litterature/a-review-of-the-pharmacokinetics-efficacy-and-safety-of-high-purity-factor-x-for-the-prophylactic-treatment-of-hereditary-factor-x-deficiency/ 2022-09-08T12:44:23+01:00 https://www.caf-dcf.be/fr/litterature/a-review-of-the-pharmacokinetics-efficacy-and-safety-of-high-purity-factor-x-for-the-prophylactic-treatment-of-hereditary-factor-x-deficiency/ 2022-09-08T12:43:47+01:00 https://www.caf-dcf.be/litterature/occupational-integration-of-adults-with-severe-haemophilia-inthemo-a-study-based-on-the-francecoag-registry/ 2022-09-08T12:42:33+01:00 https://www.caf-dcf.be/fr/litterature/occupational-integration-of-adults-with-severe-haemophilia-inthemo-a-study-based-on-the-francecoag-registry/ 2022-09-08T12:41:59+01:00 https://www.caf-dcf.be/litterature/the-impact-of-recombinant-versus-plasma-derived-factor-viii-concentrates-on-inhibitor-development-in-previously-untreated-patients-with-hemophilia-a-a-2021-update-of-a-systematic-review-and-meta-anal/ 2022-09-08T12:40:17+01:00 https://www.caf-dcf.be/fr/litterature/the-impact-of-recombinant-versus-plasma-derived-factor-viii-concentrates-on-inhibitor-development-in-previously-untreated-patients-with-hemophilia-a-a-2021-update-of-a-systematic-review-and-meta-anal/ 2022-09-08T12:39:55+01:00 https://www.caf-dcf.be/litterature/factor-ix-antibodies-and-tolerance-in-hemophilia-b-in-the-nordic-countries-the-impact-of-f9-variants-and-complications/ 2022-09-08T12:38:44+01:00 https://www.caf-dcf.be/fr/litterature/factor-ix-antibodies-and-tolerance-in-hemophilia-b-in-the-nordic-countries-the-impact-of-f9-variants-and-complications/ 2022-09-08T12:38:17+01:00 https://www.caf-dcf.be/fr/litterature/sixth-aland-island-conference-on-von-willebrand-disease/ 2022-09-08T12:36:08+01:00 https://www.caf-dcf.be/litterature/seroprevalence-to-adeno-associated-virus-type-6-in-people-with-hemophilia-b-from-a-uk-adult-cohort/ 2022-09-08T12:35:38+01:00 https://www.caf-dcf.be/fr/litterature/seroprevalence-to-adeno-associated-virus-type-6-in-people-with-hemophilia-b-from-a-uk-adult-cohort/ 2022-09-08T12:35:12+01:00 https://www.caf-dcf.be/litterature/sixth-aland-island-conference-on-von-willebrand-disease/ 2022-09-08T12:33:48+01:00 https://www.caf-dcf.be/litterature/immunoglobulin-shortage-practice-modifications-and-clinical-outcomes-in-a-reference-centre/ 2022-09-08T12:30:45+01:00 https://www.caf-dcf.be/fr/litterature/immunoglobulin-shortage-practice-modifications-and-clinical-outcomes-in-a-reference-centre/ 2022-09-08T12:30:04+01:00 https://www.caf-dcf.be/litterature/role-of-fc-core-fucosylation-in-the-effector-function-of-igg1-antibodies/ 2022-09-08T12:28:35+01:00 https://www.caf-dcf.be/fr/litterature/role-of-fc-core-fucosylation-in-the-effector-function-of-igg1-antibodies/ 2022-09-08T12:27:53+01:00 https://www.caf-dcf.be/litterature/advances-in-fibrin-based-materials-in-wound-repair-a-review/ 2022-09-08T11:03:31+01:00 https://www.caf-dcf.be/fr/litterature/advances-in-fibrin-based-materials-in-wound-repair-a-review/ 2022-09-08T11:02:08+01:00 https://www.caf-dcf.be/fr/litterature/managing-severe-hemophilia-a-in-children-pharmacotherapeutic-options/ 2022-04-08T10:04:01+01:00 https://www.caf-dcf.be/litterature/managing-severe-hemophilia-a-in-children-pharmacotherapeutic-options/ 2022-04-08T10:03:30+01:00 https://www.caf-dcf.be/fr/litterature/immunoglobulin-replacement-therapy-in-chronic-lymphocytic-leukaemia-patients-with-hypogammaglobulinaemia-and-infection/ 2022-04-08T10:00:53+01:00 https://www.caf-dcf.be/litterature/immunoglobulin-replacement-therapy-in-chronic-lymphocytic-leukaemia-patients-with-hypogammaglobulinaemia-and-infection/ 2022-04-08T10:00:25+01:00 https://www.caf-dcf.be/fr/litterature/subcutaneous-immunoglobulin-use-in-immunoglobulin-naive-patients-with-primary-immunodeficiency-a-systematic-review/ 2022-04-08T09:58:53+01:00 https://www.caf-dcf.be/litterature/subcutaneous-immunoglobulin-use-in-immunoglobulin-naive-patients-with-primary-immunodeficiency-a-systematic-review/ 2022-04-08T09:58:28+01:00 https://www.caf-dcf.be/fr/litterature/withdrawal-of-intravenous-immunoglobulin-in-chronic-inflammatory-demyelinating-polyradiculoneuropathy/ 2022-04-08T09:56:40+01:00 https://www.caf-dcf.be/litterature/withdrawal-of-intravenous-immunoglobulin-in-chronic-inflammatory-demyelinating-polyradiculoneuropathy/ 2022-04-08T09:56:15+01:00 https://www.caf-dcf.be/fr/litterature/real-life-experiences-with-goal-directed-prohemostatic-therapy-with-fibrinogen-concentrate-prothrombin-complex-concentrate-and-recombinant-factor-viia-a-retrospective-study-of-287-consecutive-patie/ 2022-04-08T09:53:54+01:00 https://www.caf-dcf.be/litterature/real-life-experiences-with-goal-directed-prohemostatic-therapy-with-fibrinogen-concentrate-prothrombin-complex-concentrate-and-recombinant-factor-viia-a-retrospective-study-of-287-consecutive-patie/ 2022-04-08T09:53:26+01:00 https://www.caf-dcf.be/fr/litterature/optimizing-fresh-frozen-plasma-transfusion-in-surgical-neonates-through-thromboelastography-a-quality-improvement-study/ 2022-04-08T09:51:37+01:00 https://www.caf-dcf.be/litterature/optimizing-fresh-frozen-plasma-transfusion-in-surgical-neonates-through-thromboelastography-a-quality-improvement-study/ 2022-04-08T09:51:09+01:00 https://www.caf-dcf.be/fr/litterature/early-cryoprecipitate-transfusion-versus-standard-care-in-severe-postpartum-haemorrhage-a-pilot-cluster-randomized-trial/ 2022-04-08T09:46:34+01:00 https://www.caf-dcf.be/litterature/early-cryoprecipitate-transfusion-versus-standard-care-in-severe-postpartum-haemorrhage-a-pilot-cluster-randomized-trial/ 2022-04-08T09:45:24+01:00 https://www.caf-dcf.be/fr/litterature/heterogeneity-of-genotype-phenotype-in-congenital-hypofibrinogenemia-a-review-of-case-reports-associated-with-bleeding-and-thrombosis/ 2022-04-08T09:43:14+01:00 https://www.caf-dcf.be/litterature/heterogeneity-of-genotype-phenotype-in-congenital-hypofibrinogenemia-a-review-of-case-reports-associated-with-bleeding-and-thrombosis/ 2022-04-08T09:42:43+01:00 https://www.caf-dcf.be/fr/litterature/postoperative-bleeding-complications-in-patients-with-hemophilia-undergoing-major-orthopedic-surgery-a-prospective-multicenter-observational-study/ 2022-04-08T09:38:57+01:00 https://www.caf-dcf.be/litterature/postoperative-bleeding-complications-in-patients-with-hemophilia-undergoing-major-orthopedic-surgery-a-prospective-multicenter-observational-study/ 2022-04-08T09:38:33+01:00 https://www.caf-dcf.be/fr/litterature/rotational-thromboelastometry-in-children-presenting-to-an-australian-major-trauma-centre-a-retrospective-cohort-study/ 2022-04-08T09:35:37+01:00 https://www.caf-dcf.be/litterature/rotational-thromboelastometry-in-children-presenting-to-an-australian-major-trauma-centre-a-retrospective-cohort-study/ 2022-04-08T09:35:07+01:00 https://www.caf-dcf.be/fr/litterature/type-2b-von-willebrand-disease-in-pregnancy-a-systematic-literature-review/ 2022-03-07T11:50:45+01:00 https://www.caf-dcf.be/litterature/type-2b-von-willebrand-disease-in-pregnancy-a-systematic-literature-review/ 2022-03-07T11:50:23+01:00 https://www.caf-dcf.be/fr/litterature/hemophilia-a-review-of-perioperative-management-for-cardiac-surgery/ 2022-03-07T11:48:39+01:00 https://www.caf-dcf.be/litterature/hemophilia-a-review-of-perioperative-management-for-cardiac-surgery/ 2022-03-07T11:48:15+01:00 https://www.caf-dcf.be/fr/litterature/report-of-surgeries-their-outcome-and-the-thrombin-generation-assay-in-patients-with-factor-xi-deficiency-a-retrospective-single-centre-study/ 2022-03-07T11:29:43+01:00 https://www.caf-dcf.be/litterature/report-of-surgeries-their-outcome-and-the-thrombin-generation-assay-in-patients-with-factor-xi-deficiency-a-retrospective-single-centre-study/ 2022-03-07T11:29:19+01:00 https://www.caf-dcf.be/fr/litterature/practical-aspects-of-transitioning-from-intravenous-to-subcutaneous-immunoglobulin-therapy-in-neuromuscular-disorders/ 2022-03-07T11:27:39+01:00 https://www.caf-dcf.be/litterature/practical-aspects-of-transitioning-from-intravenous-to-subcutaneous-immunoglobulin-therapy-in-neuromuscular-disorders/ 2022-03-07T11:27:17+01:00 https://www.caf-dcf.be/fr/litterature/mutations-accounting-for-congenital-fibrinogen-disorders-an-update/ 2022-03-07T11:24:06+01:00 https://www.caf-dcf.be/litterature/mutations-accounting-for-congenital-fibrinogen-disorders-an-update/ 2022-03-07T11:21:17+01:00 https://www.caf-dcf.be/fr/litterature/impact-of-fibrinogen-infusion-on-thrombin-generation-and-fibrin-clot-structure-in-patients-with-inherited-afibrinogenemia/ 2022-03-07T11:19:04+01:00 https://www.caf-dcf.be/litterature/impact-of-fibrinogen-infusion-on-thrombin-generation-and-fibrin-clot-structure-in-patients-with-inherited-afibrinogenemia/ 2022-03-07T11:17:43+01:00 https://www.caf-dcf.be/fr/litterature/in-vitro-comparison-of-recombinant-and-plasma-derived-von-willebrand-factor-concentrate-for-treatment-of-acquired-von-willebrand-syndrome-in-adult-extracorporeal-membrane-oxygenation-patients/ 2022-03-04T12:09:05+01:00 https://www.caf-dcf.be/litterature/in-vitro-comparison-of-recombinant-and-plasma-derived-von-willebrand-factor-concentrate-for-treatment-of-acquired-von-willebrand-syndrome-in-adult-extracorporeal-membrane-oxygenation-patients/ 2022-03-04T12:08:47+01:00 https://www.caf-dcf.be/fr/litterature/the-2021-von-willebrand-disease-guidelines-clarity-and-controversy/ 2022-03-04T12:07:05+01:00 https://www.caf-dcf.be/litterature/the-2021-von-willebrand-disease-guidelines-clarity-and-controversy/ 2022-03-04T12:06:44+01:00 https://www.caf-dcf.be/fr/litterature/type-2b-von-willebrand-disease-early-manifestation-as-neonatal-thrombocytopenia/ 2022-03-04T12:04:46+01:00 https://www.caf-dcf.be/litterature/type-2b-von-willebrand-disease-early-manifestation-as-neonatal-thrombocytopenia/ 2022-03-04T12:04:21+01:00 https://www.caf-dcf.be/fr/litterature/bone-mineral-density-in-haemophilia-a-multicenter-study-evaluating-the-impact-of-different-replacement-regimens/ 2022-03-04T12:02:58+01:00 https://www.caf-dcf.be/litterature/bone-mineral-density-in-haemophilia-a-multicenter-study-evaluating-the-impact-of-different-replacement-regimens/ 2022-03-04T12:02:37+01:00 https://www.caf-dcf.be/fr/litterature/real-world-rates-of-bleeding-factor-viii-use-and-quality-of-life-in-individuals-with-severe-haemophilia-a-receiving-prophylaxis-in-a-prospective-noninterventional-study/ 2022-03-04T12:01:17+01:00 https://www.caf-dcf.be/litterature/real-world-rates-of-bleeding-factor-viii-use-and-quality-of-life-in-individuals-with-severe-haemophilia-a-receiving-prophylaxis-in-a-prospective-noninterventional-study/ 2022-03-04T12:00:56+01:00 https://www.caf-dcf.be/fr/litterature/fviii-at-the-crossroad-of-coagulation-bone-and-immune-biology-emerging-evidence-of-biological-activities-beyond-hemostasis/ 2022-03-04T11:59:06+01:00 https://www.caf-dcf.be/litterature/fviii-at-the-crossroad-of-coagulation-bone-and-immune-biology-emerging-evidence-of-biological-activities-beyond-hemostasis/ 2022-03-04T11:58:48+01:00 https://www.caf-dcf.be/fr/litterature/haemophilia-in-france-modulization-of-the-clinical-pathway-for-patients/ 2022-03-04T11:57:22+01:00 https://www.caf-dcf.be/litterature/haemophilia-in-france-modulization-of-the-clinical-pathway-for-patients/ 2022-03-04T11:56:58+01:00 https://www.caf-dcf.be/fr/litterature/tailored-prophylaxis-in-children-with-severe-hemophilia-a-four-year-iranian-study/ 2022-03-04T11:55:21+01:00 https://www.caf-dcf.be/litterature/tailored-prophylaxis-in-children-with-severe-hemophilia-a-four-year-iranian-study/ 2022-03-04T11:55:02+01:00 https://www.caf-dcf.be/fr/litterature/intravenous-immunoglobulin-for-inflammatory-demyelinating-polyneuropathy/ 2022-03-04T11:53:12+01:00 https://www.caf-dcf.be/litterature/intravenous-immunoglobulin-for-inflammatory-demyelinating-polyneuropathy/ 2022-03-04T11:52:51+01:00 https://www.caf-dcf.be/litterature/frequency-and-clinical-correlates-of-anti-nerve-antibodies-in-a-large-population-of-cidp-patients-included-in-the-italian-database/ 2022-03-04T11:16:59+01:00 https://www.caf-dcf.be/fr/litterature/overview-of-subcutaneous-immunoglobulin-16-5-in-primary-and-secondary-immunodeficiency-diseases/ 2022-03-04T10:06:46+01:00 https://www.caf-dcf.be/litterature/overview-of-subcutaneous-immunoglobulin-16-5-in-primary-and-secondary-immunodeficiency-diseases/ 2022-03-04T10:06:23+01:00 https://www.caf-dcf.be/fr/litterature/immunoglobulin-for-multifocal-motor-neuropathy/ 2022-03-04T10:04:27+01:00 https://www.caf-dcf.be/litterature/immunoglobulin-for-multifocal-motor-neuropathy/ 2022-03-04T10:03:58+01:00 https://www.caf-dcf.be/fr/litterature/evans-syndrome-in-adults-an-observational-multicenter-study/ 2022-03-04T10:02:14+01:00